Gene Symbol | Gene ID | Gene Info |
---|---|---|
Esr2
|
ENSMUSG00000021055.7 | estrogen receptor 2 (beta) |
CRE | Gene | Distance | Association probability | Pearson corr. coef. | P-value | Plot |
---|---|---|---|---|---|---|
chr12_76176631_76177780 | Esr2 | 54 | 0.971116 | -0.16 | 2.3e-01 | Click! |
chr12_76177899_76178129 | Esr2 | 755 | 0.618547 | 0.12 | 3.8e-01 | Click! |
chr12_76195965_76197092 | Esr2 | 19269 | 0.134996 | 0.10 | 4.4e-01 | Click! |
Move your cursor over a bar to see sample name and corresponding Z-value.
Cis Regulatory Element (CRE) | Target Score | Top associated gene | Gene Info | Distance of CRE to TSS | CRE/Gene association probability |
---|---|---|---|---|---|
chr16_21908261_21909020 | 32.02 |
Gm6467 |
predicted gene 6467 |
12134 |
0.14 |
chr2_9882196_9886301 | 20.93 |
9230102O04Rik |
RIKEN cDNA 9230102O04 gene |
255 |
0.84 |
chr17_85686512_85689764 | 18.06 |
Six2 |
sine oculis-related homeobox 2 |
116 |
0.96 |
chr11_69399334_69402458 | 16.81 |
Kdm6bos |
KDM1 lysine (K)-specific demethylase 6B, opposite strand |
617 |
0.47 |
chrX_170677021_170677569 | 15.26 |
Asmt |
acetylserotonin O-methyltransferase |
4651 |
0.33 |
chr5_37826544_37829286 | 14.24 |
Msx1 |
msh homeobox 1 |
3332 |
0.25 |
chr8_121088119_121090419 | 13.61 |
Gm27530 |
predicted gene, 27530 |
4563 |
0.13 |
chr8_57326741_57329467 | 13.60 |
Hand2os1 |
Hand2, opposite strand 1 |
3871 |
0.15 |
chr1_163308490_163310681 | 13.48 |
Gm37644 |
predicted gene, 37644 |
518 |
0.77 |
chr11_32296600_32297646 | 13.14 |
Hba-a2 |
hemoglobin alpha, adult chain 2 |
495 |
0.66 |
chr1_136945385_136947968 | 12.82 |
Nr5a2 |
nuclear receptor subfamily 5, group A, member 2 |
2497 |
0.34 |
chrX_170676003_170677019 | 12.76 |
Asmt |
acetylserotonin O-methyltransferase |
3867 |
0.35 |
chr3_96332970_96334964 | 12.59 |
Gm24830 |
predicted gene, 24830 |
5542 |
0.07 |
chr2_146834060_146838027 | 12.33 |
Gm14114 |
predicted gene 14114 |
3689 |
0.27 |
chr6_52202371_52204739 | 12.21 |
Hoxa5 |
homeobox A5 |
1032 |
0.2 |
chr11_60779729_60782712 | 12.04 |
Smcr8 |
Smith-Magenis syndrome chromosome region, candidate 8 homolog (human) |
3695 |
0.1 |
chr11_32283784_32284776 | 11.97 |
Hba-a1 |
hemoglobin alpha, adult chain 1 |
469 |
0.66 |
chr5_75148315_75152589 | 11.89 |
Pdgfra |
platelet derived growth factor receptor, alpha polypeptide |
1840 |
0.2 |
chr16_95456632_95459094 | 11.81 |
Erg |
ETS transcription factor |
1382 |
0.55 |
chr7_142576289_142578620 | 11.75 |
H19 |
H19, imprinted maternally expressed transcript |
68 |
0.78 |
chr5_119685576_119687800 | 11.73 |
Tbx3os2 |
T-box 3, opposite strand 2 |
4530 |
0.17 |
chr8_57320946_57324000 | 11.68 |
Hand2os1 |
Hand2, opposite strand 1 |
1245 |
0.3 |
chr3_66977838_66980287 | 11.58 |
Shox2 |
short stature homeobox 2 |
251 |
0.9 |
chr11_96347886_96350398 | 11.39 |
Hoxb3os |
homeobox B3 and homeobox B2, opposite strand |
1219 |
0.21 |
chrX_150547515_150548479 | 11.36 |
Alas2 |
aminolevulinic acid synthase 2, erythroid |
538 |
0.44 |
chr14_63244119_63245953 | 11.19 |
Gata4 |
GATA binding protein 4 |
212 |
0.93 |
chr11_102145120_102148094 | 11.07 |
Nags |
N-acetylglutamate synthase |
241 |
0.58 |
chr7_142662290_142664788 | 10.99 |
Igf2os |
insulin-like growth factor 2, opposite strand |
1599 |
0.21 |
chr10_107483887_107486076 | 10.89 |
Myf5 |
myogenic factor 5 |
1153 |
0.46 |
chr11_102360845_102363484 | 10.87 |
Slc4a1 |
solute carrier family 4 (anion exchanger), member 1 |
1540 |
0.24 |
chr2_105125289_105128976 | 10.73 |
Wt1 |
Wilms tumor 1 homolog |
78 |
0.91 |
chr8_89041062_89042862 | 10.48 |
Sall1 |
spalt like transcription factor 1 |
2200 |
0.35 |
chr6_86078066_86079298 | 10.44 |
Add2 |
adducin 2 (beta) |
598 |
0.65 |
chr11_88235318_88236217 | 10.23 |
Gm38534 |
predicted gene, 38534 |
17601 |
0.15 |
chr11_102364387_102365146 | 10.14 |
Slc4a1 |
solute carrier family 4 (anion exchanger), member 1 |
481 |
0.67 |
chr5_37818003_37820431 | 9.97 |
Msx1 |
msh homeobox 1 |
5365 |
0.21 |
chr8_57319308_57320679 | 9.93 |
Hand2os1 |
Hand2, opposite strand 1 |
63 |
0.94 |
chr6_83068298_83071797 | 9.82 |
Tlx2 |
T cell leukemia, homeobox 2 |
178 |
0.81 |
chr13_23497689_23499269 | 9.81 |
Btn2a2 |
butyrophilin, subfamily 2, member A2 |
9622 |
0.06 |
chr13_63557270_63560459 | 9.57 |
Ptch1 |
patched 1 |
4951 |
0.16 |
chr2_115858978_115861125 | 9.46 |
Meis2 |
Meis homeobox 2 |
8816 |
0.31 |
chr8_70111696_70113061 | 8.99 |
Ncan |
neurocan |
8495 |
0.08 |
chr5_113279864_113280669 | 8.97 |
Sgsm1 |
small G protein signaling modulator 1 |
321 |
0.85 |
chr8_70329770_70331438 | 8.95 |
Gdf1 |
growth differentiation factor 1 |
787 |
0.45 |
chr19_45230983_45235468 | 8.87 |
Lbx1 |
ladybird homeobox 1 |
2587 |
0.27 |
chr11_96343236_96346574 | 8.85 |
Hoxb3 |
homeobox B3 |
1136 |
0.24 |
chr4_41272272_41273407 | 8.80 |
Ubap2 |
ubiquitin-associated protein 2 |
2277 |
0.18 |
chr5_120138122_120139268 | 8.79 |
Gm10390 |
predicted gene 10390 |
566 |
0.77 |
chr4_154635108_154637998 | 8.70 |
Prdm16 |
PR domain containing 16 |
244 |
0.83 |
chr11_99043636_99045890 | 8.69 |
Igfbp4 |
insulin-like growth factor binding protein 4 |
3 |
0.96 |
chr2_93644408_93646515 | 8.67 |
Alx4 |
aristaless-like homeobox 4 |
3073 |
0.32 |
chr7_113295089_113296008 | 8.59 |
Gm45355 |
predicted gene 45355 |
211 |
0.93 |
chr5_137485098_137486372 | 8.54 |
Epo |
erythropoietin |
81 |
0.93 |
chr12_73044500_73046647 | 8.52 |
Six1 |
sine oculis-related homeobox 1 |
282 |
0.92 |
chr8_120292266_120293650 | 8.51 |
Gse1 |
genetic suppressor element 1, coiled-coil protein |
64502 |
0.09 |
chr9_41326803_41329121 | 8.49 |
Mir100hg |
Mir100 Mirlet7a-2 Mir125b-1 cluster host gene |
676 |
0.69 |
chr6_5390098_5391379 | 8.48 |
Asb4 |
ankyrin repeat and SOCS box-containing 4 |
311 |
0.93 |
chr9_74865733_74868961 | 8.45 |
Onecut1 |
one cut domain, family member 1 |
863 |
0.54 |
chr13_3891572_3893506 | 8.43 |
Net1 |
neuroepithelial cell transforming gene 1 |
894 |
0.46 |
chr11_117779316_117780928 | 8.42 |
Tmc6 |
transmembrane channel-like gene family 6 |
472 |
0.61 |
chr3_127123282_127124895 | 8.40 |
Ank2 |
ankyrin 2, brain |
774 |
0.59 |
chr1_89991921_89993000 | 8.39 |
Asb18 |
ankyrin repeat and SOCS box-containing 18 |
3992 |
0.25 |
chr7_133114831_133116529 | 8.39 |
Ctbp2 |
C-terminal binding protein 2 |
2981 |
0.2 |
chr11_18873955_18876215 | 8.37 |
8430419K02Rik |
RIKEN cDNA 8430419K02 gene |
776 |
0.61 |
chr11_100713347_100714725 | 8.36 |
Hspb9 |
heat shock protein, alpha-crystallin-related, B9 |
114 |
0.91 |
chr7_139020697_139021233 | 8.25 |
Gm45613 |
predicted gene 45613 |
34 |
0.98 |
chr5_139540206_139542054 | 8.14 |
Uncx |
UNC homeobox |
2364 |
0.26 |
chr4_44711553_44714511 | 8.13 |
Pax5 |
paired box 5 |
2545 |
0.22 |
chr10_69925300_69927130 | 8.09 |
Ank3 |
ankyrin 3, epithelial |
82 |
0.99 |
chr2_74725879_74728683 | 8.07 |
Hoxd4 |
homeobox D4 |
207 |
0.67 |
chr16_18429039_18430122 | 8.05 |
Txnrd2 |
thioredoxin reductase 2 |
655 |
0.54 |
chr11_21992790_21995427 | 7.93 |
Otx1 |
orthodenticle homeobox 1 |
7507 |
0.25 |
chr18_37742006_37744626 | 7.92 |
Pcdhgb6 |
protocadherin gamma subfamily B, 6 |
1222 |
0.15 |
chr5_74064229_74066220 | 7.92 |
Usp46 |
ubiquitin specific peptidase 46 |
524 |
0.65 |
chr11_85889787_85891444 | 7.88 |
Tbx4 |
T-box 4 |
552 |
0.75 |
chr5_64810297_64813272 | 7.88 |
Klf3 |
Kruppel-like factor 3 (basic) |
555 |
0.71 |
chr18_11047852_11049020 | 7.88 |
Gata6os |
GATA binding protein 6, opposite strand |
799 |
0.66 |
chr6_49210050_49211632 | 7.83 |
Igf2bp3 |
insulin-like growth factor 2 mRNA binding protein 3 |
3320 |
0.2 |
chr5_119669544_119672401 | 7.81 |
Tbx3 |
T-box 3 |
46 |
0.85 |
chr12_9573836_9576858 | 7.81 |
Osr1 |
odd-skipped related transcription factor 1 |
906 |
0.56 |
chr19_5842574_5845856 | 7.78 |
Neat1 |
nuclear paraspeckle assembly transcript 1 (non-protein coding) |
1044 |
0.25 |
chr11_83850990_83852424 | 7.73 |
Hnf1b |
HNF1 homeobox B |
535 |
0.69 |
chr11_85836730_85838643 | 7.72 |
Tbx2 |
T-box 2 |
5135 |
0.14 |
chr3_99248252_99249856 | 7.71 |
Tbx15 |
T-box 15 |
4706 |
0.18 |
chr18_37720288_37722950 | 7.69 |
Pcdhgb4 |
protocadherin gamma subfamily B, 4 |
1236 |
0.14 |
chr2_180333754_180334993 | 7.52 |
Gata5 |
GATA binding protein 5 |
326 |
0.8 |
chr17_46444584_46445824 | 7.50 |
Gm5093 |
predicted gene 5093 |
5107 |
0.11 |
chr5_113799288_113800716 | 7.45 |
Tmem119 |
transmembrane protein 119 |
444 |
0.69 |
chr10_80018650_80020555 | 7.45 |
Arhgap45 |
Rho GTPase activating protein 45 |
51 |
0.93 |
chr8_23035959_23037041 | 7.44 |
Ank1 |
ankyrin 1, erythroid |
1269 |
0.45 |
chr8_121116214_121118487 | 7.44 |
Foxc2 |
forkhead box C2 |
1179 |
0.35 |
chr6_52224853_52226609 | 7.42 |
Hoxa9 |
homeobox A9 |
458 |
0.51 |
chr10_81406559_81408241 | 7.41 |
Nfic |
nuclear factor I/C |
241 |
0.76 |
chr14_67236008_67239452 | 7.40 |
Ebf2 |
early B cell factor 2 |
3086 |
0.21 |
chrX_143825863_143827628 | 7.37 |
Capn6 |
calpain 6 |
587 |
0.46 |
chr9_44340460_44342952 | 7.34 |
Hmbs |
hydroxymethylbilane synthase |
473 |
0.51 |
chr2_33639069_33641423 | 7.33 |
Lmx1b |
LIM homeobox transcription factor 1 beta |
234 |
0.85 |
chr1_170109295_170110836 | 7.28 |
Ddr2 |
discoidin domain receptor family, member 2 |
436 |
0.82 |
chr14_54478925_54480187 | 7.27 |
Rem2 |
rad and gem related GTP binding protein 2 |
2085 |
0.15 |
chr18_32557788_32558922 | 7.26 |
Gypc |
glycophorin C |
1625 |
0.41 |
chr11_97434598_97436859 | 7.23 |
Arhgap23 |
Rho GTPase activating protein 23 |
557 |
0.73 |
chr2_28619027_28619457 | 7.22 |
Gfi1b |
growth factor independent 1B |
2703 |
0.16 |
chr19_10015065_10016667 | 7.19 |
Rab3il1 |
RAB3A interacting protein (rabin3)-like 1 |
822 |
0.48 |
chr16_95584975_95586861 | 7.17 |
Erg |
ETS transcription factor |
675 |
0.79 |
chr13_55827549_55829422 | 7.16 |
Gm47071 |
predicted gene, 47071 |
2235 |
0.21 |
chr1_120269879_120270612 | 7.15 |
Steap3 |
STEAP family member 3 |
178 |
0.96 |
chr7_128243696_128244105 | 7.13 |
Tgfb1i1 |
transforming growth factor beta 1 induced transcript 1 |
2912 |
0.11 |
chr10_79881578_79883095 | 7.12 |
Prtn3 |
proteinase 3 |
553 |
0.43 |
chr12_9578132_9580204 | 7.10 |
Osr1 |
odd-skipped related transcription factor 1 |
4727 |
0.2 |
chr15_103253562_103255772 | 7.09 |
Nfe2 |
nuclear factor, erythroid derived 2 |
605 |
0.57 |
chr11_85838795_85841602 | 7.07 |
Tbx2 |
T-box 2 |
7647 |
0.13 |
chr13_51410301_51411730 | 7.06 |
S1pr3 |
sphingosine-1-phosphate receptor 3 |
2376 |
0.29 |
chr11_85829139_85831432 | 7.03 |
2610027K06Rik |
RIKEN cDNA 2610027K06 gene |
1924 |
0.21 |
chr9_55543267_55546069 | 7.01 |
Isl2 |
insulin related protein 2 (islet 2) |
2332 |
0.22 |
chr5_75152837_75154692 | 7.01 |
Gm42802 |
predicted gene 42802 |
111 |
0.58 |
chr5_119668607_119669219 | 6.99 |
Tbx3 |
T-box 3 |
1756 |
0.26 |
chr14_52022583_52023784 | 6.98 |
Gm49256 |
predicted gene, 49256 |
101 |
0.91 |
chr4_106804374_106805428 | 6.98 |
Acot11 |
acyl-CoA thioesterase 11 |
97 |
0.96 |
chr8_121118797_121121438 | 6.98 |
Foxc2 |
forkhead box C2 |
3946 |
0.14 |
chr2_147083670_147085642 | 6.93 |
Nkx2-4 |
NK2 homeobox 4 |
789 |
0.65 |
chr3_87949543_87950464 | 6.92 |
Crabp2 |
cellular retinoic acid binding protein II |
1337 |
0.25 |
chr11_82930766_82933172 | 6.90 |
Unc45bos |
unc-45 myosin chaperone B, opposite strand |
1413 |
0.19 |
chr7_44350602_44354420 | 6.90 |
Shank1 |
SH3 and multiple ankyrin repeat domains 1 |
1749 |
0.15 |
chr3_34662808_34665047 | 6.88 |
Gm42693 |
predicted gene 42693 |
362 |
0.74 |
chr10_22843057_22844289 | 6.84 |
Tcf21 |
transcription factor 21 |
23499 |
0.16 |
chr5_147304305_147307985 | 6.82 |
Cdx2 |
caudal type homeobox 2 |
1125 |
0.33 |
chr16_85549016_85550538 | 6.81 |
Cyyr1 |
cysteine and tyrosine-rich protein 1 |
640 |
0.75 |
chr2_127369985_127371247 | 6.79 |
Adra2b |
adrenergic receptor, alpha 2b |
7330 |
0.15 |
chr1_13125031_13126972 | 6.76 |
Prdm14 |
PR domain containing 14 |
1162 |
0.44 |
chrX_12151122_12152833 | 6.76 |
Bcor |
BCL6 interacting corepressor |
8369 |
0.25 |
chr10_25458395_25459149 | 6.76 |
Epb41l2 |
erythrocyte membrane protein band 4.1 like 2 |
8201 |
0.21 |
chr16_92695033_92696333 | 6.76 |
Runx1 |
runt related transcription factor 1 |
188 |
0.96 |
chr11_101892225_101894406 | 6.75 |
Meox1 |
mesenchyme homeobox 1 |
1059 |
0.4 |
chr11_88193021_88194051 | 6.73 |
Cuedc1 |
CUE domain containing 1 |
5715 |
0.18 |
chr2_25577192_25580600 | 6.73 |
Ajm1 |
apical junction component 1 |
1001 |
0.25 |
chr8_122546551_122549259 | 6.66 |
Piezo1 |
piezo-type mechanosensitive ion channel component 1 |
3424 |
0.12 |
chr12_33966605_33968831 | 6.66 |
Twist1 |
twist basic helix-loop-helix transcription factor 1 |
10047 |
0.22 |
chr12_117657998_117660727 | 6.65 |
Rapgef5 |
Rap guanine nucleotide exchange factor (GEF) 5 |
1328 |
0.51 |
chr11_45854563_45855051 | 6.65 |
Clint1 |
clathrin interactor 1 |
2843 |
0.21 |
chr11_87756102_87757558 | 6.64 |
Mir142 |
microRNA 142 |
34 |
0.59 |
chr8_84600431_84601997 | 6.64 |
Cacna1a |
calcium channel, voltage-dependent, P/Q type, alpha 1A subunit |
217 |
0.91 |
chr8_89036575_89038609 | 6.63 |
Sall1 |
spalt like transcription factor 1 |
6570 |
0.23 |
chr11_115830833_115832158 | 6.62 |
Llgl2 |
LLGL2 scribble cell polarity complex component |
473 |
0.66 |
chr10_19351991_19353468 | 6.59 |
Olig3 |
oligodendrocyte transcription factor 3 |
3804 |
0.28 |
chr4_129030423_129030574 | 6.57 |
1700086P04Rik |
RIKEN cDNA 1700086P04 gene |
27485 |
0.11 |
chr4_141617213_141618510 | 6.56 |
Tmem82 |
transmembrane protein 82 |
120 |
0.93 |
chr12_72944998_72946304 | 6.54 |
Gm26709 |
predicted gene, 26709 |
156 |
0.94 |
chr11_85833878_85836704 | 6.53 |
Tbx2 |
T-box 2 |
2740 |
0.17 |
chr1_78193153_78194695 | 6.53 |
Pax3 |
paired box 3 |
2914 |
0.3 |
chr12_86891509_86893562 | 6.52 |
Irf2bpl |
interferon regulatory factor 2 binding protein-like |
7737 |
0.19 |
chr3_88364024_88365387 | 6.52 |
Paqr6 |
progestin and adipoQ receptor family member VI |
112 |
0.89 |
chr17_29321890_29323144 | 6.51 |
Gm46603 |
predicted gene, 46603 |
32 |
0.95 |
chr7_18949615_18951696 | 6.50 |
Nova2 |
NOVA alternative splicing regulator 2 |
24767 |
0.07 |
chr13_25083128_25083551 | 6.50 |
Dcdc2a |
doublecortin domain containing 2a |
13008 |
0.18 |
chr13_23505562_23506916 | 6.49 |
n-TStga1 |
nuclear encoded tRNA serine 1 (anticodon TGA) |
11903 |
0.05 |
chr4_132075821_132077656 | 6.46 |
Epb41 |
erythrocyte membrane protein band 4.1 |
1417 |
0.25 |
chr5_114175498_114176701 | 6.46 |
Acacb |
acetyl-Coenzyme A carboxylase beta |
193 |
0.92 |
chr17_48096260_48098177 | 6.45 |
Gm49946 |
predicted gene, 49946 |
4439 |
0.13 |
chr19_5966735_5967267 | 6.45 |
Pola2 |
polymerase (DNA directed), alpha 2 |
2799 |
0.11 |
chr4_114901229_114903111 | 6.45 |
9130410C08Rik |
RIKEN cDNA 9130410C08 gene |
689 |
0.59 |
chr3_97823312_97824263 | 6.44 |
Pde4dip |
phosphodiesterase 4D interacting protein (myomegalin) |
834 |
0.65 |
chr6_23247289_23250418 | 6.42 |
Fezf1 |
Fez family zinc finger 1 |
491 |
0.76 |
chr17_78586604_78587654 | 6.40 |
Vit |
vitrin |
13184 |
0.2 |
chr6_52309839_52312950 | 6.35 |
Evx1 |
even-skipped homeobox 1 |
2104 |
0.14 |
chr8_120294780_120295786 | 6.34 |
Gse1 |
genetic suppressor element 1, coiled-coil protein |
66827 |
0.09 |
chr4_46040988_46042013 | 6.32 |
Tmod1 |
tropomodulin 1 |
2291 |
0.3 |
chr19_37686376_37687814 | 6.30 |
Cyp26c1 |
cytochrome P450, family 26, subfamily c, polypeptide 1 |
1514 |
0.39 |
chr16_38131502_38132552 | 6.29 |
Gsk3b |
glycogen synthase kinase 3 beta |
11304 |
0.19 |
chr6_136660962_136662291 | 6.27 |
Plbd1 |
phospholipase B domain containing 1 |
247 |
0.91 |
chr6_54272742_54273928 | 6.27 |
Chn2 |
chimerin 2 |
427 |
0.82 |
chr17_29493756_29495031 | 6.26 |
Pim1 |
proviral integration site 1 |
986 |
0.37 |
chr4_139832357_139834219 | 6.25 |
Pax7 |
paired box 7 |
240 |
0.94 |
chr2_166030364_166031781 | 6.25 |
Ncoa3 |
nuclear receptor coactivator 3 |
16846 |
0.15 |
chr5_119680221_119681643 | 6.23 |
Tbx3 |
T-box 3 |
683 |
0.62 |
chr13_38151091_38152938 | 6.23 |
Gm10129 |
predicted gene 10129 |
222 |
0.82 |
chr4_137480489_137481233 | 6.22 |
Hspg2 |
perlecan (heparan sulfate proteoglycan 2) |
12058 |
0.13 |
chr18_75384437_75388058 | 6.22 |
Smad7 |
SMAD family member 7 |
11333 |
0.21 |
chr5_139550965_139553757 | 6.22 |
Uncx |
UNC homeobox |
8463 |
0.18 |
chr18_64331856_64333830 | 6.19 |
St8sia3os |
ST8 alpha-N-acetyl-neuraminide alpha-2,8-sialyltransferase 3, opposite strand |
863 |
0.56 |
chr13_42300942_42302770 | 6.14 |
Edn1 |
endothelin 1 |
380 |
0.88 |
chr18_75374458_75376171 | 6.14 |
Smad7 |
SMAD family member 7 |
400 |
0.87 |
chr2_74734325_74737080 | 6.13 |
Hoxd3 |
homeobox D3 |
813 |
0.31 |
chr10_79735202_79736152 | 6.12 |
Polrmt |
polymerase (RNA) mitochondrial (DNA directed) |
1091 |
0.26 |
chr13_63273798_63275383 | 6.10 |
Gm47585 |
predicted gene, 47585 |
990 |
0.28 |
chr8_120228360_120231502 | 6.09 |
Gse1 |
genetic suppressor element 1, coiled-coil protein |
1475 |
0.32 |
chr3_30009457_30010152 | 6.09 |
Mecom |
MDS1 and EVI1 complex locus |
1635 |
0.36 |
chr3_95673620_95674691 | 6.09 |
Adamtsl4 |
ADAMTS-like 4 |
2996 |
0.14 |
chr16_94327751_94329689 | 6.07 |
Ripply3 |
ripply transcriptional repressor 3 |
300 |
0.86 |
chr2_172549301_172551909 | 6.04 |
Tfap2c |
transcription factor AP-2, gamma |
48 |
0.98 |
chr11_96202439_96204563 | 6.01 |
Hoxb13 |
homeobox B13 |
9185 |
0.1 |
chr7_133700764_133701966 | 5.98 |
Uros |
uroporphyrinogen III synthase |
1173 |
0.35 |
chr2_30779402_30779935 | 5.98 |
1700001O22Rik |
RIKEN cDNA 1700001O22 gene |
16996 |
0.12 |
chr4_106855643_106856243 | 5.97 |
Gm12746 |
predicted gene 12746 |
8023 |
0.19 |
chr7_29124042_29125535 | 5.96 |
Ryr1 |
ryanodine receptor 1, skeletal muscle |
227 |
0.84 |
chr10_111594457_111595800 | 5.95 |
4933440J02Rik |
RIKEN cDNA 4933440J02 gene |
855 |
0.55 |
chr12_72939449_72940864 | 5.95 |
4930447C04Rik |
RIKEN cDNA 4930447C04 gene |
73 |
0.75 |
chr7_99237308_99238665 | 5.94 |
Mogat2 |
monoacylglycerol O-acyltransferase 2 |
608 |
0.62 |
chr3_129216664_129219042 | 5.93 |
Pitx2 |
paired-like homeodomain transcription factor 2 |
3578 |
0.2 |
chr12_56691110_56692095 | 5.92 |
Pax9 |
paired box 9 |
165 |
0.92 |
chr17_85691735_85693137 | 5.90 |
CJ186046Rik |
Riken cDNA CJ186046 gene |
1193 |
0.46 |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
10.7 | 42.8 | GO:0003166 | bundle of His development(GO:0003166) |
10.5 | 31.6 | GO:0097168 | mesenchymal stem cell proliferation(GO:0097168) |
10.0 | 29.9 | GO:0072095 | regulation of branch elongation involved in ureteric bud branching(GO:0072095) |
7.2 | 28.6 | GO:0003253 | cardiac neural crest cell migration involved in outflow tract morphogenesis(GO:0003253) |
6.9 | 20.8 | GO:0072125 | negative regulation of glomerular mesangial cell proliferation(GO:0072125) negative regulation of glomerulus development(GO:0090194) |
6.5 | 13.0 | GO:0003278 | apoptotic process involved in heart morphogenesis(GO:0003278) |
6.4 | 19.3 | GO:2001055 | positive regulation of mesenchymal cell apoptotic process(GO:2001055) |
6.0 | 66.5 | GO:0060272 | embryonic skeletal joint morphogenesis(GO:0060272) |
5.7 | 17.1 | GO:0030538 | embryonic genitalia morphogenesis(GO:0030538) |
5.6 | 16.7 | GO:0035054 | embryonic heart tube anterior/posterior pattern specification(GO:0035054) |
5.4 | 16.2 | GO:0002930 | trabecular meshwork development(GO:0002930) |
5.2 | 15.5 | GO:0060375 | regulation of mast cell differentiation(GO:0060375) |
5.2 | 5.2 | GO:0060435 | bronchiole development(GO:0060435) |
5.1 | 15.4 | GO:0097623 | potassium ion export across plasma membrane(GO:0097623) |
5.0 | 14.9 | GO:0014707 | branchiomeric skeletal muscle development(GO:0014707) |
4.9 | 14.8 | GO:0071336 | regulation of hair follicle cell proliferation(GO:0071336) |
4.7 | 9.5 | GO:0070384 | Harderian gland development(GO:0070384) |
4.7 | 4.7 | GO:0010159 | specification of organ position(GO:0010159) |
4.7 | 27.9 | GO:0003264 | cardioblast proliferation(GO:0003263) regulation of cardioblast proliferation(GO:0003264) regulation of secondary heart field cardioblast proliferation(GO:0003266) |
4.6 | 9.3 | GO:0021524 | visceral motor neuron differentiation(GO:0021524) |
4.6 | 9.3 | GO:0072103 | glomerulus vasculature morphogenesis(GO:0072103) glomerular capillary formation(GO:0072104) |
4.6 | 13.8 | GO:0061113 | pancreas morphogenesis(GO:0061113) |
4.5 | 22.7 | GO:0007494 | midgut development(GO:0007494) |
4.5 | 8.9 | GO:0010725 | regulation of primitive erythrocyte differentiation(GO:0010725) |
4.4 | 13.3 | GO:0072309 | mesenchymal stem cell maintenance involved in metanephric nephron morphogenesis(GO:0072309) |
4.4 | 4.4 | GO:0060839 | endothelial cell fate commitment(GO:0060839) |
4.2 | 8.5 | GO:0021938 | smoothened signaling pathway involved in regulation of cerebellar granule cell precursor cell proliferation(GO:0021938) |
4.0 | 15.9 | GO:2000504 | positive regulation of blood vessel remodeling(GO:2000504) |
4.0 | 11.9 | GO:0021570 | rhombomere 4 development(GO:0021570) |
4.0 | 11.9 | GO:0038028 | insulin receptor signaling pathway via phosphatidylinositol 3-kinase(GO:0038028) |
3.8 | 11.5 | GO:0034633 | retinol transport(GO:0034633) isoprenoid transport(GO:0046864) terpenoid transport(GO:0046865) |
3.8 | 22.9 | GO:0090336 | positive regulation of brown fat cell differentiation(GO:0090336) |
3.8 | 3.8 | GO:0072048 | pattern specification involved in kidney development(GO:0061004) renal system pattern specification(GO:0072048) |
3.7 | 11.2 | GO:0046552 | eye photoreceptor cell fate commitment(GO:0042706) photoreceptor cell fate commitment(GO:0046552) |
3.7 | 3.7 | GO:0060128 | corticotropin hormone secreting cell differentiation(GO:0060128) |
3.5 | 3.5 | GO:0021913 | regulation of transcription from RNA polymerase II promoter involved in ventral spinal cord interneuron specification(GO:0021913) |
3.5 | 10.5 | GO:0021615 | glossopharyngeal nerve morphogenesis(GO:0021615) |
3.5 | 13.9 | GO:0051572 | negative regulation of histone H3-K4 methylation(GO:0051572) |
3.4 | 6.9 | GO:0003176 | aortic valve development(GO:0003176) aortic valve morphogenesis(GO:0003180) |
3.4 | 6.9 | GO:0035860 | glial cell-derived neurotrophic factor receptor signaling pathway(GO:0035860) |
3.4 | 3.4 | GO:0042520 | positive regulation of tyrosine phosphorylation of Stat4 protein(GO:0042520) |
3.4 | 10.2 | GO:0097029 | mature conventional dendritic cell differentiation(GO:0097029) |
3.4 | 13.4 | GO:1902255 | positive regulation of intrinsic apoptotic signaling pathway by p53 class mediator(GO:1902255) |
3.3 | 13.4 | GO:0032929 | negative regulation of superoxide anion generation(GO:0032929) |
3.3 | 6.6 | GO:0018992 | germ-line sex determination(GO:0018992) |
3.2 | 6.4 | GO:1901535 | regulation of DNA demethylation(GO:1901535) negative regulation of DNA demethylation(GO:1901536) |
3.2 | 6.3 | GO:2000611 | positive regulation of thyroid hormone generation(GO:2000611) |
3.1 | 3.1 | GO:0098910 | regulation of atrial cardiac muscle cell action potential(GO:0098910) |
3.1 | 3.1 | GO:0003433 | chondrocyte development involved in endochondral bone morphogenesis(GO:0003433) |
3.1 | 9.4 | GO:0032911 | negative regulation of transforming growth factor beta1 production(GO:0032911) |
3.1 | 12.5 | GO:0034653 | diterpenoid catabolic process(GO:0016103) retinoic acid catabolic process(GO:0034653) |
3.1 | 9.2 | GO:0002741 | positive regulation of cytokine secretion involved in immune response(GO:0002741) |
3.0 | 9.1 | GO:0006438 | valyl-tRNA aminoacylation(GO:0006438) |
3.0 | 3.0 | GO:0007403 | glial cell fate determination(GO:0007403) |
3.0 | 9.0 | GO:0051902 | negative regulation of mitochondrial depolarization(GO:0051902) |
3.0 | 3.0 | GO:0034146 | toll-like receptor 5 signaling pathway(GO:0034146) |
3.0 | 9.0 | GO:1900825 | regulation of membrane depolarization during cardiac muscle cell action potential(GO:1900825) |
3.0 | 9.0 | GO:0021603 | cranial nerve formation(GO:0021603) |
3.0 | 12.0 | GO:0046499 | S-adenosylmethioninamine metabolic process(GO:0046499) |
3.0 | 12.0 | GO:1900747 | negative regulation of vascular endothelial growth factor signaling pathway(GO:1900747) |
3.0 | 8.9 | GO:1902219 | intrinsic apoptotic signaling pathway in response to osmotic stress(GO:0008627) regulation of intrinsic apoptotic signaling pathway in response to osmotic stress(GO:1902218) negative regulation of intrinsic apoptotic signaling pathway in response to osmotic stress(GO:1902219) |
3.0 | 8.9 | GO:0060528 | secretory columnal luminar epithelial cell differentiation involved in prostate glandular acinus development(GO:0060528) |
3.0 | 11.8 | GO:0060298 | positive regulation of sarcomere organization(GO:0060298) |
2.9 | 14.6 | GO:0014029 | neural crest formation(GO:0014029) |
2.9 | 14.6 | GO:2000653 | regulation of genetic imprinting(GO:2000653) |
2.9 | 11.6 | GO:0014028 | notochord formation(GO:0014028) |
2.9 | 5.8 | GO:0009786 | regulation of asymmetric cell division(GO:0009786) |
2.8 | 2.8 | GO:1904502 | regulation of lipophagy(GO:1904502) positive regulation of lipophagy(GO:1904504) |
2.8 | 8.5 | GO:2000828 | regulation of parathyroid hormone secretion(GO:2000828) |
2.8 | 8.5 | GO:0045218 | zonula adherens maintenance(GO:0045218) |
2.8 | 2.8 | GO:0016561 | protein import into peroxisome matrix, translocation(GO:0016561) |
2.8 | 5.6 | GO:0034729 | histone H3-K79 methylation(GO:0034729) |
2.8 | 16.7 | GO:0007016 | cytoskeletal anchoring at plasma membrane(GO:0007016) |
2.8 | 5.5 | GO:0019371 | cyclooxygenase pathway(GO:0019371) |
2.7 | 50.9 | GO:0035115 | embryonic forelimb morphogenesis(GO:0035115) |
2.7 | 2.7 | GO:0046544 | development of secondary male sexual characteristics(GO:0046544) |
2.7 | 5.3 | GO:0061010 | gall bladder development(GO:0061010) |
2.7 | 5.3 | GO:0060931 | sinoatrial node cell development(GO:0060931) |
2.6 | 5.3 | GO:0034137 | positive regulation of toll-like receptor 2 signaling pathway(GO:0034137) |
2.6 | 7.9 | GO:0051890 | regulation of cardioblast differentiation(GO:0051890) |
2.6 | 10.5 | GO:0060480 | lung goblet cell differentiation(GO:0060480) |
2.5 | 5.1 | GO:2000054 | regulation of Wnt signaling pathway involved in dorsal/ventral axis specification(GO:2000053) negative regulation of Wnt signaling pathway involved in dorsal/ventral axis specification(GO:2000054) |
2.5 | 2.5 | GO:0071294 | cellular response to zinc ion(GO:0071294) |
2.5 | 12.7 | GO:0010587 | miRNA catabolic process(GO:0010587) |
2.5 | 2.5 | GO:0051142 | regulation of NK T cell proliferation(GO:0051140) positive regulation of NK T cell proliferation(GO:0051142) |
2.5 | 2.5 | GO:0061304 | retinal blood vessel morphogenesis(GO:0061304) |
2.5 | 12.5 | GO:0010626 | negative regulation of Schwann cell proliferation(GO:0010626) |
2.5 | 2.5 | GO:0009080 | alanine catabolic process(GO:0006524) pyruvate family amino acid catabolic process(GO:0009080) |
2.5 | 2.5 | GO:0038033 | positive regulation of endothelial cell chemotaxis by VEGF-activated vascular endothelial growth factor receptor signaling pathway(GO:0038033) |
2.5 | 7.4 | GO:0060665 | regulation of branching involved in salivary gland morphogenesis by mesenchymal-epithelial signaling(GO:0060665) |
2.5 | 7.4 | GO:1900126 | negative regulation of hyaluronan biosynthetic process(GO:1900126) |
2.5 | 4.9 | GO:0032819 | positive regulation of natural killer cell proliferation(GO:0032819) |
2.5 | 9.8 | GO:0030886 | negative regulation of myeloid dendritic cell activation(GO:0030886) |
2.4 | 7.3 | GO:0044332 | Wnt signaling pathway involved in dorsal/ventral axis specification(GO:0044332) |
2.4 | 7.3 | GO:0010956 | negative regulation of calcidiol 1-monooxygenase activity(GO:0010956) |
2.4 | 2.4 | GO:0010424 | DNA methylation on cytosine within a CG sequence(GO:0010424) DNA methylation on cytosine(GO:0032776) |
2.4 | 14.3 | GO:0010534 | regulation of activation of JAK2 kinase activity(GO:0010534) |
2.4 | 7.2 | GO:0045896 | regulation of transcription during mitosis(GO:0045896) positive regulation of transcription during mitosis(GO:0045897) |
2.4 | 23.8 | GO:0060394 | negative regulation of pathway-restricted SMAD protein phosphorylation(GO:0060394) |
2.4 | 7.1 | GO:0060573 | ventral spinal cord interneuron specification(GO:0021521) cell fate specification involved in pattern specification(GO:0060573) |
2.4 | 4.7 | GO:0048557 | embryonic digestive tract morphogenesis(GO:0048557) |
2.3 | 4.6 | GO:0021569 | rhombomere 3 development(GO:0021569) |
2.3 | 11.6 | GO:0015722 | canalicular bile acid transport(GO:0015722) |
2.3 | 2.3 | GO:0061055 | myotome development(GO:0061055) |
2.3 | 6.8 | GO:1905216 | positive regulation of mRNA binding(GO:1902416) positive regulation of RNA binding(GO:1905216) |
2.3 | 15.9 | GO:0071493 | cellular response to UV-B(GO:0071493) |
2.3 | 4.5 | GO:0060536 | cartilage morphogenesis(GO:0060536) |
2.3 | 4.5 | GO:0001757 | somite specification(GO:0001757) |
2.2 | 9.0 | GO:0046618 | drug export(GO:0046618) |
2.2 | 11.2 | GO:0045602 | negative regulation of endothelial cell differentiation(GO:0045602) |
2.2 | 6.7 | GO:0071673 | positive regulation of smooth muscle cell chemotaxis(GO:0071673) |
2.2 | 13.4 | GO:0072526 | pyridine-containing compound catabolic process(GO:0072526) |
2.2 | 8.9 | GO:2000543 | positive regulation of gastrulation(GO:2000543) |
2.2 | 2.2 | GO:0071733 | transcriptional activation by promoter-enhancer looping(GO:0071733) gene looping(GO:0090202) dsDNA loop formation(GO:0090579) |
2.2 | 6.6 | GO:0046083 | adenine metabolic process(GO:0046083) adenine biosynthetic process(GO:0046084) |
2.2 | 2.2 | GO:2000729 | mesenchymal cell proliferation involved in ureter development(GO:0072198) regulation of mesenchymal cell proliferation involved in ureter development(GO:0072199) positive regulation of mesenchymal cell proliferation involved in ureter development(GO:2000729) |
2.2 | 15.3 | GO:0031033 | myosin filament organization(GO:0031033) |
2.2 | 8.7 | GO:0006987 | activation of signaling protein activity involved in unfolded protein response(GO:0006987) |
2.2 | 4.4 | GO:0010957 | negative regulation of vitamin D biosynthetic process(GO:0010957) |
2.2 | 6.5 | GO:0045079 | negative regulation of chemokine biosynthetic process(GO:0045079) |
2.2 | 54.2 | GO:0033014 | porphyrin-containing compound biosynthetic process(GO:0006779) tetrapyrrole biosynthetic process(GO:0033014) |
2.1 | 23.6 | GO:2000637 | positive regulation of gene silencing by miRNA(GO:2000637) |
2.1 | 2.1 | GO:0071635 | negative regulation of transforming growth factor beta production(GO:0071635) |
2.1 | 19.3 | GO:0030903 | notochord development(GO:0030903) |
2.1 | 12.8 | GO:0060037 | pharyngeal system development(GO:0060037) |
2.1 | 2.1 | GO:0021563 | glossopharyngeal nerve development(GO:0021563) |
2.1 | 4.2 | GO:0048880 | sensory system development(GO:0048880) |
2.1 | 8.5 | GO:0060591 | chondroblast differentiation(GO:0060591) |
2.1 | 14.8 | GO:0030718 | germ-line stem cell population maintenance(GO:0030718) |
2.1 | 2.1 | GO:0048807 | female genitalia morphogenesis(GO:0048807) |
2.1 | 20.9 | GO:0030502 | negative regulation of bone mineralization(GO:0030502) |
2.1 | 4.2 | GO:0021797 | forebrain anterior/posterior pattern specification(GO:0021797) |
2.1 | 2.1 | GO:1901534 | positive regulation of hematopoietic progenitor cell differentiation(GO:1901534) |
2.1 | 12.4 | GO:0042590 | antigen processing and presentation of exogenous peptide antigen via MHC class I(GO:0042590) |
2.1 | 6.2 | GO:0006553 | lysine metabolic process(GO:0006553) |
2.1 | 6.2 | GO:0052173 | response to defenses of other organism involved in symbiotic interaction(GO:0052173) response to host defenses(GO:0052200) response to host(GO:0075136) |
2.1 | 2.1 | GO:0010624 | regulation of Schwann cell proliferation(GO:0010624) |
2.0 | 6.1 | GO:0003062 | regulation of heart rate by chemical signal(GO:0003062) |
2.0 | 22.5 | GO:0060670 | branching involved in labyrinthine layer morphogenesis(GO:0060670) |
2.0 | 8.2 | GO:0033634 | positive regulation of cell-cell adhesion mediated by integrin(GO:0033634) |
2.0 | 10.2 | GO:1904970 | brush border assembly(GO:1904970) |
2.0 | 8.1 | GO:0014816 | skeletal muscle satellite cell differentiation(GO:0014816) |
2.0 | 8.1 | GO:0039536 | negative regulation of RIG-I signaling pathway(GO:0039536) |
2.0 | 8.0 | GO:1990086 | lens fiber cell apoptotic process(GO:1990086) |
2.0 | 6.0 | GO:0036394 | amylase secretion(GO:0036394) |
2.0 | 4.0 | GO:0030421 | defecation(GO:0030421) |
2.0 | 2.0 | GO:0035898 | parathyroid hormone secretion(GO:0035898) |
2.0 | 19.9 | GO:0021520 | spinal cord motor neuron cell fate specification(GO:0021520) |
2.0 | 4.0 | GO:2000383 | regulation of ectoderm development(GO:2000383) negative regulation of ectoderm development(GO:2000384) |
2.0 | 2.0 | GO:0072498 | embryonic skeletal joint development(GO:0072498) |
2.0 | 11.8 | GO:0015671 | oxygen transport(GO:0015671) |
2.0 | 9.8 | GO:0097094 | craniofacial suture morphogenesis(GO:0097094) |
2.0 | 3.9 | GO:0009946 | proximal/distal axis specification(GO:0009946) specification of axis polarity(GO:0065001) |
2.0 | 2.0 | GO:0061205 | paramesonephric duct development(GO:0061205) |
1.9 | 11.5 | GO:0072674 | multinuclear osteoclast differentiation(GO:0072674) |
1.9 | 3.8 | GO:0003223 | ventricular compact myocardium morphogenesis(GO:0003223) |
1.9 | 5.8 | GO:0006362 | transcription elongation from RNA polymerase I promoter(GO:0006362) |
1.9 | 11.5 | GO:0035878 | nail development(GO:0035878) |
1.9 | 98.0 | GO:0048704 | embryonic skeletal system morphogenesis(GO:0048704) |
1.9 | 3.8 | GO:0010481 | epidermal cell division(GO:0010481) regulation of epidermal cell division(GO:0010482) |
1.9 | 3.8 | GO:1903849 | regulation of aorta morphogenesis(GO:1903847) positive regulation of aorta morphogenesis(GO:1903849) |
1.9 | 11.3 | GO:0002679 | respiratory burst involved in defense response(GO:0002679) |
1.9 | 1.9 | GO:0010979 | regulation of vitamin D 24-hydroxylase activity(GO:0010979) positive regulation of vitamin D 24-hydroxylase activity(GO:0010980) |
1.9 | 7.5 | GO:1900194 | negative regulation of oocyte maturation(GO:1900194) |
1.8 | 1.8 | GO:0048386 | positive regulation of retinoic acid receptor signaling pathway(GO:0048386) |
1.8 | 1.8 | GO:0032289 | central nervous system myelin formation(GO:0032289) |
1.8 | 29.2 | GO:0003416 | endochondral bone growth(GO:0003416) |
1.8 | 7.3 | GO:0060414 | aorta smooth muscle tissue morphogenesis(GO:0060414) |
1.8 | 5.4 | GO:0015744 | succinate transport(GO:0015744) |
1.8 | 5.4 | GO:1903660 | regulation of complement-dependent cytotoxicity(GO:1903659) negative regulation of complement-dependent cytotoxicity(GO:1903660) |
1.8 | 5.4 | GO:1900041 | negative regulation of interleukin-2 secretion(GO:1900041) |
1.8 | 1.8 | GO:0042908 | xenobiotic transport(GO:0042908) |
1.8 | 1.8 | GO:0033629 | negative regulation of cell adhesion mediated by integrin(GO:0033629) |
1.8 | 7.1 | GO:0035279 | mRNA cleavage involved in gene silencing by miRNA(GO:0035279) mRNA cleavage involved in gene silencing(GO:0098795) |
1.8 | 3.6 | GO:2000338 | chemokine (C-X-C motif) ligand 1 production(GO:0072566) regulation of chemokine (C-X-C motif) ligand 1 production(GO:2000338) |
1.8 | 1.8 | GO:0010989 | negative regulation of low-density lipoprotein particle clearance(GO:0010989) |
1.8 | 1.8 | GO:0009730 | detection of carbohydrate stimulus(GO:0009730) detection of hexose stimulus(GO:0009732) detection of monosaccharide stimulus(GO:0034287) detection of glucose(GO:0051594) |
1.8 | 3.5 | GO:0048619 | embryonic hindgut morphogenesis(GO:0048619) |
1.8 | 12.3 | GO:0060040 | retinal bipolar neuron differentiation(GO:0060040) |
1.8 | 3.5 | GO:0033686 | positive regulation of luteinizing hormone secretion(GO:0033686) |
1.8 | 5.3 | GO:0019344 | cysteine biosynthetic process(GO:0019344) |
1.8 | 12.3 | GO:2000392 | regulation of lamellipodium morphogenesis(GO:2000392) |
1.7 | 12.2 | GO:0045198 | establishment of epithelial cell apical/basal polarity(GO:0045198) |
1.7 | 5.2 | GO:0032474 | otolith morphogenesis(GO:0032474) |
1.7 | 5.2 | GO:2000346 | negative regulation of hepatocyte proliferation(GO:2000346) |
1.7 | 8.7 | GO:0018101 | protein citrullination(GO:0018101) |
1.7 | 5.2 | GO:1900107 | regulation of nodal signaling pathway(GO:1900107) |
1.7 | 1.7 | GO:0034443 | regulation of lipoprotein oxidation(GO:0034442) negative regulation of lipoprotein oxidation(GO:0034443) |
1.7 | 8.6 | GO:0030917 | midbrain-hindbrain boundary development(GO:0030917) |
1.7 | 13.7 | GO:0008343 | adult feeding behavior(GO:0008343) |
1.7 | 6.8 | GO:0042997 | negative regulation of Golgi to plasma membrane protein transport(GO:0042997) |
1.7 | 3.4 | GO:2000823 | regulation of androgen receptor activity(GO:2000823) |
1.7 | 3.4 | GO:2000382 | positive regulation of mesoderm development(GO:2000382) |
1.7 | 3.4 | GO:0060347 | heart trabecula formation(GO:0060347) |
1.7 | 10.1 | GO:0045654 | positive regulation of megakaryocyte differentiation(GO:0045654) |
1.7 | 10.0 | GO:0038092 | nodal signaling pathway(GO:0038092) |
1.7 | 11.7 | GO:0031665 | negative regulation of lipopolysaccharide-mediated signaling pathway(GO:0031665) |
1.7 | 1.7 | GO:0060066 | oviduct development(GO:0060066) |
1.7 | 11.6 | GO:0099515 | actin filament-based transport(GO:0099515) |
1.7 | 1.7 | GO:0033058 | directional locomotion(GO:0033058) |
1.6 | 6.6 | GO:0051918 | negative regulation of fibrinolysis(GO:0051918) |
1.6 | 1.6 | GO:0046666 | retinal cell programmed cell death(GO:0046666) regulation of retinal cell programmed cell death(GO:0046668) |
1.6 | 6.5 | GO:0097500 | receptor localization to nonmotile primary cilium(GO:0097500) |
1.6 | 8.2 | GO:0000820 | regulation of glutamine family amino acid metabolic process(GO:0000820) |
1.6 | 9.8 | GO:0006526 | arginine biosynthetic process(GO:0006526) |
1.6 | 4.9 | GO:0000087 | mitotic M phase(GO:0000087) |
1.6 | 9.7 | GO:0042866 | pyruvate biosynthetic process(GO:0042866) |
1.6 | 6.5 | GO:0048861 | leukemia inhibitory factor signaling pathway(GO:0048861) |
1.6 | 8.1 | GO:0032020 | ISG15-protein conjugation(GO:0032020) |
1.6 | 8.1 | GO:0051005 | negative regulation of lipoprotein lipase activity(GO:0051005) |
1.6 | 4.8 | GO:0002069 | columnar/cuboidal epithelial cell maturation(GO:0002069) glandular epithelial cell maturation(GO:0002071) |
1.6 | 8.0 | GO:0006686 | sphingomyelin biosynthetic process(GO:0006686) |
1.6 | 9.6 | GO:0060391 | positive regulation of SMAD protein import into nucleus(GO:0060391) |
1.6 | 3.2 | GO:0070814 | hydrogen sulfide biosynthetic process(GO:0070814) |
1.6 | 1.6 | GO:0071168 | protein localization to chromatin(GO:0071168) |
1.6 | 1.6 | GO:0060526 | prostate glandular acinus morphogenesis(GO:0060526) prostate epithelial cord arborization involved in prostate glandular acinus morphogenesis(GO:0060527) |
1.6 | 4.8 | GO:1901162 | serotonin biosynthetic process(GO:0042427) primary amino compound biosynthetic process(GO:1901162) |
1.6 | 6.4 | GO:0003256 | regulation of transcription from RNA polymerase II promoter involved in myocardial precursor cell differentiation(GO:0003256) |
1.6 | 4.8 | GO:2000646 | positive regulation of receptor catabolic process(GO:2000646) |
1.6 | 9.4 | GO:0042364 | water-soluble vitamin biosynthetic process(GO:0042364) |
1.6 | 3.1 | GO:0030916 | otic vesicle formation(GO:0030916) |
1.6 | 3.1 | GO:0042536 | negative regulation of tumor necrosis factor biosynthetic process(GO:0042536) |
1.6 | 4.7 | GO:2001201 | transforming growth factor-beta secretion(GO:0038044) regulation of transforming growth factor-beta secretion(GO:2001201) |
1.6 | 1.6 | GO:0030997 | regulation of centriole-centriole cohesion(GO:0030997) |
1.5 | 1.5 | GO:1901739 | regulation of myoblast fusion(GO:1901739) |
1.5 | 7.7 | GO:0014721 | voluntary skeletal muscle contraction(GO:0003010) twitch skeletal muscle contraction(GO:0014721) |
1.5 | 10.8 | GO:0001886 | endothelial cell morphogenesis(GO:0001886) |
1.5 | 3.1 | GO:0070120 | ciliary neurotrophic factor-mediated signaling pathway(GO:0070120) |
1.5 | 7.7 | GO:0006545 | glycine biosynthetic process(GO:0006545) |
1.5 | 3.1 | GO:1903011 | negative regulation of bone development(GO:1903011) |
1.5 | 7.6 | GO:0061032 | visceral serous pericardium development(GO:0061032) |
1.5 | 9.1 | GO:0033234 | negative regulation of protein sumoylation(GO:0033234) |
1.5 | 7.6 | GO:0071313 | cellular response to caffeine(GO:0071313) cellular response to purine-containing compound(GO:0071415) |
1.5 | 7.6 | GO:0070934 | CRD-mediated mRNA stabilization(GO:0070934) |
1.5 | 3.0 | GO:0061042 | vascular wound healing(GO:0061042) |
1.5 | 13.6 | GO:1990440 | positive regulation of transcription from RNA polymerase II promoter in response to endoplasmic reticulum stress(GO:1990440) |
1.5 | 9.1 | GO:0006620 | posttranslational protein targeting to membrane(GO:0006620) |
1.5 | 6.0 | GO:0000727 | double-strand break repair via break-induced replication(GO:0000727) |
1.5 | 15.1 | GO:0042789 | mRNA transcription from RNA polymerase II promoter(GO:0042789) |
1.5 | 1.5 | GO:0061146 | Peyer's patch morphogenesis(GO:0061146) |
1.5 | 1.5 | GO:2000343 | positive regulation of chemokine (C-X-C motif) ligand 2 production(GO:2000343) |
1.5 | 13.5 | GO:0009954 | proximal/distal pattern formation(GO:0009954) |
1.5 | 6.0 | GO:0048368 | lateral mesoderm development(GO:0048368) |
1.5 | 6.0 | GO:1904996 | positive regulation of leukocyte adhesion to vascular endothelial cell(GO:1904996) |
1.5 | 3.0 | GO:0009972 | cytidine catabolic process(GO:0006216) cytidine deamination(GO:0009972) cytidine metabolic process(GO:0046087) |
1.5 | 14.8 | GO:0035855 | megakaryocyte development(GO:0035855) |
1.5 | 2.9 | GO:2000630 | positive regulation of miRNA metabolic process(GO:2000630) |
1.5 | 2.9 | GO:0007223 | Wnt signaling pathway, calcium modulating pathway(GO:0007223) |
1.5 | 2.9 | GO:0071883 | activation of MAPK activity by adrenergic receptor signaling pathway(GO:0071883) |
1.5 | 4.4 | GO:0046951 | ketone body biosynthetic process(GO:0046951) |
1.4 | 4.3 | GO:1902174 | positive regulation of keratinocyte apoptotic process(GO:1902174) |
1.4 | 5.8 | GO:0048852 | diencephalon morphogenesis(GO:0048852) |
1.4 | 4.3 | GO:0050713 | negative regulation of interleukin-1 beta secretion(GO:0050713) |
1.4 | 10.1 | GO:0042511 | positive regulation of tyrosine phosphorylation of Stat1 protein(GO:0042511) |
1.4 | 4.3 | GO:0051025 | negative regulation of immunoglobulin secretion(GO:0051025) |
1.4 | 10.0 | GO:0033262 | regulation of nuclear cell cycle DNA replication(GO:0033262) |
1.4 | 4.3 | GO:0060297 | regulation of sarcomere organization(GO:0060297) |
1.4 | 4.3 | GO:0008588 | release of cytoplasmic sequestered NF-kappaB(GO:0008588) |
1.4 | 1.4 | GO:1904888 | cranial skeletal system development(GO:1904888) |
1.4 | 2.9 | GO:0016115 | terpenoid catabolic process(GO:0016115) |
1.4 | 7.1 | GO:2000561 | regulation of CD4-positive, alpha-beta T cell proliferation(GO:2000561) |
1.4 | 2.8 | GO:0060164 | regulation of timing of neuron differentiation(GO:0060164) |
1.4 | 7.1 | GO:0090136 | epithelial cell-cell adhesion(GO:0090136) |
1.4 | 4.3 | GO:0030951 | establishment or maintenance of microtubule cytoskeleton polarity(GO:0030951) |
1.4 | 2.8 | GO:0015014 | heparan sulfate proteoglycan biosynthetic process, polysaccharide chain biosynthetic process(GO:0015014) |
1.4 | 5.6 | GO:0070561 | vitamin D receptor signaling pathway(GO:0070561) |
1.4 | 2.8 | GO:2000491 | positive regulation of hepatic stellate cell activation(GO:2000491) |
1.4 | 11.2 | GO:0097062 | dendritic spine maintenance(GO:0097062) |
1.4 | 8.4 | GO:0000212 | meiotic spindle organization(GO:0000212) |
1.4 | 1.4 | GO:0061043 | regulation of vascular wound healing(GO:0061043) |
1.4 | 4.2 | GO:0016554 | cytidine to uridine editing(GO:0016554) |
1.4 | 2.8 | GO:0002540 | leukotriene production involved in inflammatory response(GO:0002540) |
1.4 | 19.4 | GO:1901741 | positive regulation of myoblast fusion(GO:1901741) |
1.4 | 5.5 | GO:0060501 | positive regulation of epithelial cell proliferation involved in lung morphogenesis(GO:0060501) |
1.4 | 1.4 | GO:0061030 | epithelial cell differentiation involved in mammary gland alveolus development(GO:0061030) |
1.4 | 5.5 | GO:0033632 | regulation of cell-cell adhesion mediated by integrin(GO:0033632) |
1.4 | 1.4 | GO:1901656 | glycoside transport(GO:1901656) |
1.4 | 4.1 | GO:0048550 | negative regulation of pinocytosis(GO:0048550) |
1.4 | 6.9 | GO:0002317 | plasma cell differentiation(GO:0002317) |
1.4 | 4.1 | GO:0043589 | skin morphogenesis(GO:0043589) |
1.4 | 12.2 | GO:0034063 | stress granule assembly(GO:0034063) |
1.3 | 4.0 | GO:0072044 | collecting duct development(GO:0072044) |
1.3 | 9.4 | GO:0031145 | anaphase-promoting complex-dependent catabolic process(GO:0031145) |
1.3 | 2.7 | GO:0021550 | medulla oblongata development(GO:0021550) |
1.3 | 2.7 | GO:0072173 | metanephric tubule morphogenesis(GO:0072173) |
1.3 | 5.3 | GO:0010668 | ectodermal cell differentiation(GO:0010668) |
1.3 | 5.3 | GO:0001842 | neural fold formation(GO:0001842) |
1.3 | 2.7 | GO:0044828 | negative regulation by host of viral genome replication(GO:0044828) |
1.3 | 2.7 | GO:0071930 | negative regulation of transcription involved in G1/S transition of mitotic cell cycle(GO:0071930) |
1.3 | 13.2 | GO:0015937 | coenzyme A biosynthetic process(GO:0015937) |
1.3 | 4.0 | GO:0001807 | regulation of type IV hypersensitivity(GO:0001807) |
1.3 | 2.6 | GO:0006549 | isoleucine metabolic process(GO:0006549) |
1.3 | 2.6 | GO:1902459 | positive regulation of stem cell population maintenance(GO:1902459) |
1.3 | 3.9 | GO:0042276 | error-prone translesion synthesis(GO:0042276) |
1.3 | 3.9 | GO:0043584 | nose development(GO:0043584) |
1.3 | 2.6 | GO:0090272 | negative regulation of fibroblast growth factor production(GO:0090272) |
1.3 | 5.2 | GO:0007144 | female meiosis I(GO:0007144) |
1.3 | 13.0 | GO:0006978 | DNA damage response, signal transduction by p53 class mediator resulting in transcription of p21 class mediator(GO:0006978) |
1.3 | 1.3 | GO:1901978 | positive regulation of cell cycle checkpoint(GO:1901978) |
1.3 | 3.9 | GO:0036066 | protein O-linked fucosylation(GO:0036066) |
1.3 | 9.0 | GO:2001140 | regulation of phospholipid transport(GO:2001138) positive regulation of phospholipid transport(GO:2001140) |
1.3 | 30.7 | GO:0060323 | head morphogenesis(GO:0060323) |
1.3 | 3.8 | GO:0001880 | Mullerian duct regression(GO:0001880) |
1.3 | 6.4 | GO:0072656 | maintenance of protein location in mitochondrion(GO:0072656) |
1.3 | 11.5 | GO:0034501 | protein localization to kinetochore(GO:0034501) |
1.3 | 7.6 | GO:0044351 | macropinocytosis(GO:0044351) |
1.3 | 10.2 | GO:0048484 | enteric nervous system development(GO:0048484) |
1.3 | 1.3 | GO:0042510 | regulation of tyrosine phosphorylation of Stat1 protein(GO:0042510) |
1.3 | 1.3 | GO:0035983 | response to trichostatin A(GO:0035983) cellular response to trichostatin A(GO:0035984) |
1.3 | 2.5 | GO:0055009 | atrial cardiac muscle tissue development(GO:0003228) atrial cardiac muscle tissue morphogenesis(GO:0055009) |
1.3 | 2.5 | GO:0038165 | oncostatin-M-mediated signaling pathway(GO:0038165) |
1.3 | 8.8 | GO:0015825 | L-serine transport(GO:0015825) |
1.3 | 2.5 | GO:0035359 | negative regulation of peroxisome proliferator activated receptor signaling pathway(GO:0035359) |
1.2 | 1.2 | GO:2000974 | negative regulation of pro-B cell differentiation(GO:2000974) |
1.2 | 2.5 | GO:2000553 | positive regulation of T-helper 2 cell cytokine production(GO:2000553) |
1.2 | 4.9 | GO:0061484 | hematopoietic stem cell homeostasis(GO:0061484) |
1.2 | 9.9 | GO:0043568 | positive regulation of insulin-like growth factor receptor signaling pathway(GO:0043568) |
1.2 | 8.6 | GO:0033690 | positive regulation of osteoblast proliferation(GO:0033690) |
1.2 | 3.7 | GO:0019626 | short-chain fatty acid catabolic process(GO:0019626) |
1.2 | 6.1 | GO:0034372 | very-low-density lipoprotein particle remodeling(GO:0034372) |
1.2 | 2.4 | GO:0035989 | tendon development(GO:0035989) |
1.2 | 4.9 | GO:0051138 | regulation of NK T cell differentiation(GO:0051136) positive regulation of NK T cell differentiation(GO:0051138) |
1.2 | 3.6 | GO:0045585 | regulation of cytotoxic T cell differentiation(GO:0045583) positive regulation of cytotoxic T cell differentiation(GO:0045585) |
1.2 | 2.4 | GO:0046532 | regulation of photoreceptor cell differentiation(GO:0046532) |
1.2 | 3.6 | GO:0061511 | centriole elongation(GO:0061511) |
1.2 | 3.6 | GO:0060017 | parathyroid gland development(GO:0060017) |
1.2 | 1.2 | GO:0014016 | neuroblast differentiation(GO:0014016) response to folic acid(GO:0051593) |
1.2 | 2.4 | GO:0061073 | ciliary body morphogenesis(GO:0061073) |
1.2 | 3.6 | GO:0015766 | disaccharide transport(GO:0015766) sucrose transport(GO:0015770) oligosaccharide transport(GO:0015772) |
1.2 | 4.8 | GO:0000320 | re-entry into mitotic cell cycle(GO:0000320) |
1.2 | 1.2 | GO:0001905 | activation of membrane attack complex(GO:0001905) regulation of activation of membrane attack complex(GO:0001969) |
1.2 | 2.4 | GO:0042435 | indole-containing compound biosynthetic process(GO:0042435) |
1.2 | 19.2 | GO:0045662 | negative regulation of myoblast differentiation(GO:0045662) |
1.2 | 14.3 | GO:0046500 | S-adenosylmethionine metabolic process(GO:0046500) |
1.2 | 2.4 | GO:0045091 | regulation of single stranded viral RNA replication via double stranded DNA intermediate(GO:0045091) |
1.2 | 6.0 | GO:0072378 | blood coagulation, fibrin clot formation(GO:0072378) |
1.2 | 9.5 | GO:0031507 | heterochromatin assembly(GO:0031507) |
1.2 | 4.8 | GO:0061635 | regulation of protein complex stability(GO:0061635) |
1.2 | 8.2 | GO:0031272 | regulation of pseudopodium assembly(GO:0031272) |
1.2 | 4.7 | GO:0006407 | rRNA export from nucleus(GO:0006407) |
1.2 | 4.7 | GO:0050689 | negative regulation of defense response to virus by host(GO:0050689) |
1.2 | 3.5 | GO:0034755 | iron ion transmembrane transport(GO:0034755) |
1.2 | 1.2 | GO:0039534 | negative regulation of MDA-5 signaling pathway(GO:0039534) |
1.2 | 2.3 | GO:0090611 | ubiquitin-independent protein catabolic process via the multivesicular body sorting pathway(GO:0090611) |
1.2 | 4.7 | GO:1904948 | midbrain dopaminergic neuron differentiation(GO:1904948) |
1.2 | 1.2 | GO:0032252 | secretory granule localization(GO:0032252) |
1.2 | 2.3 | GO:2000418 | positive regulation of eosinophil migration(GO:2000418) |
1.2 | 1.2 | GO:0048048 | embryonic eye morphogenesis(GO:0048048) |
1.2 | 4.6 | GO:0008595 | tripartite regional subdivision(GO:0007351) anterior/posterior axis specification, embryo(GO:0008595) |
1.2 | 2.3 | GO:0031268 | pseudopodium organization(GO:0031268) |
1.2 | 1.2 | GO:0036289 | peptidyl-serine autophosphorylation(GO:0036289) |
1.2 | 3.5 | GO:0014842 | skeletal muscle satellite cell proliferation(GO:0014841) regulation of skeletal muscle satellite cell proliferation(GO:0014842) |
1.2 | 2.3 | GO:0036462 | TRAIL-activated apoptotic signaling pathway(GO:0036462) |
1.1 | 2.3 | GO:0061052 | negative regulation of cell growth involved in cardiac muscle cell development(GO:0061052) |
1.1 | 3.4 | GO:0042481 | regulation of odontogenesis(GO:0042481) |
1.1 | 4.6 | GO:0034154 | toll-like receptor 7 signaling pathway(GO:0034154) |
1.1 | 3.4 | GO:0060753 | regulation of mast cell chemotaxis(GO:0060753) |
1.1 | 6.8 | GO:0060713 | labyrinthine layer morphogenesis(GO:0060713) |
1.1 | 6.8 | GO:0051639 | actin filament network formation(GO:0051639) |
1.1 | 3.4 | GO:0018199 | peptidyl-glutamine modification(GO:0018199) |
1.1 | 2.2 | GO:0032290 | peripheral nervous system myelin formation(GO:0032290) |
1.1 | 1.1 | GO:0048625 | myoblast fate commitment(GO:0048625) |
1.1 | 3.4 | GO:2000574 | regulation of microtubule motor activity(GO:2000574) |
1.1 | 1.1 | GO:0048009 | insulin-like growth factor receptor signaling pathway(GO:0048009) |
1.1 | 5.6 | GO:0000447 | endonucleolytic cleavage in ITS1 to separate SSU-rRNA from 5.8S rRNA and LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA)(GO:0000447) |
1.1 | 2.2 | GO:0033088 | negative regulation of immature T cell proliferation in thymus(GO:0033088) |
1.1 | 4.5 | GO:0060056 | mammary gland involution(GO:0060056) |
1.1 | 1.1 | GO:0035622 | intrahepatic bile duct development(GO:0035622) |
1.1 | 5.6 | GO:2000348 | regulation of CD40 signaling pathway(GO:2000348) |
1.1 | 6.7 | GO:0002457 | T cell antigen processing and presentation(GO:0002457) |
1.1 | 2.2 | GO:0006933 | negative regulation of cell adhesion involved in substrate-bound cell migration(GO:0006933) |
1.1 | 4.4 | GO:0090308 | regulation of methylation-dependent chromatin silencing(GO:0090308) |
1.1 | 15.5 | GO:0090162 | establishment of epithelial cell polarity(GO:0090162) |
1.1 | 3.3 | GO:0048566 | embryonic digestive tract development(GO:0048566) |
1.1 | 2.2 | GO:0048069 | eye pigmentation(GO:0048069) |
1.1 | 2.2 | GO:0000720 | pyrimidine dimer repair by nucleotide-excision repair(GO:0000720) |
1.1 | 2.2 | GO:1903242 | regulation of cardiac muscle adaptation(GO:0010612) regulation of cardiac muscle hypertrophy in response to stress(GO:1903242) |
1.1 | 1.1 | GO:0035262 | gonad morphogenesis(GO:0035262) |
1.1 | 2.2 | GO:1902263 | apoptotic process involved in embryonic digit morphogenesis(GO:1902263) |
1.1 | 4.3 | GO:0046512 | diol biosynthetic process(GO:0034312) sphingosine biosynthetic process(GO:0046512) |
1.1 | 9.8 | GO:0061179 | negative regulation of insulin secretion involved in cellular response to glucose stimulus(GO:0061179) |
1.1 | 6.5 | GO:0046598 | positive regulation of viral entry into host cell(GO:0046598) |
1.1 | 3.3 | GO:0010835 | regulation of protein ADP-ribosylation(GO:0010835) |
1.1 | 1.1 | GO:0002894 | type IIa hypersensitivity(GO:0001794) regulation of type IIa hypersensitivity(GO:0001796) positive regulation of type IIa hypersensitivity(GO:0001798) type II hypersensitivity(GO:0002445) regulation of type II hypersensitivity(GO:0002892) positive regulation of type II hypersensitivity(GO:0002894) |
1.1 | 5.4 | GO:0070365 | hepatocyte differentiation(GO:0070365) |
1.1 | 4.3 | GO:1903423 | positive regulation of synaptic vesicle recycling(GO:1903423) |
1.1 | 2.2 | GO:0060648 | mammary gland bud morphogenesis(GO:0060648) |
1.1 | 2.2 | GO:0006982 | response to lipid hydroperoxide(GO:0006982) |
1.1 | 3.2 | GO:1903795 | regulation of inorganic anion transmembrane transport(GO:1903795) |
1.1 | 3.2 | GO:0010387 | COP9 signalosome assembly(GO:0010387) |
1.1 | 3.2 | GO:1903224 | regulation of endodermal cell differentiation(GO:1903224) |
1.1 | 3.2 | GO:1990705 | cholangiocyte proliferation(GO:1990705) |
1.1 | 3.2 | GO:0009240 | isopentenyl diphosphate biosynthetic process(GO:0009240) isopentenyl diphosphate biosynthetic process, mevalonate pathway(GO:0019287) |
1.1 | 4.3 | GO:0015858 | nucleoside transport(GO:0015858) |
1.1 | 2.1 | GO:0030540 | female genitalia development(GO:0030540) |
1.1 | 6.4 | GO:0006346 | methylation-dependent chromatin silencing(GO:0006346) |
1.1 | 4.2 | GO:0048664 | neuron fate determination(GO:0048664) |
1.1 | 3.2 | GO:0051105 | regulation of DNA ligation(GO:0051105) positive regulation of DNA ligation(GO:0051106) |
1.1 | 4.2 | GO:0006449 | regulation of translational termination(GO:0006449) |
1.1 | 10.5 | GO:0019081 | viral translation(GO:0019081) |
1.0 | 5.2 | GO:0033152 | immunoglobulin V(D)J recombination(GO:0033152) |
1.0 | 6.3 | GO:0071569 | protein ufmylation(GO:0071569) |
1.0 | 4.2 | GO:0002159 | desmosome assembly(GO:0002159) |
1.0 | 7.3 | GO:0060586 | multicellular organismal iron ion homeostasis(GO:0060586) |
1.0 | 1.0 | GO:0060192 | negative regulation of phospholipase activity(GO:0010519) negative regulation of lipase activity(GO:0060192) |
1.0 | 10.3 | GO:0006924 | activation-induced cell death of T cells(GO:0006924) |
1.0 | 3.1 | GO:0060768 | regulation of epithelial cell proliferation involved in prostate gland development(GO:0060768) |
1.0 | 4.1 | GO:0000056 | ribosomal small subunit export from nucleus(GO:0000056) |
1.0 | 6.2 | GO:0006559 | L-phenylalanine catabolic process(GO:0006559) erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process(GO:1902222) |
1.0 | 16.4 | GO:0048706 | embryonic skeletal system development(GO:0048706) |
1.0 | 1.0 | GO:0002072 | optic cup morphogenesis involved in camera-type eye development(GO:0002072) |
1.0 | 3.1 | GO:0032227 | negative regulation of synaptic transmission, dopaminergic(GO:0032227) |
1.0 | 4.1 | GO:0070836 | plasma membrane raft assembly(GO:0044854) plasma membrane raft organization(GO:0044857) caveola assembly(GO:0070836) |
1.0 | 2.0 | GO:0070358 | actin polymerization-dependent cell motility(GO:0070358) |
1.0 | 3.0 | GO:0019401 | glycerol biosynthetic process(GO:0006114) alditol biosynthetic process(GO:0019401) |
1.0 | 8.1 | GO:0035563 | positive regulation of chromatin binding(GO:0035563) |
1.0 | 6.1 | GO:0015669 | gas transport(GO:0015669) |
1.0 | 3.0 | GO:0048295 | positive regulation of isotype switching to IgE isotypes(GO:0048295) |
1.0 | 5.0 | GO:0060352 | cell adhesion molecule production(GO:0060352) |
1.0 | 2.0 | GO:0006059 | hexitol metabolic process(GO:0006059) |
1.0 | 7.0 | GO:0038166 | angiotensin-activated signaling pathway(GO:0038166) |
1.0 | 1.0 | GO:0061101 | neuroendocrine cell differentiation(GO:0061101) |
1.0 | 2.0 | GO:1900109 | regulation of histone H3-K9 dimethylation(GO:1900109) |
1.0 | 2.0 | GO:0034136 | negative regulation of toll-like receptor 2 signaling pathway(GO:0034136) |
1.0 | 4.0 | GO:0034383 | low-density lipoprotein particle clearance(GO:0034383) |
1.0 | 2.0 | GO:0036091 | positive regulation of transcription from RNA polymerase II promoter in response to oxidative stress(GO:0036091) |
1.0 | 3.9 | GO:0007406 | negative regulation of neuroblast proliferation(GO:0007406) |
1.0 | 2.9 | GO:0060290 | transdifferentiation(GO:0060290) |
1.0 | 4.9 | GO:1902166 | negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator(GO:1902166) |
1.0 | 2.9 | GO:1900029 | positive regulation of ruffle assembly(GO:1900029) |
1.0 | 2.9 | GO:0042374 | phylloquinone metabolic process(GO:0042374) phylloquinone catabolic process(GO:0042376) quinone catabolic process(GO:1901662) |
1.0 | 1.0 | GO:0032808 | lacrimal gland development(GO:0032808) |
1.0 | 3.9 | GO:0070314 | G1 to G0 transition(GO:0070314) |
1.0 | 3.9 | GO:0090188 | negative regulation of pancreatic juice secretion(GO:0090188) |
1.0 | 1.9 | GO:0070318 | positive regulation of G0 to G1 transition(GO:0070318) |
1.0 | 1.0 | GO:0044340 | canonical Wnt signaling pathway involved in regulation of cell proliferation(GO:0044340) |
1.0 | 4.8 | GO:0030853 | negative regulation of granulocyte differentiation(GO:0030853) |
1.0 | 1.0 | GO:0071677 | positive regulation of mononuclear cell migration(GO:0071677) |
1.0 | 1.0 | GO:0042726 | flavin-containing compound metabolic process(GO:0042726) |
1.0 | 2.9 | GO:0035413 | positive regulation of catenin import into nucleus(GO:0035413) |
1.0 | 1.9 | GO:0086029 | Purkinje myocyte to ventricular cardiac muscle cell signaling(GO:0086029) Purkinje myocyte to ventricular cardiac muscle cell communication(GO:0086068) |
1.0 | 2.9 | GO:0071638 | negative regulation of monocyte chemotactic protein-1 production(GO:0071638) |
1.0 | 1.0 | GO:1905065 | positive regulation of vascular smooth muscle cell differentiation(GO:1905065) |
1.0 | 2.9 | GO:0014883 | transition between fast and slow fiber(GO:0014883) |
1.0 | 1.9 | GO:0060579 | ventral spinal cord interneuron fate commitment(GO:0060579) cell fate commitment involved in pattern specification(GO:0060581) |
1.0 | 6.7 | GO:0022027 | interkinetic nuclear migration(GO:0022027) |
1.0 | 3.8 | GO:0007296 | vitellogenesis(GO:0007296) |
1.0 | 4.8 | GO:0045719 | negative regulation of glycogen biosynthetic process(GO:0045719) |
0.9 | 19.0 | GO:0060021 | palate development(GO:0060021) |
0.9 | 4.7 | GO:0007042 | lysosomal lumen acidification(GO:0007042) |
0.9 | 1.9 | GO:0010255 | carbohydrate mediated signaling(GO:0009756) hexose mediated signaling(GO:0009757) sugar mediated signaling pathway(GO:0010182) glucose mediated signaling pathway(GO:0010255) |
0.9 | 1.9 | GO:0006741 | NADP biosynthetic process(GO:0006741) |
0.9 | 4.7 | GO:0035188 | blastocyst hatching(GO:0001835) hatching(GO:0035188) organism emergence from protective structure(GO:0071684) |
0.9 | 3.8 | GO:0031293 | membrane protein intracellular domain proteolysis(GO:0031293) |
0.9 | 1.9 | GO:0046104 | thymidine metabolic process(GO:0046104) |
0.9 | 2.8 | GO:0032439 | endosome localization(GO:0032439) |
0.9 | 1.9 | GO:0032075 | positive regulation of nuclease activity(GO:0032075) |
0.9 | 0.9 | GO:0060379 | cardiac muscle cell myoblast differentiation(GO:0060379) |
0.9 | 0.9 | GO:0033210 | leptin-mediated signaling pathway(GO:0033210) |
0.9 | 6.5 | GO:0070863 | positive regulation of protein exit from endoplasmic reticulum(GO:0070863) |
0.9 | 3.7 | GO:1903553 | positive regulation of extracellular exosome assembly(GO:1903553) |
0.9 | 3.7 | GO:0071763 | nuclear membrane organization(GO:0071763) |
0.9 | 7.4 | GO:0043129 | surfactant homeostasis(GO:0043129) |
0.9 | 1.9 | GO:0032202 | telomere assembly(GO:0032202) |
0.9 | 1.9 | GO:1990928 | response to amino acid starvation(GO:1990928) |
0.9 | 4.6 | GO:0048563 | post-embryonic organ morphogenesis(GO:0048563) |
0.9 | 25.8 | GO:0030326 | embryonic limb morphogenesis(GO:0030326) embryonic appendage morphogenesis(GO:0035113) |
0.9 | 4.6 | GO:0033572 | transferrin transport(GO:0033572) |
0.9 | 2.8 | GO:0048023 | positive regulation of melanin biosynthetic process(GO:0048023) positive regulation of secondary metabolite biosynthetic process(GO:1900378) |
0.9 | 1.8 | GO:0002752 | cell surface pattern recognition receptor signaling pathway(GO:0002752) |
0.9 | 1.8 | GO:0060390 | regulation of SMAD protein import into nucleus(GO:0060390) |
0.9 | 5.5 | GO:0014807 | regulation of somitogenesis(GO:0014807) |
0.9 | 5.5 | GO:0050765 | negative regulation of phagocytosis(GO:0050765) |
0.9 | 5.5 | GO:0031053 | primary miRNA processing(GO:0031053) |
0.9 | 3.7 | GO:0090156 | negative regulation of sphingolipid biosynthetic process(GO:0090155) cellular sphingolipid homeostasis(GO:0090156) |
0.9 | 0.9 | GO:0032782 | bile acid secretion(GO:0032782) |
0.9 | 2.7 | GO:0038026 | reelin-mediated signaling pathway(GO:0038026) |
0.9 | 0.9 | GO:0072053 | renal inner medulla development(GO:0072053) |
0.9 | 0.9 | GO:0032803 | low-density lipoprotein particle receptor catabolic process(GO:0032802) regulation of low-density lipoprotein particle receptor catabolic process(GO:0032803) negative regulation of receptor catabolic process(GO:2000645) |
0.9 | 0.9 | GO:0060718 | chorionic trophoblast cell differentiation(GO:0060718) |
0.9 | 13.6 | GO:0016339 | calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules(GO:0016339) |
0.9 | 3.6 | GO:1901678 | iron coordination entity transport(GO:1901678) |
0.9 | 1.8 | GO:0002351 | serotonin production involved in inflammatory response(GO:0002351) serotonin secretion involved in inflammatory response(GO:0002442) |
0.9 | 4.5 | GO:0051451 | myoblast migration(GO:0051451) |
0.9 | 3.6 | GO:0035814 | negative regulation of renal sodium excretion(GO:0035814) |
0.9 | 4.5 | GO:0050930 | induction of positive chemotaxis(GO:0050930) |
0.9 | 0.9 | GO:0032875 | regulation of DNA endoreduplication(GO:0032875) DNA endoreduplication(GO:0042023) |
0.9 | 1.8 | GO:0010897 | negative regulation of triglyceride catabolic process(GO:0010897) |
0.9 | 3.6 | GO:0097428 | protein maturation by iron-sulfur cluster transfer(GO:0097428) |
0.9 | 4.4 | GO:0050755 | chemokine metabolic process(GO:0050755) |
0.9 | 0.9 | GO:0006113 | fermentation(GO:0006113) glucose catabolic process to lactate(GO:0019659) glycolytic fermentation(GO:0019660) glucose catabolic process to lactate via pyruvate(GO:0019661) |
0.9 | 2.7 | GO:0015747 | urate transport(GO:0015747) |
0.9 | 7.1 | GO:0045721 | negative regulation of gluconeogenesis(GO:0045721) |
0.9 | 1.8 | GO:0060762 | regulation of branching involved in mammary gland duct morphogenesis(GO:0060762) |
0.9 | 6.2 | GO:0035721 | intraciliary retrograde transport(GO:0035721) |
0.9 | 3.5 | GO:0018214 | protein carboxylation(GO:0018214) |
0.9 | 0.9 | GO:2000097 | regulation of smooth muscle cell-matrix adhesion(GO:2000097) |
0.9 | 4.4 | GO:0010961 | cellular magnesium ion homeostasis(GO:0010961) |
0.9 | 2.6 | GO:0042167 | heme catabolic process(GO:0042167) pigment catabolic process(GO:0046149) |
0.9 | 7.0 | GO:0009186 | deoxyribonucleoside diphosphate metabolic process(GO:0009186) |
0.9 | 2.6 | GO:0046642 | negative regulation of alpha-beta T cell proliferation(GO:0046642) |
0.9 | 1.7 | GO:0050687 | negative regulation of defense response to virus(GO:0050687) |
0.9 | 0.9 | GO:0002125 | maternal aggressive behavior(GO:0002125) |
0.9 | 1.7 | GO:0010748 | negative regulation of plasma membrane long-chain fatty acid transport(GO:0010748) |
0.9 | 1.7 | GO:0033504 | floor plate development(GO:0033504) |
0.9 | 0.9 | GO:0006990 | positive regulation of transcription from RNA polymerase II promoter involved in unfolded protein response(GO:0006990) |
0.9 | 2.6 | GO:0043922 | negative regulation by host of viral transcription(GO:0043922) |
0.9 | 2.6 | GO:0071816 | protein insertion into ER membrane(GO:0045048) tail-anchored membrane protein insertion into ER membrane(GO:0071816) |
0.9 | 0.9 | GO:0033184 | positive regulation of histone ubiquitination(GO:0033184) |
0.9 | 4.3 | GO:0045332 | phospholipid translocation(GO:0045332) |
0.9 | 0.9 | GO:0001560 | regulation of cell growth by extracellular stimulus(GO:0001560) |
0.9 | 2.6 | GO:1990414 | replication-born double-strand break repair via sister chromatid exchange(GO:1990414) |
0.9 | 2.6 | GO:0051964 | negative regulation of synapse assembly(GO:0051964) |
0.9 | 9.5 | GO:0035879 | lactate transport(GO:0015727) lactate transmembrane transport(GO:0035873) plasma membrane lactate transport(GO:0035879) |
0.9 | 3.4 | GO:0090557 | establishment of endothelial intestinal barrier(GO:0090557) |
0.9 | 1.7 | GO:0045917 | positive regulation of complement activation(GO:0045917) positive regulation of protein activation cascade(GO:2000259) |
0.9 | 3.4 | GO:1901727 | positive regulation of histone deacetylase activity(GO:1901727) |
0.9 | 3.4 | GO:1903300 | negative regulation of glucokinase activity(GO:0033132) negative regulation of hexokinase activity(GO:1903300) |
0.9 | 3.4 | GO:0006907 | pinocytosis(GO:0006907) |
0.9 | 4.3 | GO:0008063 | Toll signaling pathway(GO:0008063) |
0.9 | 17.9 | GO:0015701 | bicarbonate transport(GO:0015701) |
0.8 | 5.1 | GO:0050917 | sensory perception of umami taste(GO:0050917) |
0.8 | 2.5 | GO:0070345 | negative regulation of fat cell proliferation(GO:0070345) |
0.8 | 1.7 | GO:0006166 | purine ribonucleoside salvage(GO:0006166) |
0.8 | 1.7 | GO:2001032 | regulation of double-strand break repair via nonhomologous end joining(GO:2001032) |
0.8 | 2.5 | GO:0015705 | iodide transport(GO:0015705) |
0.8 | 6.7 | GO:0006123 | mitochondrial electron transport, cytochrome c to oxygen(GO:0006123) |
0.8 | 2.5 | GO:0014733 | regulation of skeletal muscle adaptation(GO:0014733) |
0.8 | 6.7 | GO:0097284 | hepatocyte apoptotic process(GO:0097284) |
0.8 | 0.8 | GO:0008215 | polyamine catabolic process(GO:0006598) spermine metabolic process(GO:0008215) spermine catabolic process(GO:0046208) |
0.8 | 9.2 | GO:1900017 | positive regulation of cytokine production involved in inflammatory response(GO:1900017) |
0.8 | 2.5 | GO:0035358 | regulation of peroxisome proliferator activated receptor signaling pathway(GO:0035358) |
0.8 | 0.8 | GO:0001834 | trophectodermal cell proliferation(GO:0001834) |
0.8 | 3.3 | GO:1902626 | assembly of large subunit precursor of preribosome(GO:1902626) |
0.8 | 0.8 | GO:0032329 | serine transport(GO:0032329) |
0.8 | 5.8 | GO:2000353 | positive regulation of endothelial cell apoptotic process(GO:2000353) |
0.8 | 4.9 | GO:0050667 | homocysteine metabolic process(GO:0050667) |
0.8 | 11.5 | GO:0010761 | fibroblast migration(GO:0010761) |
0.8 | 2.5 | GO:0060539 | diaphragm development(GO:0060539) |
0.8 | 4.1 | GO:0032464 | positive regulation of protein homooligomerization(GO:0032464) |
0.8 | 0.8 | GO:1903899 | positive regulation of PERK-mediated unfolded protein response(GO:1903899) |
0.8 | 5.7 | GO:0010226 | response to lithium ion(GO:0010226) |
0.8 | 2.4 | GO:2000767 | positive regulation of cytoplasmic translation(GO:2000767) |
0.8 | 4.9 | GO:0051026 | chiasma assembly(GO:0051026) |
0.8 | 1.6 | GO:0046643 | regulation of gamma-delta T cell differentiation(GO:0045586) regulation of gamma-delta T cell activation(GO:0046643) |
0.8 | 4.8 | GO:1900364 | negative regulation of mRNA polyadenylation(GO:1900364) |
0.8 | 0.8 | GO:0002874 | chronic inflammatory response to antigenic stimulus(GO:0002439) regulation of chronic inflammatory response to antigenic stimulus(GO:0002874) |
0.8 | 3.2 | GO:0009299 | mRNA transcription(GO:0009299) |
0.8 | 0.8 | GO:1900121 | negative regulation of receptor binding(GO:1900121) |
0.8 | 5.6 | GO:2001241 | positive regulation of extrinsic apoptotic signaling pathway in absence of ligand(GO:2001241) |
0.8 | 3.9 | GO:1901223 | negative regulation of NIK/NF-kappaB signaling(GO:1901223) |
0.8 | 2.4 | GO:0002414 | immunoglobulin transcytosis in epithelial cells(GO:0002414) |
0.8 | 3.9 | GO:0006528 | asparagine metabolic process(GO:0006528) |
0.8 | 3.1 | GO:0048251 | elastic fiber assembly(GO:0048251) |
0.8 | 1.6 | GO:0006562 | proline catabolic process(GO:0006562) |
0.8 | 3.9 | GO:0010838 | positive regulation of keratinocyte proliferation(GO:0010838) |
0.8 | 0.8 | GO:0002726 | positive regulation of T cell cytokine production(GO:0002726) |
0.8 | 1.6 | GO:0048296 | isotype switching to IgA isotypes(GO:0048290) regulation of isotype switching to IgA isotypes(GO:0048296) |
0.8 | 2.3 | GO:1990036 | calcium ion import into sarcoplasmic reticulum(GO:1990036) |
0.8 | 1.6 | GO:2000110 | negative regulation of macrophage apoptotic process(GO:2000110) |
0.8 | 1.6 | GO:0090031 | positive regulation of steroid hormone biosynthetic process(GO:0090031) |
0.8 | 7.0 | GO:0060216 | definitive hemopoiesis(GO:0060216) |
0.8 | 2.3 | GO:1904668 | positive regulation of ubiquitin protein ligase activity(GO:1904668) |
0.8 | 0.8 | GO:2000507 | positive regulation of energy homeostasis(GO:2000507) |
0.8 | 3.1 | GO:0032000 | positive regulation of fatty acid beta-oxidation(GO:0032000) |
0.8 | 1.5 | GO:0021798 | forebrain dorsal/ventral pattern formation(GO:0021798) |
0.8 | 2.3 | GO:0072530 | purine nucleoside transmembrane transport(GO:0015860) purine-containing compound transmembrane transport(GO:0072530) nucleoside transmembrane transport(GO:1901642) |
0.8 | 3.8 | GO:0045040 | protein import into mitochondrial outer membrane(GO:0045040) |
0.8 | 3.1 | GO:0048739 | cardiac muscle fiber development(GO:0048739) |
0.8 | 0.8 | GO:0033622 | integrin activation(GO:0033622) |
0.8 | 2.3 | GO:0031937 | positive regulation of chromatin silencing(GO:0031937) |
0.8 | 1.5 | GO:0001866 | NK T cell proliferation(GO:0001866) |
0.8 | 2.3 | GO:0034144 | negative regulation of toll-like receptor 4 signaling pathway(GO:0034144) |
0.8 | 6.1 | GO:0006677 | glycosylceramide metabolic process(GO:0006677) |
0.8 | 0.8 | GO:0035520 | monoubiquitinated protein deubiquitination(GO:0035520) |
0.8 | 5.3 | GO:0043249 | erythrocyte maturation(GO:0043249) |
0.8 | 3.8 | GO:2001214 | positive regulation of vasculogenesis(GO:2001214) |
0.8 | 3.8 | GO:0042517 | positive regulation of tyrosine phosphorylation of Stat3 protein(GO:0042517) |
0.8 | 3.0 | GO:0048304 | positive regulation of isotype switching to IgG isotypes(GO:0048304) |
0.8 | 2.3 | GO:0007039 | protein catabolic process in the vacuole(GO:0007039) |
0.8 | 0.8 | GO:2000826 | regulation of heart morphogenesis(GO:2000826) |
0.8 | 6.8 | GO:0042159 | lipoprotein catabolic process(GO:0042159) |
0.7 | 2.2 | GO:2001260 | regulation of semaphorin-plexin signaling pathway(GO:2001260) |
0.7 | 1.5 | GO:2000359 | regulation of binding of sperm to zona pellucida(GO:2000359) |
0.7 | 1.5 | GO:0051081 | membrane disassembly(GO:0030397) nuclear envelope disassembly(GO:0051081) |
0.7 | 3.0 | GO:0038031 | non-canonical Wnt signaling pathway via JNK cascade(GO:0038031) |
0.7 | 10.4 | GO:0006144 | purine nucleobase metabolic process(GO:0006144) |
0.7 | 0.7 | GO:1900368 | regulation of RNA interference(GO:1900368) |
0.7 | 3.7 | GO:0060135 | maternal process involved in female pregnancy(GO:0060135) |
0.7 | 0.7 | GO:0030908 | intein-mediated protein splicing(GO:0016539) protein splicing(GO:0030908) |
0.7 | 14.7 | GO:0030865 | cortical cytoskeleton organization(GO:0030865) |
0.7 | 4.4 | GO:0032060 | bleb assembly(GO:0032060) |
0.7 | 6.6 | GO:1903504 | regulation of mitotic cell cycle spindle assembly checkpoint(GO:0090266) regulation of mitotic spindle checkpoint(GO:1903504) |
0.7 | 0.7 | GO:1902165 | regulation of intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator(GO:1902165) |
0.7 | 3.6 | GO:0007168 | receptor guanylyl cyclase signaling pathway(GO:0007168) |
0.7 | 1.5 | GO:0071462 | cellular response to water stimulus(GO:0071462) |
0.7 | 3.6 | GO:0030213 | hyaluronan biosynthetic process(GO:0030213) |
0.7 | 0.7 | GO:1900193 | regulation of oocyte maturation(GO:1900193) |
0.7 | 2.9 | GO:0030309 | poly-N-acetyllactosamine metabolic process(GO:0030309) poly-N-acetyllactosamine biosynthetic process(GO:0030311) |
0.7 | 10.1 | GO:0000028 | ribosomal small subunit assembly(GO:0000028) |
0.7 | 2.2 | GO:0046341 | CDP-diacylglycerol metabolic process(GO:0046341) |
0.7 | 5.8 | GO:0042730 | fibrinolysis(GO:0042730) |
0.7 | 5.8 | GO:0006855 | drug transmembrane transport(GO:0006855) |
0.7 | 2.9 | GO:0006116 | NADH oxidation(GO:0006116) |
0.7 | 5.7 | GO:1900119 | positive regulation of execution phase of apoptosis(GO:1900119) |
0.7 | 1.4 | GO:0046340 | diacylglycerol catabolic process(GO:0046340) |
0.7 | 5.7 | GO:0043217 | myelin maintenance(GO:0043217) |
0.7 | 0.7 | GO:0048633 | positive regulation of skeletal muscle tissue growth(GO:0048633) |
0.7 | 0.7 | GO:0036016 | response to interleukin-3(GO:0036015) cellular response to interleukin-3(GO:0036016) |
0.7 | 2.1 | GO:1902268 | negative regulation of polyamine transmembrane transport(GO:1902268) |
0.7 | 0.7 | GO:0033030 | negative regulation of neutrophil apoptotic process(GO:0033030) |
0.7 | 7.1 | GO:0000737 | DNA catabolic process, endonucleolytic(GO:0000737) |
0.7 | 1.4 | GO:0090370 | negative regulation of cholesterol efflux(GO:0090370) |
0.7 | 2.8 | GO:0045792 | negative regulation of cell size(GO:0045792) |
0.7 | 2.1 | GO:0042359 | vitamin D metabolic process(GO:0042359) |
0.7 | 1.4 | GO:0046135 | pyrimidine ribonucleoside catabolic process(GO:0046133) pyrimidine nucleoside catabolic process(GO:0046135) |
0.7 | 2.1 | GO:0006768 | biotin metabolic process(GO:0006768) |
0.7 | 2.1 | GO:0035694 | mitochondrial protein catabolic process(GO:0035694) |
0.7 | 2.1 | GO:0031118 | rRNA pseudouridine synthesis(GO:0031118) |
0.7 | 2.8 | GO:0070127 | tRNA aminoacylation for mitochondrial protein translation(GO:0070127) |
0.7 | 2.1 | GO:0006597 | spermine biosynthetic process(GO:0006597) |
0.7 | 4.1 | GO:0002693 | positive regulation of cellular extravasation(GO:0002693) |
0.7 | 2.8 | GO:0061029 | eyelid development in camera-type eye(GO:0061029) |
0.7 | 2.8 | GO:0060213 | regulation of nuclear-transcribed mRNA poly(A) tail shortening(GO:0060211) positive regulation of nuclear-transcribed mRNA poly(A) tail shortening(GO:0060213) |
0.7 | 2.8 | GO:0032933 | response to sterol depletion(GO:0006991) SREBP signaling pathway(GO:0032933) cellular response to sterol depletion(GO:0071501) |
0.7 | 0.7 | GO:1901723 | negative regulation of cell proliferation involved in kidney development(GO:1901723) |
0.7 | 4.1 | GO:0044872 | lipoprotein transport(GO:0042953) lipoprotein localization(GO:0044872) |
0.7 | 2.1 | GO:0007097 | nuclear migration(GO:0007097) |
0.7 | 0.7 | GO:0036123 | histone H3-K9 dimethylation(GO:0036123) |
0.7 | 0.7 | GO:0060572 | morphogenesis of an epithelial bud(GO:0060572) |
0.7 | 6.8 | GO:0018904 | ether metabolic process(GO:0018904) |
0.7 | 1.4 | GO:0030578 | PML body organization(GO:0030578) |
0.7 | 3.4 | GO:0000103 | sulfate assimilation(GO:0000103) |
0.7 | 4.1 | GO:0070493 | thrombin receptor signaling pathway(GO:0070493) |
0.7 | 2.7 | GO:0032196 | transposition(GO:0032196) |
0.7 | 1.3 | GO:0044004 | killing by symbiont of host cells(GO:0001907) disruption by symbiont of host cell(GO:0044004) |
0.7 | 3.4 | GO:0071157 | negative regulation of cell cycle arrest(GO:0071157) |
0.7 | 1.3 | GO:0072310 | glomerular visceral epithelial cell development(GO:0072015) glomerular epithelial cell development(GO:0072310) |
0.7 | 2.0 | GO:0060988 | lipid tube assembly(GO:0060988) |
0.7 | 2.0 | GO:0010273 | detoxification of copper ion(GO:0010273) stress response to copper ion(GO:1990169) |
0.7 | 1.3 | GO:0010936 | negative regulation of macrophage cytokine production(GO:0010936) |
0.7 | 3.4 | GO:0001672 | regulation of chromatin assembly or disassembly(GO:0001672) |
0.7 | 2.7 | GO:2000051 | negative regulation of non-canonical Wnt signaling pathway(GO:2000051) |
0.7 | 1.3 | GO:0016480 | negative regulation of transcription from RNA polymerase III promoter(GO:0016480) |
0.7 | 4.0 | GO:0030206 | chondroitin sulfate biosynthetic process(GO:0030206) |
0.7 | 2.0 | GO:0045964 | positive regulation of catecholamine metabolic process(GO:0045915) positive regulation of dopamine metabolic process(GO:0045964) |
0.7 | 0.7 | GO:2000017 | positive regulation of determination of dorsal identity(GO:2000017) |
0.7 | 0.7 | GO:0006001 | fructose catabolic process(GO:0006001) fructose catabolic process to hydroxyacetone phosphate and glyceraldehyde-3-phosphate(GO:0061624) glycolytic process through fructose-1-phosphate(GO:0061625) |
0.7 | 0.7 | GO:0035137 | hindlimb morphogenesis(GO:0035137) |
0.7 | 0.7 | GO:0035630 | bone mineralization involved in bone maturation(GO:0035630) |
0.7 | 0.7 | GO:0070234 | positive regulation of T cell apoptotic process(GO:0070234) |
0.7 | 5.3 | GO:0071578 | zinc II ion transmembrane import(GO:0071578) |
0.7 | 5.3 | GO:0000059 | protein import into nucleus, docking(GO:0000059) |
0.7 | 0.7 | GO:0035988 | chondrocyte proliferation(GO:0035988) |
0.7 | 2.6 | GO:0008090 | retrograde axonal transport(GO:0008090) |
0.7 | 3.3 | GO:0046874 | quinolinate metabolic process(GO:0046874) |
0.7 | 1.3 | GO:0002634 | regulation of germinal center formation(GO:0002634) |
0.7 | 0.7 | GO:0009750 | response to fructose(GO:0009750) cellular response to fructose stimulus(GO:0071332) |
0.7 | 1.3 | GO:0031296 | B cell costimulation(GO:0031296) |
0.7 | 1.3 | GO:0019042 | viral latency(GO:0019042) |
0.6 | 3.9 | GO:0008216 | spermidine metabolic process(GO:0008216) |
0.6 | 3.2 | GO:0015712 | hexose phosphate transport(GO:0015712) glucose-6-phosphate transport(GO:0015760) |
0.6 | 7.1 | GO:0048305 | immunoglobulin secretion(GO:0048305) |
0.6 | 1.3 | GO:1901164 | negative regulation of trophoblast cell migration(GO:1901164) |
0.6 | 1.3 | GO:0002337 | B-1a B cell differentiation(GO:0002337) |
0.6 | 1.9 | GO:0015889 | cobalamin transport(GO:0015889) |
0.6 | 2.6 | GO:0034379 | very-low-density lipoprotein particle assembly(GO:0034379) |
0.6 | 41.0 | GO:0001890 | placenta development(GO:0001890) |
0.6 | 2.6 | GO:0060147 | regulation of posttranscriptional gene silencing(GO:0060147) regulation of gene silencing by RNA(GO:0060966) |
0.6 | 7.0 | GO:0031571 | mitotic G1 DNA damage checkpoint(GO:0031571) |
0.6 | 2.6 | GO:0045136 | development of secondary sexual characteristics(GO:0045136) |
0.6 | 1.3 | GO:0072033 | renal vesicle formation(GO:0072033) ureteric bud invasion(GO:0072092) |
0.6 | 1.9 | GO:0033631 | cell-cell adhesion mediated by integrin(GO:0033631) |
0.6 | 1.9 | GO:1902895 | positive regulation of pri-miRNA transcription from RNA polymerase II promoter(GO:1902895) |
0.6 | 1.9 | GO:0032485 | regulation of Ral protein signal transduction(GO:0032485) |
0.6 | 1.3 | GO:1990441 | negative regulation of transcription from RNA polymerase II promoter in response to endoplasmic reticulum stress(GO:1990441) |
0.6 | 4.4 | GO:0032967 | positive regulation of collagen biosynthetic process(GO:0032967) |
0.6 | 1.9 | GO:0000183 | chromatin silencing at rDNA(GO:0000183) |
0.6 | 2.5 | GO:0045717 | negative regulation of fatty acid biosynthetic process(GO:0045717) |
0.6 | 3.7 | GO:0006450 | regulation of translational fidelity(GO:0006450) |
0.6 | 0.6 | GO:0042088 | T-helper 1 type immune response(GO:0042088) |
0.6 | 0.6 | GO:1901896 | positive regulation of calcium-transporting ATPase activity(GO:1901896) |
0.6 | 2.5 | GO:0042104 | positive regulation of activated T cell proliferation(GO:0042104) |
0.6 | 1.8 | GO:0006420 | arginyl-tRNA aminoacylation(GO:0006420) |
0.6 | 0.6 | GO:1903116 | positive regulation of actin filament-based movement(GO:1903116) |
0.6 | 1.2 | GO:0002322 | B cell proliferation involved in immune response(GO:0002322) |
0.6 | 2.4 | GO:0071918 | urea transmembrane transport(GO:0071918) |
0.6 | 1.8 | GO:0045839 | negative regulation of mitotic nuclear division(GO:0045839) |
0.6 | 1.8 | GO:0043201 | response to leucine(GO:0043201) cellular response to leucine(GO:0071233) |
0.6 | 0.6 | GO:0048333 | mesodermal cell differentiation(GO:0048333) |
0.6 | 0.6 | GO:2000048 | negative regulation of cell-cell adhesion mediated by cadherin(GO:2000048) |
0.6 | 0.6 | GO:0006901 | vesicle coating(GO:0006901) |
0.6 | 1.8 | GO:0048539 | bone marrow development(GO:0048539) |
0.6 | 2.4 | GO:0007023 | post-chaperonin tubulin folding pathway(GO:0007023) |
0.6 | 1.2 | GO:0014866 | skeletal myofibril assembly(GO:0014866) |
0.6 | 2.4 | GO:0090527 | actin filament reorganization(GO:0090527) |
0.6 | 1.2 | GO:0044557 | relaxation of smooth muscle(GO:0044557) relaxation of vascular smooth muscle(GO:0060087) |
0.6 | 5.3 | GO:0007288 | sperm axoneme assembly(GO:0007288) |
0.6 | 0.6 | GO:0097070 | ductus arteriosus closure(GO:0097070) |
0.6 | 2.4 | GO:0009162 | deoxyribonucleoside monophosphate metabolic process(GO:0009162) |
0.6 | 0.6 | GO:0032790 | ribosome disassembly(GO:0032790) |
0.6 | 4.1 | GO:0030212 | hyaluronan metabolic process(GO:0030212) |
0.6 | 2.9 | GO:0043173 | nucleotide salvage(GO:0043173) |
0.6 | 0.6 | GO:0001777 | T cell homeostatic proliferation(GO:0001777) regulation of T cell homeostatic proliferation(GO:0046013) |
0.6 | 1.7 | GO:0071361 | cellular response to ethanol(GO:0071361) |
0.6 | 1.2 | GO:0030208 | dermatan sulfate biosynthetic process(GO:0030208) |
0.6 | 4.7 | GO:0000188 | inactivation of MAPK activity(GO:0000188) |
0.6 | 3.5 | GO:0008298 | intracellular mRNA localization(GO:0008298) |
0.6 | 0.6 | GO:0061156 | pulmonary artery morphogenesis(GO:0061156) |
0.6 | 4.0 | GO:0032460 | negative regulation of protein oligomerization(GO:0032460) |
0.6 | 0.6 | GO:0042360 | vitamin E metabolic process(GO:0042360) |
0.6 | 2.3 | GO:0007379 | segment specification(GO:0007379) |
0.6 | 2.3 | GO:0052055 | modulation by symbiont of host molecular function(GO:0052055) |
0.6 | 0.6 | GO:0006188 | IMP biosynthetic process(GO:0006188) |
0.6 | 2.9 | GO:0000972 | transcription-dependent tethering of RNA polymerase II gene DNA at nuclear periphery(GO:0000972) |
0.6 | 1.1 | GO:0033260 | nuclear DNA replication(GO:0033260) |
0.6 | 1.7 | GO:0009629 | response to gravity(GO:0009629) |
0.6 | 1.7 | GO:0002017 | regulation of blood volume by renal aldosterone(GO:0002017) |
0.6 | 0.6 | GO:0090335 | regulation of brown fat cell differentiation(GO:0090335) |
0.6 | 0.6 | GO:0033087 | negative regulation of immature T cell proliferation(GO:0033087) |
0.6 | 1.7 | GO:0051775 | response to redox state(GO:0051775) |
0.6 | 1.7 | GO:0014043 | negative regulation of neuron maturation(GO:0014043) |
0.6 | 1.1 | GO:0072395 | signal transduction involved in cell cycle checkpoint(GO:0072395) signal transduction involved in DNA integrity checkpoint(GO:0072401) signal transduction involved in DNA damage checkpoint(GO:0072422) |
0.6 | 2.8 | GO:0045723 | positive regulation of fatty acid biosynthetic process(GO:0045723) |
0.6 | 0.6 | GO:0071455 | cellular response to increased oxygen levels(GO:0036295) cellular response to hyperoxia(GO:0071455) |
0.6 | 2.8 | GO:0030575 | nuclear body organization(GO:0030575) |
0.6 | 1.1 | GO:0043379 | memory T cell differentiation(GO:0043379) |
0.6 | 0.6 | GO:0035092 | sperm chromatin condensation(GO:0035092) |
0.6 | 1.1 | GO:0032483 | regulation of Rab protein signal transduction(GO:0032483) |
0.6 | 5.0 | GO:0000244 | spliceosomal tri-snRNP complex assembly(GO:0000244) |
0.6 | 2.2 | GO:0015868 | purine ribonucleotide transport(GO:0015868) |
0.6 | 7.7 | GO:0006379 | mRNA cleavage(GO:0006379) |
0.6 | 1.7 | GO:0018343 | protein farnesylation(GO:0018343) |
0.6 | 1.7 | GO:1903543 | regulation of exosomal secretion(GO:1903541) positive regulation of exosomal secretion(GO:1903543) |
0.6 | 0.6 | GO:0060968 | regulation of gene silencing(GO:0060968) |
0.6 | 1.7 | GO:0090219 | negative regulation of lipid kinase activity(GO:0090219) |
0.5 | 1.1 | GO:0031052 | programmed DNA elimination(GO:0031049) chromosome breakage(GO:0031052) |
0.5 | 6.0 | GO:0003351 | epithelial cilium movement(GO:0003351) |
0.5 | 1.1 | GO:0042769 | DNA damage response, detection of DNA damage(GO:0042769) |
0.5 | 3.3 | GO:0046851 | negative regulation of bone resorption(GO:0045779) negative regulation of bone remodeling(GO:0046851) |
0.5 | 1.1 | GO:0036492 | regulation of translation in response to endoplasmic reticulum stress(GO:0036490) regulation of translation initiation in response to endoplasmic reticulum stress(GO:0036491) eiF2alpha phosphorylation in response to endoplasmic reticulum stress(GO:0036492) negative regulation of endoplasmic reticulum stress-induced eIF2 alpha phosphorylation(GO:1903912) |
0.5 | 2.2 | GO:1902231 | positive regulation of intrinsic apoptotic signaling pathway in response to DNA damage(GO:1902231) |
0.5 | 1.1 | GO:0006566 | threonine metabolic process(GO:0006566) |
0.5 | 0.5 | GO:0097501 | stress response to metal ion(GO:0097501) |
0.5 | 0.5 | GO:0050748 | negative regulation of lipoprotein metabolic process(GO:0050748) |
0.5 | 2.2 | GO:0051988 | regulation of attachment of spindle microtubules to kinetochore(GO:0051988) |
0.5 | 2.2 | GO:0042149 | cellular response to glucose starvation(GO:0042149) |
0.5 | 4.9 | GO:0042744 | hydrogen peroxide catabolic process(GO:0042744) |
0.5 | 4.9 | GO:0006047 | UDP-N-acetylglucosamine metabolic process(GO:0006047) |
0.5 | 2.2 | GO:0016584 | nucleosome positioning(GO:0016584) |
0.5 | 1.6 | GO:0006624 | vacuolar protein processing(GO:0006624) |
0.5 | 1.1 | GO:0018208 | peptidyl-proline modification(GO:0018208) |
0.5 | 8.6 | GO:0045071 | negative regulation of viral genome replication(GO:0045071) |
0.5 | 2.2 | GO:0035330 | regulation of hippo signaling(GO:0035330) |
0.5 | 0.5 | GO:0033326 | cerebrospinal fluid secretion(GO:0033326) |
0.5 | 1.1 | GO:0035973 | aggrephagy(GO:0035973) |
0.5 | 6.4 | GO:0046174 | polyol catabolic process(GO:0046174) |
0.5 | 0.5 | GO:0072718 | response to cisplatin(GO:0072718) |
0.5 | 1.1 | GO:0003091 | renal water homeostasis(GO:0003091) |
0.5 | 1.6 | GO:0006285 | base-excision repair, AP site formation(GO:0006285) |
0.5 | 1.1 | GO:0043328 | late endosome to vacuole transport via multivesicular body sorting pathway(GO:0032511) protein targeting to vacuole involved in ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway(GO:0043328) |
0.5 | 1.1 | GO:0002361 | CD4-positive, CD25-positive, alpha-beta regulatory T cell differentiation(GO:0002361) |
0.5 | 9.0 | GO:0010862 | positive regulation of pathway-restricted SMAD protein phosphorylation(GO:0010862) |
0.5 | 1.1 | GO:0070164 | negative regulation of adiponectin secretion(GO:0070164) |
0.5 | 1.6 | GO:0030857 | negative regulation of epithelial cell differentiation(GO:0030857) |
0.5 | 4.8 | GO:0036159 | inner dynein arm assembly(GO:0036159) |
0.5 | 6.3 | GO:0006693 | prostanoid metabolic process(GO:0006692) prostaglandin metabolic process(GO:0006693) |
0.5 | 3.7 | GO:0015838 | amino-acid betaine transport(GO:0015838) |
0.5 | 0.5 | GO:1904684 | regulation of metalloendopeptidase activity(GO:1904683) negative regulation of metalloendopeptidase activity(GO:1904684) negative regulation of metallopeptidase activity(GO:1905049) |
0.5 | 3.1 | GO:0045351 | type I interferon biosynthetic process(GO:0045351) |
0.5 | 0.5 | GO:1900739 | regulation of protein insertion into mitochondrial membrane involved in apoptotic signaling pathway(GO:1900739) positive regulation of protein insertion into mitochondrial membrane involved in apoptotic signaling pathway(GO:1900740) |
0.5 | 0.5 | GO:0021538 | epithalamus development(GO:0021538) habenula development(GO:0021986) |
0.5 | 1.5 | GO:0090080 | positive regulation of MAPKKK cascade by fibroblast growth factor receptor signaling pathway(GO:0090080) |
0.5 | 1.0 | GO:0045683 | negative regulation of epidermis development(GO:0045683) |
0.5 | 2.0 | GO:0051694 | pointed-end actin filament capping(GO:0051694) |
0.5 | 5.6 | GO:0006471 | protein ADP-ribosylation(GO:0006471) |
0.5 | 0.5 | GO:0018894 | dibenzo-p-dioxin metabolic process(GO:0018894) |
0.5 | 3.0 | GO:0001833 | inner cell mass cell proliferation(GO:0001833) |
0.5 | 1.0 | GO:1903715 | regulation of aerobic respiration(GO:1903715) |
0.5 | 3.5 | GO:0048535 | lymph node development(GO:0048535) |
0.5 | 1.0 | GO:0051661 | maintenance of centrosome location(GO:0051661) |
0.5 | 1.5 | GO:1902608 | regulation of large conductance calcium-activated potassium channel activity(GO:1902606) positive regulation of large conductance calcium-activated potassium channel activity(GO:1902608) |
0.5 | 4.5 | GO:0070269 | pyroptosis(GO:0070269) |
0.5 | 2.5 | GO:0031935 | regulation of chromatin silencing(GO:0031935) |
0.5 | 2.0 | GO:0043985 | histone H4-R3 methylation(GO:0043985) |
0.5 | 1.0 | GO:2000679 | positive regulation of transcription regulatory region DNA binding(GO:2000679) |
0.5 | 3.5 | GO:0009396 | folic acid-containing compound biosynthetic process(GO:0009396) |
0.5 | 6.5 | GO:0006801 | superoxide metabolic process(GO:0006801) |
0.5 | 5.0 | GO:0051984 | positive regulation of chromosome segregation(GO:0051984) |
0.5 | 2.0 | GO:1902230 | negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage(GO:1902230) |
0.5 | 0.5 | GO:2000354 | regulation of ovarian follicle development(GO:2000354) |
0.5 | 6.5 | GO:0002903 | negative regulation of B cell apoptotic process(GO:0002903) |
0.5 | 3.0 | GO:0071318 | cellular response to ATP(GO:0071318) |
0.5 | 1.5 | GO:0033273 | response to vitamin(GO:0033273) |
0.5 | 1.0 | GO:0007290 | spermatid nucleus elongation(GO:0007290) |
0.5 | 3.0 | GO:0019262 | N-acetylneuraminate catabolic process(GO:0019262) |
0.5 | 1.0 | GO:0002378 | immunoglobulin biosynthetic process(GO:0002378) |
0.5 | 0.5 | GO:0010693 | negative regulation of alkaline phosphatase activity(GO:0010693) |
0.5 | 4.4 | GO:0034723 | DNA replication-dependent nucleosome assembly(GO:0006335) DNA replication-dependent nucleosome organization(GO:0034723) |
0.5 | 10.7 | GO:0000027 | ribosomal large subunit assembly(GO:0000027) |
0.5 | 0.5 | GO:1904354 | negative regulation of telomere capping(GO:1904354) |
0.5 | 1.0 | GO:0035519 | protein K29-linked ubiquitination(GO:0035519) |
0.5 | 1.5 | GO:0065005 | protein-lipid complex assembly(GO:0065005) |
0.5 | 1.5 | GO:1903232 | melanosome assembly(GO:1903232) |
0.5 | 1.9 | GO:2000254 | regulation of male germ cell proliferation(GO:2000254) |
0.5 | 1.0 | GO:0051466 | positive regulation of corticotropin-releasing hormone secretion(GO:0051466) |
0.5 | 1.0 | GO:0046016 | positive regulation of transcription by glucose(GO:0046016) |
0.5 | 0.5 | GO:1901668 | regulation of superoxide dismutase activity(GO:1901668) |
0.5 | 0.5 | GO:0009957 | epidermal cell fate specification(GO:0009957) |
0.5 | 1.4 | GO:0035526 | retrograde transport, plasma membrane to Golgi(GO:0035526) |
0.5 | 1.0 | GO:0043366 | beta selection(GO:0043366) |
0.5 | 1.0 | GO:0046121 | deoxyribonucleoside catabolic process(GO:0046121) |
0.5 | 1.4 | GO:0008292 | acetylcholine biosynthetic process(GO:0008292) acetate ester biosynthetic process(GO:1900620) |
0.5 | 2.8 | GO:0030277 | maintenance of gastrointestinal epithelium(GO:0030277) |
0.5 | 3.3 | GO:0006356 | regulation of transcription from RNA polymerase I promoter(GO:0006356) |
0.5 | 1.4 | GO:0043031 | negative regulation of macrophage activation(GO:0043031) |
0.5 | 2.8 | GO:0044146 | negative regulation of growth of symbiont in host(GO:0044130) negative regulation of growth of symbiont involved in interaction with host(GO:0044146) |
0.5 | 0.9 | GO:0050872 | white fat cell differentiation(GO:0050872) |
0.5 | 0.9 | GO:0016080 | synaptic vesicle targeting(GO:0016080) |
0.5 | 1.4 | GO:0050968 | detection of chemical stimulus involved in sensory perception of pain(GO:0050968) |
0.5 | 3.7 | GO:0048821 | erythrocyte development(GO:0048821) |
0.5 | 0.5 | GO:0001555 | oocyte growth(GO:0001555) |
0.5 | 1.4 | GO:0044778 | meiotic DNA integrity checkpoint(GO:0044778) |
0.5 | 2.3 | GO:0061469 | regulation of type B pancreatic cell proliferation(GO:0061469) |
0.5 | 1.8 | GO:0002002 | regulation of angiotensin levels in blood(GO:0002002) |
0.5 | 2.3 | GO:0000395 | mRNA 5'-splice site recognition(GO:0000395) |
0.5 | 0.9 | GO:0045084 | positive regulation of interleukin-12 biosynthetic process(GO:0045084) |
0.5 | 1.8 | GO:0060252 | positive regulation of glial cell proliferation(GO:0060252) |
0.5 | 0.9 | GO:1901979 | regulation of inward rectifier potassium channel activity(GO:1901979) |
0.5 | 1.4 | GO:0009992 | cellular water homeostasis(GO:0009992) |
0.5 | 0.9 | GO:0010216 | maintenance of DNA methylation(GO:0010216) |
0.5 | 3.2 | GO:0032801 | receptor catabolic process(GO:0032801) |
0.5 | 4.1 | GO:0002098 | tRNA wobble uridine modification(GO:0002098) |
0.5 | 5.4 | GO:0030199 | collagen fibril organization(GO:0030199) |
0.5 | 0.5 | GO:0034035 | purine ribonucleoside bisphosphate metabolic process(GO:0034035) |
0.5 | 1.4 | GO:0072531 | pyrimidine-containing compound transmembrane transport(GO:0072531) nucleotide transmembrane transport(GO:1901679) |
0.5 | 3.2 | GO:0070935 | 3'-UTR-mediated mRNA stabilization(GO:0070935) |
0.5 | 3.6 | GO:0043567 | regulation of insulin-like growth factor receptor signaling pathway(GO:0043567) |
0.5 | 1.8 | GO:0051387 | negative regulation of neurotrophin TRK receptor signaling pathway(GO:0051387) |
0.5 | 1.8 | GO:0031076 | embryonic camera-type eye development(GO:0031076) |
0.4 | 4.5 | GO:0072678 | T cell migration(GO:0072678) |
0.4 | 2.7 | GO:0048255 | mRNA stabilization(GO:0048255) |
0.4 | 1.3 | GO:1904694 | negative regulation of vascular smooth muscle contraction(GO:1904694) |
0.4 | 2.7 | GO:0051085 | chaperone mediated protein folding requiring cofactor(GO:0051085) |
0.4 | 2.2 | GO:0010884 | positive regulation of lipid storage(GO:0010884) |
0.4 | 0.4 | GO:1904238 | glomerular mesangial cell differentiation(GO:0072008) glomerular mesangial cell development(GO:0072144) pericyte cell differentiation(GO:1904238) |
0.4 | 1.3 | GO:1904479 | negative regulation of intestinal absorption(GO:1904479) |
0.4 | 0.4 | GO:0034163 | regulation of toll-like receptor 9 signaling pathway(GO:0034163) positive regulation of toll-like receptor 9 signaling pathway(GO:0034165) |
0.4 | 1.3 | GO:0002756 | MyD88-independent toll-like receptor signaling pathway(GO:0002756) |
0.4 | 10.9 | GO:0006284 | base-excision repair(GO:0006284) |
0.4 | 2.2 | GO:0001867 | complement activation, lectin pathway(GO:0001867) |
0.4 | 6.1 | GO:0010569 | regulation of double-strand break repair via homologous recombination(GO:0010569) |
0.4 | 0.9 | GO:0002581 | negative regulation of antigen processing and presentation of peptide or polysaccharide antigen via MHC class II(GO:0002581) |
0.4 | 2.6 | GO:0006012 | galactose metabolic process(GO:0006012) |
0.4 | 1.3 | GO:0036444 | calcium ion transmembrane import into mitochondrion(GO:0036444) |
0.4 | 4.7 | GO:0007250 | activation of NF-kappaB-inducing kinase activity(GO:0007250) |
0.4 | 2.2 | GO:0035726 | common myeloid progenitor cell proliferation(GO:0035726) |
0.4 | 0.4 | GO:0003415 | chondrocyte hypertrophy(GO:0003415) |
0.4 | 0.4 | GO:0034499 | late endosome to Golgi transport(GO:0034499) |
0.4 | 2.1 | GO:0070475 | rRNA base methylation(GO:0070475) |
0.4 | 0.9 | GO:1901873 | regulation of post-translational protein modification(GO:1901873) negative regulation of post-translational protein modification(GO:1901874) |
0.4 | 2.1 | GO:0006555 | methionine metabolic process(GO:0006555) |
0.4 | 1.3 | GO:0002227 | innate immune response in mucosa(GO:0002227) |
0.4 | 0.9 | GO:0006361 | transcription initiation from RNA polymerase I promoter(GO:0006361) |
0.4 | 1.3 | GO:0098535 | de novo centriole assembly(GO:0098535) |
0.4 | 0.4 | GO:1901026 | ripoptosome assembly(GO:0097343) ripoptosome assembly involved in necroptotic process(GO:1901026) |
0.4 | 1.3 | GO:2000210 | positive regulation of anoikis(GO:2000210) |
0.4 | 3.0 | GO:0072643 | interferon-gamma secretion(GO:0072643) |
0.4 | 7.2 | GO:0071108 | protein K48-linked deubiquitination(GO:0071108) |
0.4 | 7.2 | GO:0031018 | endocrine pancreas development(GO:0031018) |
0.4 | 0.4 | GO:0048696 | regulation of collateral sprouting in absence of injury(GO:0048696) |
0.4 | 0.4 | GO:0007440 | foregut morphogenesis(GO:0007440) |
0.4 | 1.3 | GO:1904707 | positive regulation of vascular smooth muscle cell proliferation(GO:1904707) |
0.4 | 0.8 | GO:0001542 | ovulation from ovarian follicle(GO:0001542) |
0.4 | 3.3 | GO:0000305 | response to oxygen radical(GO:0000305) |
0.4 | 3.3 | GO:0032793 | positive regulation of CREB transcription factor activity(GO:0032793) |
0.4 | 0.4 | GO:0007398 | ectoderm development(GO:0007398) |
0.4 | 4.1 | GO:0030901 | midbrain development(GO:0030901) |
0.4 | 0.4 | GO:0007181 | transforming growth factor beta receptor complex assembly(GO:0007181) |
0.4 | 0.4 | GO:0031441 | negative regulation of mRNA 3'-end processing(GO:0031441) |
0.4 | 1.2 | GO:0051045 | negative regulation of membrane protein ectodomain proteolysis(GO:0051045) |
0.4 | 1.6 | GO:2000628 | regulation of miRNA metabolic process(GO:2000628) |
0.4 | 0.8 | GO:0014041 | regulation of neuron maturation(GO:0014041) |
0.4 | 0.8 | GO:0007199 | G-protein coupled receptor signaling pathway coupled to cGMP nucleotide second messenger(GO:0007199) |
0.4 | 0.8 | GO:0048239 | negative regulation of DNA recombination at telomere(GO:0048239) regulation of DNA recombination at telomere(GO:0072695) |
0.4 | 4.0 | GO:0043552 | positive regulation of phosphatidylinositol 3-kinase activity(GO:0043552) |
0.4 | 2.0 | GO:0006561 | proline biosynthetic process(GO:0006561) |
0.4 | 0.8 | GO:0046271 | phenylpropanoid catabolic process(GO:0046271) |
0.4 | 0.4 | GO:0042045 | epithelial fluid transport(GO:0042045) |
0.4 | 0.4 | GO:0002606 | positive regulation of dendritic cell antigen processing and presentation(GO:0002606) |
0.4 | 2.0 | GO:0002755 | MyD88-dependent toll-like receptor signaling pathway(GO:0002755) |
0.4 | 0.4 | GO:0018027 | peptidyl-lysine dimethylation(GO:0018027) |
0.4 | 0.8 | GO:0000722 | telomere maintenance via recombination(GO:0000722) |
0.4 | 2.4 | GO:0034122 | negative regulation of toll-like receptor signaling pathway(GO:0034122) |
0.4 | 1.2 | GO:0045006 | DNA deamination(GO:0045006) |
0.4 | 9.4 | GO:0018279 | protein N-linked glycosylation via asparagine(GO:0018279) |
0.4 | 0.8 | GO:0014878 | response to electrical stimulus involved in regulation of muscle adaptation(GO:0014878) |
0.4 | 0.8 | GO:0070858 | negative regulation of bile acid biosynthetic process(GO:0070858) negative regulation of bile acid metabolic process(GO:1904252) |
0.4 | 1.2 | GO:0051388 | positive regulation of neurotrophin TRK receptor signaling pathway(GO:0051388) |
0.4 | 1.6 | GO:0032211 | negative regulation of telomere maintenance via telomerase(GO:0032211) |
0.4 | 0.8 | GO:0071907 | determination of pancreatic left/right asymmetry(GO:0035469) determination of digestive tract left/right asymmetry(GO:0071907) determination of liver left/right asymmetry(GO:0071910) |
0.4 | 0.8 | GO:0030859 | polarized epithelial cell differentiation(GO:0030859) |
0.4 | 1.2 | GO:0010958 | regulation of amino acid import(GO:0010958) |
0.4 | 1.2 | GO:0010760 | negative regulation of macrophage chemotaxis(GO:0010760) |
0.4 | 3.5 | GO:0043011 | myeloid dendritic cell differentiation(GO:0043011) |
0.4 | 3.8 | GO:0006817 | phosphate ion transport(GO:0006817) |
0.4 | 0.8 | GO:0042693 | muscle cell fate commitment(GO:0042693) |
0.4 | 0.4 | GO:0050847 | progesterone receptor signaling pathway(GO:0050847) |
0.4 | 6.5 | GO:0000413 | protein peptidyl-prolyl isomerization(GO:0000413) |
0.4 | 6.1 | GO:0051693 | actin filament capping(GO:0051693) |
0.4 | 1.9 | GO:0000479 | endonucleolytic cleavage of tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA)(GO:0000479) |
0.4 | 2.3 | GO:0045292 | mRNA cis splicing, via spliceosome(GO:0045292) |
0.4 | 0.4 | GO:0090503 | RNA phosphodiester bond hydrolysis, exonucleolytic(GO:0090503) |
0.4 | 0.8 | GO:0007060 | male meiosis chromosome segregation(GO:0007060) |
0.4 | 3.0 | GO:0002507 | tolerance induction(GO:0002507) |
0.4 | 1.1 | GO:0045591 | positive regulation of regulatory T cell differentiation(GO:0045591) |
0.4 | 1.1 | GO:0070125 | mitochondrial translational elongation(GO:0070125) |
0.4 | 0.4 | GO:0071169 | establishment of protein localization to chromatin(GO:0071169) |
0.4 | 3.8 | GO:0019432 | triglyceride biosynthetic process(GO:0019432) |
0.4 | 1.5 | GO:0043551 | regulation of phosphatidylinositol 3-kinase activity(GO:0043551) |
0.4 | 0.4 | GO:0071724 | response to bacterial lipopeptide(GO:0070339) cellular response to bacterial lipoprotein(GO:0071220) cellular response to bacterial lipopeptide(GO:0071221) response to diacyl bacterial lipopeptide(GO:0071724) cellular response to diacyl bacterial lipopeptide(GO:0071726) |
0.4 | 0.4 | GO:0048021 | regulation of melanin biosynthetic process(GO:0048021) negative regulation of melanin biosynthetic process(GO:0048022) regulation of secondary metabolite biosynthetic process(GO:1900376) negative regulation of secondary metabolite biosynthetic process(GO:1900377) |
0.4 | 1.9 | GO:0080154 | regulation of fertilization(GO:0080154) |
0.4 | 1.9 | GO:0002251 | organ or tissue specific immune response(GO:0002251) mucosal immune response(GO:0002385) |
0.4 | 3.0 | GO:0070233 | negative regulation of T cell apoptotic process(GO:0070233) |
0.4 | 0.7 | GO:0008594 | photoreceptor cell morphogenesis(GO:0008594) |
0.4 | 3.0 | GO:0045577 | regulation of B cell differentiation(GO:0045577) |
0.4 | 1.9 | GO:0001709 | cell fate determination(GO:0001709) |
0.4 | 0.4 | GO:0043489 | RNA stabilization(GO:0043489) |
0.4 | 6.2 | GO:0050873 | brown fat cell differentiation(GO:0050873) |
0.4 | 4.4 | GO:0046597 | negative regulation of viral entry into host cell(GO:0046597) |
0.4 | 1.1 | GO:0061370 | testosterone biosynthetic process(GO:0061370) |
0.4 | 1.1 | GO:0045053 | protein retention in Golgi apparatus(GO:0045053) |
0.4 | 0.4 | GO:0002840 | T cell mediated immune response to tumor cell(GO:0002424) regulation of T cell mediated immune response to tumor cell(GO:0002840) |
0.4 | 2.9 | GO:1990126 | retrograde transport, endosome to plasma membrane(GO:1990126) |
0.4 | 1.1 | GO:0006627 | protein processing involved in protein targeting to mitochondrion(GO:0006627) |
0.4 | 1.1 | GO:0032926 | negative regulation of activin receptor signaling pathway(GO:0032926) |
0.4 | 1.1 | GO:1900426 | positive regulation of defense response to bacterium(GO:1900426) |
0.4 | 1.4 | GO:0070086 | ubiquitin-dependent endocytosis(GO:0070086) |
0.4 | 0.7 | GO:0070488 | neutrophil aggregation(GO:0070488) |
0.4 | 0.7 | GO:0006068 | ethanol catabolic process(GO:0006068) |
0.4 | 0.7 | GO:2000737 | negative regulation of stem cell differentiation(GO:2000737) |
0.4 | 1.4 | GO:0043276 | anoikis(GO:0043276) |
0.4 | 4.6 | GO:0060218 | hematopoietic stem cell differentiation(GO:0060218) |
0.4 | 0.4 | GO:1903774 | positive regulation of viral budding via host ESCRT complex(GO:1903774) |
0.4 | 0.7 | GO:0018158 | protein oxidation(GO:0018158) |
0.4 | 0.7 | GO:0045059 | positive thymic T cell selection(GO:0045059) |
0.4 | 1.4 | GO:0033623 | regulation of integrin activation(GO:0033623) |
0.3 | 3.5 | GO:0030318 | melanocyte differentiation(GO:0030318) |
0.3 | 1.0 | GO:0043137 | DNA replication, removal of RNA primer(GO:0043137) |
0.3 | 0.7 | GO:1902237 | positive regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway(GO:1902237) |
0.3 | 0.3 | GO:0048208 | vesicle targeting, rough ER to cis-Golgi(GO:0048207) COPII vesicle coating(GO:0048208) |
0.3 | 2.4 | GO:0051382 | kinetochore assembly(GO:0051382) |
0.3 | 2.4 | GO:0061088 | sequestering of zinc ion(GO:0032119) regulation of sequestering of zinc ion(GO:0061088) |
0.3 | 0.7 | GO:0006290 | pyrimidine dimer repair(GO:0006290) |
0.3 | 3.5 | GO:0045947 | negative regulation of translational initiation(GO:0045947) |
0.3 | 3.1 | GO:0060575 | intestinal epithelial cell differentiation(GO:0060575) |
0.3 | 0.3 | GO:0060760 | positive regulation of response to cytokine stimulus(GO:0060760) |
0.3 | 10.7 | GO:0006956 | complement activation(GO:0006956) |
0.3 | 1.4 | GO:0002329 | pre-B cell differentiation(GO:0002329) |
0.3 | 2.1 | GO:0006308 | DNA catabolic process(GO:0006308) |
0.3 | 0.3 | GO:0030222 | eosinophil differentiation(GO:0030222) |
0.3 | 0.3 | GO:0071243 | cellular response to arsenic-containing substance(GO:0071243) |
0.3 | 0.7 | GO:1901185 | negative regulation of ERBB signaling pathway(GO:1901185) |
0.3 | 1.4 | GO:0033327 | Leydig cell differentiation(GO:0033327) |
0.3 | 1.0 | GO:1990845 | diet induced thermogenesis(GO:0002024) adaptive thermogenesis(GO:1990845) |
0.3 | 0.7 | GO:0044375 | regulation of peroxisome size(GO:0044375) |
0.3 | 0.3 | GO:1904714 | regulation of chaperone-mediated autophagy(GO:1904714) |
0.3 | 0.3 | GO:0051088 | positive regulation of macrophage fusion(GO:0034241) monocyte activation(GO:0042117) PMA-inducible membrane protein ectodomain proteolysis(GO:0051088) |
0.3 | 5.7 | GO:0045109 | intermediate filament organization(GO:0045109) |
0.3 | 2.0 | GO:0006020 | inositol metabolic process(GO:0006020) |
0.3 | 5.1 | GO:0030488 | tRNA methylation(GO:0030488) |
0.3 | 0.7 | GO:0015884 | folic acid transport(GO:0015884) |
0.3 | 0.3 | GO:1903054 | negative regulation of extracellular matrix organization(GO:1903054) |
0.3 | 0.3 | GO:0060947 | cardiac vascular smooth muscle cell differentiation(GO:0060947) |
0.3 | 0.3 | GO:0046831 | regulation of RNA export from nucleus(GO:0046831) |
0.3 | 1.7 | GO:0000076 | DNA replication checkpoint(GO:0000076) |
0.3 | 2.0 | GO:0031167 | rRNA methylation(GO:0031167) |
0.3 | 1.7 | GO:0080182 | histone H3-K4 trimethylation(GO:0080182) |
0.3 | 0.7 | GO:0040034 | regulation of development, heterochronic(GO:0040034) |
0.3 | 2.6 | GO:0030513 | positive regulation of BMP signaling pathway(GO:0030513) |
0.3 | 2.3 | GO:0045879 | negative regulation of smoothened signaling pathway(GO:0045879) |
0.3 | 1.3 | GO:0070966 | nuclear-transcribed mRNA catabolic process, no-go decay(GO:0070966) |
0.3 | 1.0 | GO:0006543 | glutamine catabolic process(GO:0006543) |
0.3 | 3.6 | GO:0006390 | transcription from mitochondrial promoter(GO:0006390) |
0.3 | 0.6 | GO:0045060 | negative thymic T cell selection(GO:0045060) |
0.3 | 1.0 | GO:0002158 | osteoclast proliferation(GO:0002158) |
0.3 | 7.3 | GO:0031424 | keratinization(GO:0031424) |
0.3 | 0.9 | GO:0097421 | liver regeneration(GO:0097421) |
0.3 | 1.3 | GO:0032897 | negative regulation of viral transcription(GO:0032897) |
0.3 | 3.8 | GO:0006826 | iron ion transport(GO:0006826) |
0.3 | 0.3 | GO:0034239 | regulation of macrophage fusion(GO:0034239) |
0.3 | 0.6 | GO:0034086 | maintenance of sister chromatid cohesion(GO:0034086) maintenance of mitotic sister chromatid cohesion(GO:0034088) |
0.3 | 0.3 | GO:0002339 | B cell selection(GO:0002339) |
0.3 | 1.2 | GO:0051697 | protein delipidation(GO:0051697) |
0.3 | 0.3 | GO:0042531 | positive regulation of tyrosine phosphorylation of STAT protein(GO:0042531) |
0.3 | 0.9 | GO:0033762 | response to glucagon(GO:0033762) |
0.3 | 0.9 | GO:0071447 | cellular response to hydroperoxide(GO:0071447) |
0.3 | 1.5 | GO:0052805 | histidine metabolic process(GO:0006547) histidine catabolic process(GO:0006548) imidazole-containing compound catabolic process(GO:0052805) |
0.3 | 1.2 | GO:0007063 | regulation of sister chromatid cohesion(GO:0007063) |
0.3 | 0.6 | GO:0045041 | protein import into mitochondrial intermembrane space(GO:0045041) |
0.3 | 4.0 | GO:0006730 | one-carbon metabolic process(GO:0006730) |
0.3 | 1.2 | GO:0032620 | interleukin-17 production(GO:0032620) |
0.3 | 0.3 | GO:0008635 | activation of cysteine-type endopeptidase activity involved in apoptotic process by cytochrome c(GO:0008635) |
0.3 | 4.0 | GO:0050891 | multicellular organismal water homeostasis(GO:0050891) |
0.3 | 0.3 | GO:0040031 | snRNA modification(GO:0040031) |
0.3 | 0.9 | GO:0015871 | choline transport(GO:0015871) |
0.3 | 1.5 | GO:0045144 | meiotic sister chromatid segregation(GO:0045144) meiotic sister chromatid cohesion(GO:0051177) |
0.3 | 1.8 | GO:0010826 | negative regulation of centrosome duplication(GO:0010826) negative regulation of centrosome cycle(GO:0046606) |
0.3 | 2.4 | GO:0018206 | peptidyl-methionine modification(GO:0018206) |
0.3 | 1.2 | GO:0051534 | negative regulation of NFAT protein import into nucleus(GO:0051534) |
0.3 | 1.2 | GO:0000154 | rRNA modification(GO:0000154) |
0.3 | 1.2 | GO:0046060 | dATP metabolic process(GO:0046060) |
0.3 | 1.8 | GO:0031639 | plasminogen activation(GO:0031639) |
0.3 | 1.5 | GO:2000757 | negative regulation of peptidyl-lysine acetylation(GO:2000757) |
0.3 | 0.6 | GO:0034421 | post-translational protein acetylation(GO:0034421) |
0.3 | 0.3 | GO:0051084 | 'de novo' protein folding(GO:0006458) 'de novo' posttranslational protein folding(GO:0051084) |
0.3 | 0.6 | GO:0006269 | DNA replication, synthesis of RNA primer(GO:0006269) |
0.3 | 0.9 | GO:0070544 | histone H3-K36 demethylation(GO:0070544) |
0.3 | 3.9 | GO:0044243 | multicellular organism catabolic process(GO:0044243) |
0.3 | 4.2 | GO:0030970 | retrograde protein transport, ER to cytosol(GO:0030970) |
0.3 | 1.8 | GO:0042795 | snRNA transcription from RNA polymerase II promoter(GO:0042795) |
0.3 | 0.9 | GO:0000957 | mitochondrial RNA catabolic process(GO:0000957) regulation of mitochondrial RNA catabolic process(GO:0000960) |
0.3 | 0.9 | GO:0070389 | chaperone cofactor-dependent protein refolding(GO:0070389) |
0.3 | 0.3 | GO:0048711 | positive regulation of astrocyte differentiation(GO:0048711) |
0.3 | 3.5 | GO:0030521 | androgen receptor signaling pathway(GO:0030521) |
0.3 | 1.8 | GO:0018026 | peptidyl-lysine monomethylation(GO:0018026) |
0.3 | 0.6 | GO:0031069 | hair follicle morphogenesis(GO:0031069) |
0.3 | 1.5 | GO:0033627 | cell adhesion mediated by integrin(GO:0033627) |
0.3 | 9.0 | GO:0042274 | ribosomal small subunit biogenesis(GO:0042274) |
0.3 | 1.5 | GO:0043562 | cellular response to nitrogen starvation(GO:0006995) cellular response to nitrogen levels(GO:0043562) |
0.3 | 4.6 | GO:0000387 | spliceosomal snRNP assembly(GO:0000387) |
0.3 | 1.7 | GO:0090312 | positive regulation of protein deacetylation(GO:0090312) |
0.3 | 1.1 | GO:0051546 | keratinocyte migration(GO:0051546) |
0.3 | 1.1 | GO:0090286 | cytoskeletal anchoring at nuclear membrane(GO:0090286) |
0.3 | 4.0 | GO:0007498 | mesoderm development(GO:0007498) |
0.3 | 0.6 | GO:0042423 | catechol-containing compound biosynthetic process(GO:0009713) catecholamine biosynthetic process(GO:0042423) |
0.3 | 1.1 | GO:0002023 | reduction of food intake in response to dietary excess(GO:0002023) |
0.3 | 2.2 | GO:0035518 | histone H2A monoubiquitination(GO:0035518) |
0.3 | 0.6 | GO:0006222 | UMP biosynthetic process(GO:0006222) pyrimidine ribonucleoside monophosphate metabolic process(GO:0009173) pyrimidine ribonucleoside monophosphate biosynthetic process(GO:0009174) UMP metabolic process(GO:0046049) |
0.3 | 3.0 | GO:0009303 | rRNA transcription(GO:0009303) |
0.3 | 0.3 | GO:1900025 | negative regulation of substrate adhesion-dependent cell spreading(GO:1900025) |
0.3 | 3.5 | GO:0048286 | lung alveolus development(GO:0048286) |
0.3 | 1.1 | GO:0033081 | regulation of T cell differentiation in thymus(GO:0033081) regulation of thymocyte aggregation(GO:2000398) |
0.3 | 1.6 | GO:0090220 | telomere localization(GO:0034397) chromosome localization to nuclear envelope involved in homologous chromosome segregation(GO:0090220) |
0.3 | 0.3 | GO:0060433 | bronchus development(GO:0060433) |
0.3 | 0.3 | GO:0061428 | peptidyl-aspartic acid modification(GO:0018197) negative regulation of transcription from RNA polymerase II promoter in response to hypoxia(GO:0061428) |
0.3 | 1.9 | GO:0070536 | protein K63-linked deubiquitination(GO:0070536) |
0.3 | 0.8 | GO:0042492 | gamma-delta T cell differentiation(GO:0042492) gamma-delta T cell activation(GO:0046629) |
0.3 | 1.1 | GO:1904294 | positive regulation of ERAD pathway(GO:1904294) |
0.3 | 0.8 | GO:0070682 | proteasome regulatory particle assembly(GO:0070682) |
0.3 | 0.8 | GO:0001553 | luteinization(GO:0001553) |
0.3 | 2.1 | GO:0006517 | protein deglycosylation(GO:0006517) |
0.3 | 1.0 | GO:0045199 | maintenance of epithelial cell apical/basal polarity(GO:0045199) |
0.3 | 8.9 | GO:0030316 | osteoclast differentiation(GO:0030316) |
0.3 | 0.3 | GO:1900102 | negative regulation of endoplasmic reticulum unfolded protein response(GO:1900102) |
0.3 | 0.3 | GO:0019372 | lipoxygenase pathway(GO:0019372) |
0.3 | 0.3 | GO:0003383 | apical constriction(GO:0003383) |
0.3 | 1.0 | GO:1901341 | positive regulation of store-operated calcium channel activity(GO:1901341) |
0.3 | 0.3 | GO:0046607 | positive regulation of centrosome cycle(GO:0046607) |
0.3 | 2.3 | GO:0045620 | negative regulation of lymphocyte differentiation(GO:0045620) |
0.3 | 0.3 | GO:0006244 | pyrimidine nucleotide catabolic process(GO:0006244) |
0.3 | 0.3 | GO:0016259 | selenocysteine metabolic process(GO:0016259) |
0.3 | 0.3 | GO:0042421 | norepinephrine biosynthetic process(GO:0042421) |
0.3 | 1.5 | GO:0042135 | neurotransmitter catabolic process(GO:0042135) |
0.3 | 0.3 | GO:0046880 | regulation of follicle-stimulating hormone secretion(GO:0046880) |
0.3 | 0.8 | GO:0050849 | negative regulation of calcium-mediated signaling(GO:0050849) |
0.3 | 0.3 | GO:0003164 | His-Purkinje system development(GO:0003164) |
0.3 | 1.3 | GO:0018126 | protein hydroxylation(GO:0018126) |
0.3 | 0.3 | GO:0038061 | NIK/NF-kappaB signaling(GO:0038061) |
0.3 | 1.8 | GO:0016114 | terpenoid biosynthetic process(GO:0016114) |
0.3 | 7.3 | GO:0038034 | signal transduction in absence of ligand(GO:0038034) extrinsic apoptotic signaling pathway in absence of ligand(GO:0097192) |
0.3 | 0.8 | GO:0042759 | long-chain fatty acid biosynthetic process(GO:0042759) |
0.3 | 1.5 | GO:0006488 | dolichol-linked oligosaccharide biosynthetic process(GO:0006488) |
0.3 | 0.3 | GO:0046984 | regulation of hemoglobin biosynthetic process(GO:0046984) |
0.3 | 7.5 | GO:0071391 | cellular response to estrogen stimulus(GO:0071391) |
0.2 | 0.5 | GO:0009624 | response to nematode(GO:0009624) |
0.2 | 0.7 | GO:0006546 | glycine catabolic process(GO:0006546) glycine decarboxylation via glycine cleavage system(GO:0019464) |
0.2 | 1.2 | GO:0046006 | regulation of activated T cell proliferation(GO:0046006) |
0.2 | 1.0 | GO:0036158 | outer dynein arm assembly(GO:0036158) |
0.2 | 1.0 | GO:0010815 | bradykinin catabolic process(GO:0010815) |
0.2 | 1.7 | GO:0000394 | RNA splicing, via endonucleolytic cleavage and ligation(GO:0000394) |
0.2 | 2.7 | GO:0046677 | response to antibiotic(GO:0046677) |
0.2 | 2.2 | GO:0051205 | protein insertion into membrane(GO:0051205) |
0.2 | 0.2 | GO:0045940 | positive regulation of steroid metabolic process(GO:0045940) |
0.2 | 1.9 | GO:0071166 | ribonucleoprotein complex localization(GO:0071166) |
0.2 | 0.2 | GO:0001955 | blood vessel maturation(GO:0001955) |
0.2 | 0.2 | GO:0060332 | positive regulation of response to interferon-gamma(GO:0060332) positive regulation of interferon-gamma-mediated signaling pathway(GO:0060335) |
0.2 | 1.2 | GO:0061157 | mRNA destabilization(GO:0061157) |
0.2 | 0.2 | GO:0009109 | coenzyme catabolic process(GO:0009109) |
0.2 | 0.2 | GO:0006551 | leucine metabolic process(GO:0006551) |
0.2 | 0.2 | GO:0001803 | type III hypersensitivity(GO:0001802) regulation of type III hypersensitivity(GO:0001803) positive regulation of type III hypersensitivity(GO:0001805) |
0.2 | 0.5 | GO:1903334 | positive regulation of protein folding(GO:1903334) |
0.2 | 0.7 | GO:0032494 | response to peptidoglycan(GO:0032494) |
0.2 | 0.2 | GO:0061450 | trophoblast cell migration(GO:0061450) |
0.2 | 1.4 | GO:0046835 | carbohydrate phosphorylation(GO:0046835) |
0.2 | 0.5 | GO:0034115 | negative regulation of heterotypic cell-cell adhesion(GO:0034115) regulation of cell-cell adhesion involved in gastrulation(GO:0070587) |
0.2 | 0.7 | GO:1902093 | positive regulation of sperm motility(GO:1902093) |
0.2 | 1.8 | GO:0031468 | nuclear envelope reassembly(GO:0031468) |
0.2 | 0.7 | GO:0016264 | gap junction assembly(GO:0016264) |
0.2 | 0.7 | GO:0030836 | positive regulation of actin filament depolymerization(GO:0030836) |
0.2 | 3.8 | GO:0051983 | regulation of chromosome segregation(GO:0051983) |
0.2 | 0.7 | GO:0035947 | regulation of gluconeogenesis by regulation of transcription from RNA polymerase II promoter(GO:0035947) positive regulation of gluconeogenesis by positive regulation of transcription from RNA polymerase II promoter(GO:0035948) |
0.2 | 0.2 | GO:1903377 | negative regulation of oxidative stress-induced neuron intrinsic apoptotic signaling pathway(GO:1903377) |
0.2 | 0.7 | GO:0048630 | skeletal muscle tissue growth(GO:0048630) |
0.2 | 0.9 | GO:0051151 | negative regulation of smooth muscle cell differentiation(GO:0051151) |
0.2 | 1.5 | GO:0003352 | regulation of cilium movement(GO:0003352) |
0.2 | 0.4 | GO:0005984 | disaccharide metabolic process(GO:0005984) |
0.2 | 1.8 | GO:0051131 | chaperone-mediated protein complex assembly(GO:0051131) |
0.2 | 0.2 | GO:0071608 | macrophage inflammatory protein-1 alpha production(GO:0071608) |
0.2 | 0.4 | GO:1904995 | negative regulation of leukocyte tethering or rolling(GO:1903237) negative regulation of leukocyte adhesion to vascular endothelial cell(GO:1904995) |
0.2 | 0.4 | GO:0030239 | myofibril assembly(GO:0030239) |
0.2 | 0.4 | GO:0009071 | serine family amino acid catabolic process(GO:0009071) |
0.2 | 0.2 | GO:0010637 | negative regulation of mitochondrial fusion(GO:0010637) |
0.2 | 0.2 | GO:0042222 | interleukin-1 biosynthetic process(GO:0042222) |
0.2 | 0.8 | GO:0006474 | N-terminal protein amino acid acetylation(GO:0006474) |
0.2 | 0.4 | GO:0090166 | Golgi disassembly(GO:0090166) |
0.2 | 0.2 | GO:0044126 | regulation of growth of symbiont in host(GO:0044126) modulation of growth of symbiont involved in interaction with host(GO:0044144) |
0.2 | 4.4 | GO:0009952 | anterior/posterior pattern specification(GO:0009952) |
0.2 | 0.4 | GO:0006776 | vitamin A metabolic process(GO:0006776) |
0.2 | 1.7 | GO:0033962 | cytoplasmic mRNA processing body assembly(GO:0033962) |
0.2 | 0.6 | GO:0035404 | histone-serine phosphorylation(GO:0035404) histone H3-S10 phosphorylation(GO:0043987) |
0.2 | 0.4 | GO:0045616 | regulation of keratinocyte differentiation(GO:0045616) |
0.2 | 0.2 | GO:0043101 | purine-containing compound salvage(GO:0043101) |
0.2 | 1.4 | GO:0070166 | enamel mineralization(GO:0070166) |
0.2 | 1.2 | GO:0006384 | transcription initiation from RNA polymerase III promoter(GO:0006384) |
0.2 | 0.8 | GO:0060340 | positive regulation of type I interferon-mediated signaling pathway(GO:0060340) |
0.2 | 0.4 | GO:0032727 | positive regulation of interferon-alpha production(GO:0032727) |
0.2 | 0.2 | GO:0045342 | MHC class II biosynthetic process(GO:0045342) regulation of MHC class II biosynthetic process(GO:0045346) negative regulation of MHC class II biosynthetic process(GO:0045347) |
0.2 | 0.6 | GO:0051970 | negative regulation of transmission of nerve impulse(GO:0051970) |
0.2 | 0.2 | GO:0097084 | vascular smooth muscle cell development(GO:0097084) |
0.2 | 0.4 | GO:1904263 | positive regulation of TORC1 signaling(GO:1904263) |
0.2 | 3.4 | GO:0043001 | Golgi to plasma membrane protein transport(GO:0043001) |
0.2 | 0.2 | GO:0060051 | negative regulation of protein glycosylation(GO:0060051) |
0.2 | 7.6 | GO:0032543 | mitochondrial translation(GO:0032543) |
0.2 | 0.2 | GO:0006714 | sesquiterpenoid metabolic process(GO:0006714) |
0.2 | 0.6 | GO:0042732 | D-xylose metabolic process(GO:0042732) |
0.2 | 3.2 | GO:0048240 | sperm capacitation(GO:0048240) |
0.2 | 0.6 | GO:0010561 | negative regulation of glycoprotein biosynthetic process(GO:0010561) |
0.2 | 3.3 | GO:0014020 | primary neural tube formation(GO:0014020) |
0.2 | 1.3 | GO:0048714 | positive regulation of oligodendrocyte differentiation(GO:0048714) |
0.2 | 0.4 | GO:0006435 | threonyl-tRNA aminoacylation(GO:0006435) |
0.2 | 0.2 | GO:0003344 | pericardium morphogenesis(GO:0003344) |
0.2 | 2.5 | GO:0097194 | execution phase of apoptosis(GO:0097194) |
0.2 | 1.3 | GO:0051457 | maintenance of protein location in nucleus(GO:0051457) |
0.2 | 0.2 | GO:0097466 | glycoprotein ERAD pathway(GO:0097466) response to glycoprotein(GO:1904587) |
0.2 | 1.4 | GO:0045639 | positive regulation of myeloid cell differentiation(GO:0045639) |
0.2 | 0.2 | GO:1901317 | regulation of sperm motility(GO:1901317) |
0.2 | 3.0 | GO:0019835 | cytolysis(GO:0019835) |
0.2 | 0.2 | GO:0046641 | positive regulation of alpha-beta T cell proliferation(GO:0046641) |
0.2 | 0.2 | GO:0070199 | establishment of protein localization to chromosome(GO:0070199) |
0.2 | 2.5 | GO:0030520 | intracellular estrogen receptor signaling pathway(GO:0030520) |
0.2 | 0.5 | GO:2001224 | positive regulation of neuron migration(GO:2001224) |
0.2 | 0.9 | GO:0071985 | multivesicular body sorting pathway(GO:0071985) |
0.2 | 0.2 | GO:0035426 | extracellular matrix-cell signaling(GO:0035426) |
0.2 | 0.2 | GO:1901725 | regulation of histone deacetylase activity(GO:1901725) |
0.2 | 1.7 | GO:0018298 | protein-chromophore linkage(GO:0018298) |
0.2 | 1.2 | GO:0045214 | sarcomere organization(GO:0045214) |
0.2 | 0.2 | GO:0006415 | translational termination(GO:0006415) |
0.2 | 5.1 | GO:0051865 | protein autoubiquitination(GO:0051865) |
0.2 | 1.0 | GO:2000036 | regulation of stem cell population maintenance(GO:2000036) |
0.2 | 0.7 | GO:0021984 | adenohypophysis development(GO:0021984) |
0.2 | 0.3 | GO:0051410 | detoxification of nitrogen compound(GO:0051410) cellular detoxification of nitrogen compound(GO:0070458) |
0.2 | 0.2 | GO:0072429 | response to intra-S DNA damage checkpoint signaling(GO:0072429) |
0.2 | 5.2 | GO:0006505 | GPI anchor metabolic process(GO:0006505) |
0.2 | 1.7 | GO:0050853 | B cell receptor signaling pathway(GO:0050853) |
0.2 | 0.7 | GO:0006228 | UTP biosynthetic process(GO:0006228) UTP metabolic process(GO:0046051) |
0.2 | 0.2 | GO:0048730 | epidermis morphogenesis(GO:0048730) |
0.2 | 0.2 | GO:0015842 | aminergic neurotransmitter loading into synaptic vesicle(GO:0015842) neurotransmitter loading into synaptic vesicle(GO:0098700) |
0.2 | 0.3 | GO:0046813 | receptor-mediated virion attachment to host cell(GO:0046813) |
0.2 | 1.0 | GO:2000480 | negative regulation of cAMP-dependent protein kinase activity(GO:2000480) |
0.2 | 0.3 | GO:0044789 | modulation by host of viral release from host cell(GO:0044789) positive regulation by host of viral release from host cell(GO:0044791) |
0.2 | 0.2 | GO:0006610 | ribosomal protein import into nucleus(GO:0006610) |
0.2 | 0.5 | GO:2000678 | negative regulation of transcription regulatory region DNA binding(GO:2000678) |
0.2 | 0.3 | GO:1902410 | mitotic cytokinetic process(GO:1902410) |
0.2 | 0.8 | GO:0046037 | GMP metabolic process(GO:0046037) |
0.2 | 0.2 | GO:0042637 | catagen(GO:0042637) |
0.2 | 0.6 | GO:0002349 | histamine production involved in inflammatory response(GO:0002349) histamine secretion involved in inflammatory response(GO:0002441) histamine secretion by mast cell(GO:0002553) |
0.2 | 0.6 | GO:0009235 | cobalamin metabolic process(GO:0009235) |
0.2 | 0.5 | GO:0002827 | positive regulation of T-helper 1 type immune response(GO:0002827) |
0.2 | 1.7 | GO:0016578 | histone deubiquitination(GO:0016578) |
0.2 | 0.2 | GO:0055094 | response to lipoprotein particle(GO:0055094) |
0.2 | 0.8 | GO:0007175 | negative regulation of epidermal growth factor-activated receptor activity(GO:0007175) |
0.2 | 2.6 | GO:0045600 | positive regulation of fat cell differentiation(GO:0045600) |
0.2 | 2.0 | GO:0001562 | response to protozoan(GO:0001562) |
0.2 | 0.8 | GO:0002076 | osteoblast development(GO:0002076) |
0.2 | 0.3 | GO:0006868 | glutamine transport(GO:0006868) |
0.2 | 0.9 | GO:0006465 | signal peptide processing(GO:0006465) |
0.2 | 0.5 | GO:0006670 | sphingosine metabolic process(GO:0006670) |
0.2 | 1.1 | GO:0006353 | DNA-templated transcription, termination(GO:0006353) |
0.2 | 1.8 | GO:0030261 | chromosome condensation(GO:0030261) |
0.2 | 5.1 | GO:0010501 | RNA secondary structure unwinding(GO:0010501) |
0.2 | 0.3 | GO:0050779 | RNA destabilization(GO:0050779) |
0.2 | 0.8 | GO:0061099 | negative regulation of protein tyrosine kinase activity(GO:0061099) |
0.1 | 0.1 | GO:0021882 | regulation of transcription from RNA polymerase II promoter involved in forebrain neuron fate commitment(GO:0021882) |
0.1 | 0.6 | GO:0051725 | protein de-ADP-ribosylation(GO:0051725) |
0.1 | 3.7 | GO:0002181 | cytoplasmic translation(GO:0002181) |
0.1 | 0.9 | GO:0043968 | histone H2A acetylation(GO:0043968) |
0.1 | 1.0 | GO:0006607 | NLS-bearing protein import into nucleus(GO:0006607) |
0.1 | 8.4 | GO:0051028 | mRNA transport(GO:0051028) |
0.1 | 1.6 | GO:0042761 | very long-chain fatty acid biosynthetic process(GO:0042761) |
0.1 | 0.3 | GO:1900153 | regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay(GO:1900151) positive regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay(GO:1900153) |
0.1 | 0.4 | GO:0090043 | regulation of tubulin deacetylation(GO:0090043) |
0.1 | 1.5 | GO:0010842 | retina layer formation(GO:0010842) |
0.1 | 0.1 | GO:0000729 | DNA double-strand break processing(GO:0000729) |
0.1 | 0.4 | GO:0061515 | myeloid cell development(GO:0061515) |
0.1 | 0.4 | GO:0046782 | regulation of viral transcription(GO:0046782) |
0.1 | 0.3 | GO:0018242 | protein O-linked glycosylation via serine(GO:0018242) |
0.1 | 0.3 | GO:0032527 | protein exit from endoplasmic reticulum(GO:0032527) |
0.1 | 0.1 | GO:0007135 | meiosis II(GO:0007135) |
0.1 | 0.1 | GO:0030656 | regulation of vitamin metabolic process(GO:0030656) |
0.1 | 0.8 | GO:0001778 | plasma membrane repair(GO:0001778) |
0.1 | 0.3 | GO:2000467 | positive regulation of glycogen (starch) synthase activity(GO:2000467) |
0.1 | 0.1 | GO:0060330 | regulation of response to interferon-gamma(GO:0060330) |
0.1 | 0.3 | GO:0071799 | response to prostaglandin D(GO:0071798) cellular response to prostaglandin D stimulus(GO:0071799) |
0.1 | 0.1 | GO:0015819 | lysine transport(GO:0015819) |
0.1 | 0.1 | GO:0050717 | positive regulation of interleukin-1 alpha secretion(GO:0050717) |
0.1 | 0.3 | GO:0006563 | L-serine metabolic process(GO:0006563) |
0.1 | 0.1 | GO:0033700 | phospholipid efflux(GO:0033700) |
0.1 | 0.9 | GO:0002566 | somatic diversification of immune receptors via somatic mutation(GO:0002566) somatic hypermutation of immunoglobulin genes(GO:0016446) |
0.1 | 1.2 | GO:0008299 | isoprenoid biosynthetic process(GO:0008299) |
0.1 | 0.3 | GO:0043504 | mitochondrial DNA repair(GO:0043504) |
0.1 | 0.1 | GO:2000721 | positive regulation of transcription from RNA polymerase II promoter involved in smooth muscle cell differentiation(GO:2000721) |
0.1 | 0.8 | GO:0032611 | interleukin-1 beta production(GO:0032611) |
0.1 | 2.3 | GO:0070206 | protein trimerization(GO:0070206) |
0.1 | 1.5 | GO:0051601 | exocyst localization(GO:0051601) |
0.1 | 0.4 | GO:0036092 | phosphatidylinositol-3-phosphate biosynthetic process(GO:0036092) |
0.1 | 0.2 | GO:0036438 | maintenance of lens transparency(GO:0036438) |
0.1 | 1.2 | GO:0044458 | motile cilium assembly(GO:0044458) |
0.1 | 0.1 | GO:0002826 | negative regulation of T-helper 1 type immune response(GO:0002826) |
0.1 | 0.4 | GO:0061014 | positive regulation of mRNA catabolic process(GO:0061014) |
0.1 | 0.1 | GO:0060681 | branch elongation involved in ureteric bud branching(GO:0060681) |
0.1 | 8.7 | GO:0042254 | ribosome biogenesis(GO:0042254) |
0.1 | 0.5 | GO:0033299 | secretion of lysosomal enzymes(GO:0033299) |
0.1 | 0.4 | GO:1903337 | positive regulation of vacuolar transport(GO:1903337) |
0.1 | 0.1 | GO:0035740 | CD8-positive, alpha-beta T cell proliferation(GO:0035740) |
0.1 | 0.6 | GO:0061615 | glycolytic process through fructose-6-phosphate(GO:0061615) |
0.1 | 0.4 | GO:0090261 | positive regulation of inclusion body assembly(GO:0090261) |
0.1 | 0.1 | GO:0001767 | establishment of lymphocyte polarity(GO:0001767) establishment of T cell polarity(GO:0001768) |
0.1 | 1.7 | GO:0006446 | regulation of translational initiation(GO:0006446) |
0.1 | 0.7 | GO:0007064 | mitotic sister chromatid cohesion(GO:0007064) |
0.1 | 0.5 | GO:1900745 | positive regulation of p38MAPK cascade(GO:1900745) |
0.1 | 0.5 | GO:0035590 | purinergic nucleotide receptor signaling pathway(GO:0035590) |
0.1 | 0.3 | GO:0002070 | epithelial cell maturation(GO:0002070) |
0.1 | 0.5 | GO:0072673 | lamellipodium morphogenesis(GO:0072673) |
0.1 | 0.1 | GO:0035509 | negative regulation of myosin-light-chain-phosphatase activity(GO:0035509) |
0.1 | 0.1 | GO:0051503 | adenine nucleotide transport(GO:0051503) |
0.1 | 0.1 | GO:0048070 | regulation of developmental pigmentation(GO:0048070) |
0.1 | 0.1 | GO:0014873 | response to muscle activity involved in regulation of muscle adaptation(GO:0014873) |
0.1 | 1.4 | GO:1900004 | regulation of serine-type endopeptidase activity(GO:1900003) negative regulation of serine-type endopeptidase activity(GO:1900004) regulation of serine-type peptidase activity(GO:1902571) negative regulation of serine-type peptidase activity(GO:1902572) |
0.1 | 0.1 | GO:0002576 | platelet degranulation(GO:0002576) |
0.1 | 0.6 | GO:0097006 | regulation of plasma lipoprotein particle levels(GO:0097006) |
0.1 | 0.1 | GO:0002825 | regulation of T-helper 1 type immune response(GO:0002825) |
0.1 | 1.2 | GO:1903146 | regulation of mitophagy(GO:1903146) |
0.1 | 0.2 | GO:0071941 | nitrogen cycle metabolic process(GO:0071941) |
0.1 | 0.1 | GO:1903887 | motile primary cilium assembly(GO:1903887) |
0.1 | 0.7 | GO:0007549 | dosage compensation(GO:0007549) dosage compensation by inactivation of X chromosome(GO:0009048) |
0.1 | 0.1 | GO:0018243 | protein O-linked glycosylation via threonine(GO:0018243) |
0.1 | 2.4 | GO:0000724 | double-strand break repair via homologous recombination(GO:0000724) recombinational repair(GO:0000725) |
0.1 | 0.4 | GO:0000730 | DNA recombinase assembly(GO:0000730) double-strand break repair via synthesis-dependent strand annealing(GO:0045003) |
0.1 | 0.4 | GO:0017182 | peptidyl-diphthamide metabolic process(GO:0017182) peptidyl-diphthamide biosynthetic process from peptidyl-histidine(GO:0017183) peptidyl-histidine modification(GO:0018202) |
0.1 | 0.2 | GO:0001983 | baroreceptor response to increased systemic arterial blood pressure(GO:0001983) |
0.1 | 0.3 | GO:0070723 | response to cholesterol(GO:0070723) |
0.1 | 0.3 | GO:1902857 | positive regulation of nonmotile primary cilium assembly(GO:1902857) |
0.1 | 0.5 | GO:0006213 | pyrimidine nucleoside metabolic process(GO:0006213) |
0.1 | 0.8 | GO:0051898 | negative regulation of protein kinase B signaling(GO:0051898) |
0.1 | 0.1 | GO:0042362 | fat-soluble vitamin biosynthetic process(GO:0042362) |
0.1 | 2.5 | GO:0007229 | integrin-mediated signaling pathway(GO:0007229) |
0.1 | 0.3 | GO:0036265 | RNA (guanine-N7)-methylation(GO:0036265) |
0.1 | 0.1 | GO:0007089 | traversing start control point of mitotic cell cycle(GO:0007089) |
0.1 | 0.3 | GO:0080111 | DNA demethylation(GO:0080111) |
0.1 | 0.1 | GO:0045054 | constitutive secretory pathway(GO:0045054) |
0.1 | 0.1 | GO:0002455 | humoral immune response mediated by circulating immunoglobulin(GO:0002455) |
0.1 | 3.0 | GO:0035036 | sperm-egg recognition(GO:0035036) |
0.1 | 0.3 | GO:0035372 | protein localization to microtubule(GO:0035372) |
0.1 | 0.2 | GO:0001865 | NK T cell differentiation(GO:0001865) |
0.1 | 0.2 | GO:0002408 | myeloid dendritic cell chemotaxis(GO:0002408) |
0.1 | 0.5 | GO:0042178 | xenobiotic catabolic process(GO:0042178) |
0.1 | 0.2 | GO:0090073 | positive regulation of protein homodimerization activity(GO:0090073) |
0.1 | 0.2 | GO:0051132 | NK T cell activation(GO:0051132) |
0.1 | 0.6 | GO:0034315 | regulation of Arp2/3 complex-mediated actin nucleation(GO:0034315) |
0.1 | 1.4 | GO:0006270 | DNA replication initiation(GO:0006270) |
0.1 | 0.2 | GO:2000659 | regulation of interleukin-1-mediated signaling pathway(GO:2000659) |
0.1 | 0.8 | GO:0043486 | histone exchange(GO:0043486) |
0.1 | 0.2 | GO:0061083 | regulation of protein refolding(GO:0061083) |
0.1 | 0.3 | GO:0000389 | mRNA 3'-splice site recognition(GO:0000389) |
0.1 | 0.8 | GO:0003341 | cilium movement(GO:0003341) |
0.1 | 1.5 | GO:0000184 | nuclear-transcribed mRNA catabolic process, nonsense-mediated decay(GO:0000184) |
0.1 | 0.4 | GO:0007140 | male meiosis(GO:0007140) |
0.1 | 0.1 | GO:1901563 | response to camptothecin(GO:1901563) |
0.1 | 0.4 | GO:0034551 | respiratory chain complex III assembly(GO:0017062) mitochondrial respiratory chain complex III assembly(GO:0034551) mitochondrial respiratory chain complex III biogenesis(GO:0097033) |
0.1 | 0.1 | GO:0046884 | follicle-stimulating hormone secretion(GO:0046884) |
0.1 | 0.1 | GO:0001732 | formation of cytoplasmic translation initiation complex(GO:0001732) |
0.1 | 1.5 | GO:0071346 | cellular response to interferon-gamma(GO:0071346) |
0.1 | 0.3 | GO:0021983 | pituitary gland development(GO:0021983) |
0.1 | 1.0 | GO:0006301 | postreplication repair(GO:0006301) |
0.1 | 0.2 | GO:0032770 | positive regulation of monooxygenase activity(GO:0032770) |
0.1 | 0.1 | GO:0000491 | small nucleolar ribonucleoprotein complex assembly(GO:0000491) box C/D snoRNP assembly(GO:0000492) |
0.1 | 0.1 | GO:0034505 | tooth mineralization(GO:0034505) |
0.1 | 0.1 | GO:0010840 | regulation of circadian sleep/wake cycle, wakefulness(GO:0010840) circadian sleep/wake cycle, wakefulness(GO:0042746) |
0.1 | 0.1 | GO:0019676 | ammonia assimilation cycle(GO:0019676) |
0.1 | 0.4 | GO:0006477 | protein sulfation(GO:0006477) |
0.1 | 0.2 | GO:0042270 | protection from natural killer cell mediated cytotoxicity(GO:0042270) |
0.1 | 3.4 | GO:0008203 | cholesterol metabolic process(GO:0008203) |
0.1 | 0.2 | GO:0018094 | protein polyglycylation(GO:0018094) |
0.1 | 0.3 | GO:0016540 | protein autoprocessing(GO:0016540) |
0.1 | 0.1 | GO:0043654 | recognition of apoptotic cell(GO:0043654) |
0.1 | 0.1 | GO:2000680 | regulation of rubidium ion transport(GO:2000680) |
0.1 | 0.4 | GO:0000083 | regulation of transcription involved in G1/S transition of mitotic cell cycle(GO:0000083) |
0.1 | 0.1 | GO:0071360 | cellular response to exogenous dsRNA(GO:0071360) |
0.1 | 0.1 | GO:0048669 | collateral sprouting in absence of injury(GO:0048669) |
0.1 | 0.3 | GO:0070307 | lens fiber cell development(GO:0070307) |
0.1 | 0.2 | GO:0006348 | chromatin silencing at telomere(GO:0006348) |
0.1 | 0.2 | GO:0070459 | prolactin secretion(GO:0070459) |
0.1 | 0.1 | GO:0000715 | nucleotide-excision repair, DNA damage recognition(GO:0000715) |
0.1 | 0.1 | GO:0051383 | kinetochore organization(GO:0051383) |
0.1 | 0.1 | GO:0051771 | negative regulation of nitric-oxide synthase biosynthetic process(GO:0051771) |
0.1 | 0.2 | GO:0044597 | polyketide metabolic process(GO:0030638) aminoglycoside antibiotic metabolic process(GO:0030647) daunorubicin metabolic process(GO:0044597) doxorubicin metabolic process(GO:0044598) |
0.1 | 0.3 | GO:0055090 | acylglycerol homeostasis(GO:0055090) triglyceride homeostasis(GO:0070328) |
0.1 | 0.5 | GO:0035904 | aorta development(GO:0035904) |
0.1 | 0.4 | GO:0045582 | positive regulation of T cell differentiation(GO:0045582) |
0.1 | 0.1 | GO:0009067 | aspartate family amino acid biosynthetic process(GO:0009067) |
0.1 | 0.4 | GO:0015721 | bile acid and bile salt transport(GO:0015721) |
0.1 | 0.1 | GO:0002238 | response to molecule of fungal origin(GO:0002238) |
0.1 | 0.1 | GO:0044704 | single-organism reproductive behavior(GO:0044704) |
0.1 | 0.4 | GO:0035608 | protein deglutamylation(GO:0035608) |
0.1 | 5.4 | GO:0071230 | cellular response to amino acid stimulus(GO:0071230) |
0.1 | 0.1 | GO:0071494 | cellular response to UV-C(GO:0071494) |
0.1 | 0.1 | GO:0016075 | rRNA catabolic process(GO:0016075) |
0.1 | 0.2 | GO:0019482 | beta-alanine metabolic process(GO:0019482) |
0.1 | 0.1 | GO:0035459 | cargo loading into vesicle(GO:0035459) |
0.1 | 0.4 | GO:0016926 | protein desumoylation(GO:0016926) |
0.1 | 0.5 | GO:0032515 | negative regulation of phosphoprotein phosphatase activity(GO:0032515) |
0.1 | 0.3 | GO:0006706 | steroid catabolic process(GO:0006706) |
0.1 | 0.3 | GO:0051782 | negative regulation of cell division(GO:0051782) |
0.1 | 0.1 | GO:0002584 | negative regulation of antigen processing and presentation of peptide antigen(GO:0002584) |
0.1 | 0.1 | GO:0008272 | sulfate transport(GO:0008272) |
0.1 | 0.1 | GO:0046909 | intermembrane transport(GO:0046909) |
0.1 | 0.1 | GO:0006069 | ethanol metabolic process(GO:0006067) ethanol oxidation(GO:0006069) |
0.1 | 0.1 | GO:0006930 | substrate-dependent cell migration, cell extension(GO:0006930) |
0.1 | 0.6 | GO:0044380 | protein localization to cytoskeleton(GO:0044380) |
0.1 | 0.1 | GO:0090209 | negative regulation of triglyceride metabolic process(GO:0090209) |
0.1 | 1.1 | GO:0043966 | histone H3 acetylation(GO:0043966) |
0.1 | 0.4 | GO:0048025 | negative regulation of mRNA splicing, via spliceosome(GO:0048025) |
0.0 | 1.9 | GO:0002286 | T cell activation involved in immune response(GO:0002286) |
0.0 | 0.0 | GO:0044783 | G1 DNA damage checkpoint(GO:0044783) |
0.0 | 0.1 | GO:0098764 | M phase(GO:0000279) meiotic prophase I(GO:0007128) prophase(GO:0051324) meiotic cell cycle phase(GO:0098762) meiosis I cell cycle phase(GO:0098764) |
0.0 | 0.1 | GO:0042226 | interleukin-6 biosynthetic process(GO:0042226) |
0.0 | 1.2 | GO:0006890 | retrograde vesicle-mediated transport, Golgi to ER(GO:0006890) |
0.0 | 0.1 | GO:0035457 | cellular response to interferon-alpha(GO:0035457) |
0.0 | 0.1 | GO:0009263 | deoxyribonucleotide biosynthetic process(GO:0009263) |
0.0 | 0.5 | GO:0030150 | protein import into mitochondrial matrix(GO:0030150) |
0.0 | 0.0 | GO:0042636 | negative regulation of hair cycle(GO:0042636) |
0.0 | 2.5 | GO:0002244 | hematopoietic progenitor cell differentiation(GO:0002244) |
0.0 | 0.1 | GO:0000711 | meiotic DNA repair synthesis(GO:0000711) |
0.0 | 0.3 | GO:0045824 | negative regulation of innate immune response(GO:0045824) |
0.0 | 0.1 | GO:1902202 | regulation of hepatocyte growth factor receptor signaling pathway(GO:1902202) |
0.0 | 0.1 | GO:0071468 | cellular response to acidic pH(GO:0071468) |
0.0 | 0.1 | GO:0042573 | retinoic acid metabolic process(GO:0042573) |
0.0 | 2.1 | GO:0007599 | hemostasis(GO:0007599) |
0.0 | 0.1 | GO:0019852 | L-ascorbic acid metabolic process(GO:0019852) |
0.0 | 0.5 | GO:0042058 | regulation of epidermal growth factor receptor signaling pathway(GO:0042058) |
0.0 | 0.9 | GO:0003333 | amino acid transmembrane transport(GO:0003333) |
0.0 | 0.0 | GO:0090231 | regulation of spindle checkpoint(GO:0090231) |
0.0 | 0.1 | GO:0051029 | rRNA transport(GO:0051029) |
0.0 | 0.2 | GO:0031529 | ruffle organization(GO:0031529) |
0.0 | 0.1 | GO:2000351 | regulation of endothelial cell apoptotic process(GO:2000351) |
0.0 | 0.1 | GO:0042534 | tumor necrosis factor biosynthetic process(GO:0042533) regulation of tumor necrosis factor biosynthetic process(GO:0042534) |
0.0 | 0.0 | GO:0010735 | positive regulation of transcription via serum response element binding(GO:0010735) |
0.0 | 0.1 | GO:0034121 | regulation of toll-like receptor signaling pathway(GO:0034121) |
0.0 | 0.1 | GO:0006107 | oxaloacetate metabolic process(GO:0006107) |
0.0 | 0.3 | GO:0002377 | immunoglobulin production(GO:0002377) |
0.0 | 0.1 | GO:0051657 | maintenance of organelle location(GO:0051657) |
0.0 | 0.2 | GO:0043046 | DNA methylation involved in gamete generation(GO:0043046) |
0.0 | 0.1 | GO:0090026 | positive regulation of monocyte chemotaxis(GO:0090026) |
0.0 | 0.1 | GO:0030579 | ubiquitin-dependent SMAD protein catabolic process(GO:0030579) |
0.0 | 0.1 | GO:0031947 | negative regulation of glucocorticoid metabolic process(GO:0031944) negative regulation of glucocorticoid biosynthetic process(GO:0031947) |
0.0 | 0.0 | GO:0070827 | chromatin maintenance(GO:0070827) |
0.0 | 0.1 | GO:0048384 | retinoic acid receptor signaling pathway(GO:0048384) |
0.0 | 0.1 | GO:2000786 | positive regulation of autophagosome assembly(GO:2000786) |
0.0 | 2.6 | GO:0019236 | response to pheromone(GO:0019236) |
0.0 | 0.1 | GO:0071359 | cellular response to dsRNA(GO:0071359) |
0.0 | 0.0 | GO:0035278 | miRNA mediated inhibition of translation(GO:0035278) |
0.0 | 0.0 | GO:0030950 | establishment or maintenance of actin cytoskeleton polarity(GO:0030950) |
0.0 | 0.1 | GO:0006398 | mRNA 3'-end processing by stem-loop binding and cleavage(GO:0006398) |
0.0 | 0.0 | GO:0010992 | ubiquitin homeostasis(GO:0010992) |
0.0 | 0.0 | GO:0002248 | connective tissue replacement involved in inflammatory response wound healing(GO:0002248) connective tissue replacement(GO:0097709) |
0.0 | 0.1 | GO:0015893 | drug transport(GO:0015893) |
0.0 | 0.1 | GO:1900165 | negative regulation of interleukin-6 secretion(GO:1900165) |
0.0 | 0.0 | GO:0072677 | eosinophil migration(GO:0072677) |
0.0 | 0.5 | GO:0000079 | regulation of cyclin-dependent protein serine/threonine kinase activity(GO:0000079) |
0.0 | 0.0 | GO:0060157 | urinary bladder development(GO:0060157) |
0.0 | 0.1 | GO:0048733 | sebaceous gland development(GO:0048733) |
0.0 | 0.0 | GO:0051342 | regulation of cyclic-nucleotide phosphodiesterase activity(GO:0051342) |
0.0 | 0.1 | GO:0006342 | chromatin silencing(GO:0006342) |
0.0 | 0.0 | GO:0046520 | sphingoid biosynthetic process(GO:0046520) |
0.0 | 0.0 | GO:1902071 | regulation of hypoxia-inducible factor-1alpha signaling pathway(GO:1902071) |
0.0 | 0.0 | GO:0070417 | cellular response to cold(GO:0070417) |
0.0 | 0.0 | GO:0034214 | protein hexamerization(GO:0034214) |
0.0 | 0.2 | GO:0052696 | flavonoid biosynthetic process(GO:0009813) flavonoid glucuronidation(GO:0052696) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
4.9 | 24.3 | GO:0031838 | haptoglobin-hemoglobin complex(GO:0031838) |
2.9 | 8.6 | GO:0005833 | hemoglobin complex(GO:0005833) |
2.5 | 15.3 | GO:0014731 | spectrin-associated cytoskeleton(GO:0014731) |
2.5 | 10.1 | GO:0031466 | Cul5-RING ubiquitin ligase complex(GO:0031466) |
2.4 | 7.3 | GO:1990907 | beta-catenin-TCF complex(GO:1990907) |
2.4 | 29.2 | GO:0098643 | fibrillar collagen trimer(GO:0005583) banded collagen fibril(GO:0098643) |
2.2 | 6.6 | GO:0097058 | CRLF-CLCF1 complex(GO:0097058) |
2.1 | 6.4 | GO:1990597 | AIP1-IRE1 complex(GO:1990597) |
2.1 | 2.1 | GO:0044393 | microspike(GO:0044393) |
2.0 | 6.1 | GO:0070552 | BRISC complex(GO:0070552) |
2.0 | 6.0 | GO:0034365 | discoidal high-density lipoprotein particle(GO:0034365) |
1.9 | 7.5 | GO:0019907 | cyclin-dependent protein kinase activating kinase holoenzyme complex(GO:0019907) |
1.8 | 5.4 | GO:0035985 | senescence-associated heterochromatin focus(GO:0035985) |
1.8 | 3.6 | GO:0034679 | integrin alpha9-beta1 complex(GO:0034679) |
1.8 | 12.3 | GO:0005577 | fibrinogen complex(GO:0005577) |
1.7 | 6.9 | GO:0061689 | tricellular tight junction(GO:0061689) |
1.7 | 8.6 | GO:0032133 | chromosome passenger complex(GO:0032133) |
1.7 | 17.1 | GO:0031254 | uropod(GO:0001931) cell trailing edge(GO:0031254) |
1.7 | 13.4 | GO:0005861 | troponin complex(GO:0005861) |
1.7 | 6.7 | GO:0042567 | insulin-like growth factor binding protein complex(GO:0016942) growth factor complex(GO:0036454) insulin-like growth factor ternary complex(GO:0042567) |
1.7 | 6.6 | GO:0071141 | SMAD protein complex(GO:0071141) |
1.6 | 6.6 | GO:0005593 | FACIT collagen trimer(GO:0005593) |
1.6 | 8.2 | GO:0042406 | extrinsic component of endoplasmic reticulum membrane(GO:0042406) |
1.6 | 14.0 | GO:0043020 | NADPH oxidase complex(GO:0043020) |
1.5 | 7.5 | GO:0033256 | I-kappaB/NF-kappaB complex(GO:0033256) |
1.5 | 5.9 | GO:0097452 | GAIT complex(GO:0097452) |
1.5 | 1.5 | GO:0035061 | interchromatin granule(GO:0035061) |
1.4 | 4.3 | GO:0034363 | intermediate-density lipoprotein particle(GO:0034363) |
1.4 | 2.8 | GO:0005608 | laminin-3 complex(GO:0005608) |
1.4 | 8.4 | GO:0090571 | RNA polymerase II transcription repressor complex(GO:0090571) |
1.4 | 480.0 | GO:0005667 | transcription factor complex(GO:0005667) |
1.3 | 6.6 | GO:0070937 | CRD-mediated mRNA stability complex(GO:0070937) |
1.3 | 10.5 | GO:0030056 | hemidesmosome(GO:0030056) |
1.3 | 3.9 | GO:0031074 | nucleocytoplasmic shuttling complex(GO:0031074) |
1.3 | 3.8 | GO:0005914 | spot adherens junction(GO:0005914) |
1.3 | 1.3 | GO:0032585 | multivesicular body membrane(GO:0032585) |
1.2 | 3.7 | GO:0005971 | ribonucleoside-diphosphate reductase complex(GO:0005971) |
1.2 | 5.0 | GO:0097524 | sperm plasma membrane(GO:0097524) |
1.2 | 9.9 | GO:0034992 | microtubule organizing center attachment site(GO:0034992) LINC complex(GO:0034993) |
1.2 | 6.1 | GO:0005638 | lamin filament(GO:0005638) |
1.2 | 6.1 | GO:0033093 | Weibel-Palade body(GO:0033093) |
1.2 | 8.5 | GO:0005688 | U6 snRNP(GO:0005688) |
1.2 | 3.6 | GO:0046691 | intracellular canaliculus(GO:0046691) |
1.2 | 3.6 | GO:0031143 | pseudopodium(GO:0031143) |
1.2 | 9.7 | GO:0005677 | chromatin silencing complex(GO:0005677) |
1.2 | 2.4 | GO:0005775 | vacuolar lumen(GO:0005775) |
1.2 | 4.7 | GO:1990130 | Iml1 complex(GO:1990130) |
1.2 | 3.5 | GO:0033596 | TSC1-TSC2 complex(GO:0033596) |
1.2 | 3.5 | GO:0048179 | activin receptor complex(GO:0048179) |
1.2 | 3.5 | GO:0097427 | microtubule bundle(GO:0097427) |
1.1 | 2.3 | GO:0097057 | TRAF2-GSTP1 complex(GO:0097057) |
1.1 | 60.7 | GO:0017053 | transcriptional repressor complex(GO:0017053) |
1.1 | 5.7 | GO:0016281 | eukaryotic translation initiation factor 4F complex(GO:0016281) |
1.1 | 5.5 | GO:0031298 | replication fork protection complex(GO:0031298) |
1.1 | 5.5 | GO:0016461 | unconventional myosin complex(GO:0016461) |
1.1 | 6.6 | GO:0005915 | zonula adherens(GO:0005915) |
1.1 | 3.3 | GO:0005610 | laminin-5 complex(GO:0005610) |
1.1 | 8.4 | GO:0045179 | apical cortex(GO:0045179) |
1.0 | 3.1 | GO:0071438 | invadopodium membrane(GO:0071438) |
1.0 | 4.1 | GO:0031094 | platelet dense tubular network(GO:0031094) |
1.0 | 4.1 | GO:0044530 | supraspliceosomal complex(GO:0044530) |
1.0 | 4.1 | GO:0016600 | flotillin complex(GO:0016600) |
1.0 | 6.1 | GO:0097342 | ripoptosome(GO:0097342) |
1.0 | 3.0 | GO:0070110 | ciliary neurotrophic factor receptor complex(GO:0070110) |
1.0 | 4.0 | GO:0002189 | ribose phosphate diphosphokinase complex(GO:0002189) |
1.0 | 9.9 | GO:0034361 | very-low-density lipoprotein particle(GO:0034361) triglyceride-rich lipoprotein particle(GO:0034385) |
1.0 | 1.0 | GO:0005850 | eukaryotic translation initiation factor 2 complex(GO:0005850) |
1.0 | 3.9 | GO:0042825 | TAP complex(GO:0042825) |
1.0 | 3.9 | GO:0005642 | annulate lamellae(GO:0005642) |
1.0 | 6.7 | GO:0001650 | fibrillar center(GO:0001650) |
0.9 | 13.8 | GO:0031430 | M band(GO:0031430) |
0.9 | 8.3 | GO:0005614 | interstitial matrix(GO:0005614) |
0.9 | 10.1 | GO:0031528 | microvillus membrane(GO:0031528) |
0.9 | 21.0 | GO:0000791 | euchromatin(GO:0000791) |
0.9 | 3.6 | GO:0000938 | GARP complex(GO:0000938) |
0.9 | 20.7 | GO:0008305 | integrin complex(GO:0008305) |
0.9 | 8.1 | GO:0005751 | mitochondrial respiratory chain complex IV(GO:0005751) |
0.9 | 2.7 | GO:0016222 | procollagen-proline 4-dioxygenase complex(GO:0016222) |
0.9 | 26.6 | GO:0016235 | aggresome(GO:0016235) |
0.9 | 2.7 | GO:0097543 | ciliary inversin compartment(GO:0097543) |
0.9 | 2.6 | GO:0044194 | cytolytic granule(GO:0044194) |
0.9 | 3.5 | GO:0019815 | B cell receptor complex(GO:0019815) |
0.9 | 0.9 | GO:0038201 | TOR complex(GO:0038201) |
0.9 | 2.6 | GO:0071818 | BAT3 complex(GO:0071818) ER membrane insertion complex(GO:0072379) |
0.9 | 7.8 | GO:0097542 | ciliary tip(GO:0097542) |
0.9 | 6.9 | GO:0098554 | cytoplasmic side of endoplasmic reticulum membrane(GO:0098554) |
0.9 | 14.6 | GO:0045120 | pronucleus(GO:0045120) |
0.9 | 6.0 | GO:0008290 | F-actin capping protein complex(GO:0008290) |
0.9 | 34.9 | GO:0022627 | cytosolic small ribosomal subunit(GO:0022627) |
0.8 | 3.4 | GO:0030121 | AP-1 adaptor complex(GO:0030121) |
0.8 | 10.1 | GO:0005641 | nuclear envelope lumen(GO:0005641) |
0.8 | 1.7 | GO:0097149 | centralspindlin complex(GO:0097149) |
0.8 | 3.4 | GO:0000322 | storage vacuole(GO:0000322) |
0.8 | 1.6 | GO:0005967 | mitochondrial pyruvate dehydrogenase complex(GO:0005967) |
0.8 | 13.9 | GO:0002102 | podosome(GO:0002102) |
0.8 | 7.0 | GO:0042581 | specific granule(GO:0042581) |
0.8 | 3.1 | GO:0044462 | cell outer membrane(GO:0009279) cell envelope(GO:0030313) external encapsulating structure part(GO:0044462) |
0.8 | 16.1 | GO:0042588 | zymogen granule(GO:0042588) |
0.8 | 3.1 | GO:1990357 | terminal web(GO:1990357) |
0.8 | 3.0 | GO:0035339 | SPOTS complex(GO:0035339) |
0.7 | 0.7 | GO:0097443 | sorting endosome(GO:0097443) |
0.7 | 21.6 | GO:0010494 | cytoplasmic stress granule(GO:0010494) |
0.7 | 0.7 | GO:0000177 | cytoplasmic exosome (RNase complex)(GO:0000177) |
0.7 | 0.7 | GO:0005686 | U2 snRNP(GO:0005686) |
0.7 | 5.8 | GO:0000243 | commitment complex(GO:0000243) |
0.7 | 2.9 | GO:0097136 | Bcl-2 family protein complex(GO:0097136) |
0.7 | 4.3 | GO:0000138 | Golgi trans cisterna(GO:0000138) |
0.7 | 2.1 | GO:0005947 | mitochondrial alpha-ketoglutarate dehydrogenase complex(GO:0005947) |
0.7 | 0.7 | GO:0005682 | U5 snRNP(GO:0005682) |
0.7 | 2.1 | GO:0071001 | U4/U6 snRNP(GO:0071001) |
0.7 | 6.4 | GO:0036128 | CatSper complex(GO:0036128) |
0.7 | 1.4 | GO:0002193 | MAML1-RBP-Jkappa- ICN1 complex(GO:0002193) |
0.7 | 9.8 | GO:0005865 | striated muscle thin filament(GO:0005865) |
0.7 | 2.1 | GO:0090661 | box H/ACA telomerase RNP complex(GO:0090661) |
0.7 | 43.8 | GO:0022625 | cytosolic large ribosomal subunit(GO:0022625) |
0.7 | 3.4 | GO:0045178 | basal part of cell(GO:0045178) |
0.7 | 1.4 | GO:0033186 | CAF-1 complex(GO:0033186) |
0.7 | 5.4 | GO:0031512 | motile primary cilium(GO:0031512) |
0.7 | 2.7 | GO:1990712 | HFE-transferrin receptor complex(GO:1990712) |
0.7 | 14.6 | GO:0034451 | centriolar satellite(GO:0034451) |
0.7 | 1.3 | GO:0005952 | cAMP-dependent protein kinase complex(GO:0005952) |
0.7 | 42.9 | GO:0005581 | collagen trimer(GO:0005581) |
0.7 | 2.6 | GO:0000942 | condensed nuclear chromosome outer kinetochore(GO:0000942) |
0.7 | 1.3 | GO:0048476 | Holliday junction resolvase complex(GO:0048476) |
0.7 | 2.0 | GO:0042827 | platelet dense granule(GO:0042827) |
0.6 | 7.1 | GO:0034663 | endoplasmic reticulum chaperone complex(GO:0034663) |
0.6 | 1.3 | GO:0001651 | dense fibrillar component(GO:0001651) |
0.6 | 2.6 | GO:0031467 | Cul7-RING ubiquitin ligase complex(GO:0031467) |
0.6 | 3.8 | GO:0090543 | Flemming body(GO:0090543) |
0.6 | 1.9 | GO:0000015 | phosphopyruvate hydratase complex(GO:0000015) |
0.6 | 1.3 | GO:0016589 | NURF complex(GO:0016589) |
0.6 | 3.8 | GO:0000781 | chromosome, telomeric region(GO:0000781) |
0.6 | 2.5 | GO:0035748 | myelin sheath abaxonal region(GO:0035748) |
0.6 | 12.3 | GO:0051233 | spindle midzone(GO:0051233) |
0.6 | 6.7 | GO:0031672 | A band(GO:0031672) |
0.6 | 2.4 | GO:0043202 | lysosomal lumen(GO:0043202) |
0.6 | 6.6 | GO:0042612 | MHC class I protein complex(GO:0042612) |
0.6 | 0.6 | GO:0031265 | CD95 death-inducing signaling complex(GO:0031265) |
0.6 | 3.0 | GO:0042105 | alpha-beta T cell receptor complex(GO:0042105) |
0.6 | 4.2 | GO:0097431 | mitotic spindle pole(GO:0097431) |
0.6 | 5.4 | GO:0046581 | intercellular canaliculus(GO:0046581) |
0.6 | 1.8 | GO:0034362 | low-density lipoprotein particle(GO:0034362) |
0.6 | 3.0 | GO:0070578 | RISC-loading complex(GO:0070578) |
0.6 | 2.4 | GO:0031313 | extrinsic component of endosome membrane(GO:0031313) |
0.6 | 1.2 | GO:0005687 | U4 snRNP(GO:0005687) |
0.6 | 2.4 | GO:0008024 | cyclin/CDK positive transcription elongation factor complex(GO:0008024) |
0.6 | 0.6 | GO:0033202 | DNA helicase complex(GO:0033202) |
0.6 | 1.2 | GO:0048787 | presynaptic active zone membrane(GO:0048787) |
0.6 | 2.3 | GO:0000444 | MIS12/MIND type complex(GO:0000444) |
0.6 | 1.2 | GO:0031618 | nuclear pericentric heterochromatin(GO:0031618) |
0.6 | 2.9 | GO:0031983 | vesicle lumen(GO:0031983) |
0.6 | 2.3 | GO:0005818 | aster(GO:0005818) |
0.6 | 1.7 | GO:1990423 | RZZ complex(GO:1990423) |
0.6 | 2.3 | GO:0072557 | IPAF inflammasome complex(GO:0072557) |
0.6 | 23.8 | GO:0000932 | cytoplasmic mRNA processing body(GO:0000932) |
0.6 | 4.0 | GO:1990909 | Wnt signalosome(GO:1990909) |
0.6 | 5.6 | GO:0000783 | telomere cap complex(GO:0000782) nuclear telomere cap complex(GO:0000783) |
0.6 | 31.7 | GO:0042641 | actomyosin(GO:0042641) |
0.6 | 3.3 | GO:0070776 | H3 histone acetyltransferase complex(GO:0070775) MOZ/MORF histone acetyltransferase complex(GO:0070776) |
0.6 | 1.1 | GO:0043219 | lateral loop(GO:0043219) |
0.6 | 1.7 | GO:0032299 | ribonuclease H2 complex(GO:0032299) |
0.5 | 15.9 | GO:0016529 | sarcoplasmic reticulum(GO:0016529) |
0.5 | 2.2 | GO:0097169 | AIM2 inflammasome complex(GO:0097169) |
0.5 | 1.6 | GO:0044611 | nuclear pore inner ring(GO:0044611) |
0.5 | 1.1 | GO:0045277 | respiratory chain complex IV(GO:0045277) |
0.5 | 2.7 | GO:0001674 | female germ cell nucleus(GO:0001674) |
0.5 | 43.1 | GO:0072562 | blood microparticle(GO:0072562) |
0.5 | 2.1 | GO:0031227 | intrinsic component of endoplasmic reticulum membrane(GO:0031227) |
0.5 | 8.6 | GO:0000307 | cyclin-dependent protein kinase holoenzyme complex(GO:0000307) |
0.5 | 9.1 | GO:0005732 | small nucleolar ribonucleoprotein complex(GO:0005732) |
0.5 | 1.1 | GO:0033185 | dolichol-phosphate-mannose synthase complex(GO:0033185) |
0.5 | 1.1 | GO:0000814 | ESCRT II complex(GO:0000814) |
0.5 | 5.8 | GO:0031233 | intrinsic component of external side of plasma membrane(GO:0031233) |
0.5 | 0.5 | GO:0097418 | neurofibrillary tangle(GO:0097418) |
0.5 | 2.1 | GO:0008622 | epsilon DNA polymerase complex(GO:0008622) |
0.5 | 12.9 | GO:0005771 | multivesicular body(GO:0005771) |
0.5 | 3.6 | GO:0032045 | guanyl-nucleotide exchange factor complex(GO:0032045) |
0.5 | 19.4 | GO:0045095 | keratin filament(GO:0045095) |
0.5 | 10.2 | GO:0005680 | anaphase-promoting complex(GO:0005680) |
0.5 | 0.5 | GO:0000152 | nuclear ubiquitin ligase complex(GO:0000152) |
0.5 | 1.0 | GO:0071204 | histone pre-mRNA 3'end processing complex(GO:0071204) |
0.5 | 2.5 | GO:0042629 | mast cell granule(GO:0042629) |
0.5 | 1.0 | GO:0005927 | muscle tendon junction(GO:0005927) |
0.5 | 4.4 | GO:0031616 | spindle pole centrosome(GO:0031616) |
0.5 | 1.0 | GO:0033588 | Elongator holoenzyme complex(GO:0033588) |
0.5 | 1.0 | GO:0005956 | protein kinase CK2 complex(GO:0005956) |
0.5 | 5.2 | GO:0042555 | MCM complex(GO:0042555) |
0.5 | 1.9 | GO:0034098 | VCP-NPL4-UFD1 AAA ATPase complex(GO:0034098) |
0.5 | 0.5 | GO:0000346 | transcription export complex(GO:0000346) |
0.5 | 2.8 | GO:0070938 | contractile ring(GO:0070938) |
0.5 | 2.3 | GO:0072357 | PTW/PP1 phosphatase complex(GO:0072357) |
0.5 | 45.6 | GO:0000793 | condensed chromosome(GO:0000793) |
0.5 | 29.7 | GO:0005604 | basement membrane(GO:0005604) |
0.5 | 1.4 | GO:0035838 | growing cell tip(GO:0035838) |
0.4 | 0.9 | GO:0072559 | NLRP3 inflammasome complex(GO:0072559) |
0.4 | 1.8 | GO:0035861 | site of double-strand break(GO:0035861) |
0.4 | 1.3 | GO:0035355 | Toll-like receptor 2-Toll-like receptor 6 protein complex(GO:0035355) |
0.4 | 5.8 | GO:0005736 | DNA-directed RNA polymerase I complex(GO:0005736) |
0.4 | 23.2 | GO:0005902 | microvillus(GO:0005902) |
0.4 | 3.6 | GO:0036157 | outer dynein arm(GO:0036157) |
0.4 | 1.3 | GO:0005658 | alpha DNA polymerase:primase complex(GO:0005658) |
0.4 | 1.8 | GO:0005796 | Golgi lumen(GO:0005796) |
0.4 | 3.1 | GO:0008385 | IkappaB kinase complex(GO:0008385) |
0.4 | 3.9 | GO:0043034 | costamere(GO:0043034) |
0.4 | 10.4 | GO:0015030 | Cajal body(GO:0015030) |
0.4 | 4.8 | GO:0031588 | nucleotide-activated protein kinase complex(GO:0031588) |
0.4 | 1.3 | GO:0030485 | smooth muscle contractile fiber(GO:0030485) |
0.4 | 0.8 | GO:0016234 | inclusion body(GO:0016234) |
0.4 | 3.3 | GO:0000506 | glycosylphosphatidylinositol-N-acetylglucosaminyltransferase (GPI-GnT) complex(GO:0000506) |
0.4 | 1.2 | GO:0005955 | calcineurin complex(GO:0005955) |
0.4 | 5.8 | GO:0071010 | prespliceosome(GO:0071010) |
0.4 | 5.7 | GO:0000145 | exocyst(GO:0000145) |
0.4 | 2.0 | GO:0032009 | early phagosome(GO:0032009) |
0.4 | 0.8 | GO:0009331 | glycerol-3-phosphate dehydrogenase complex(GO:0009331) |
0.4 | 4.0 | GO:0001891 | phagocytic cup(GO:0001891) |
0.4 | 0.4 | GO:0044299 | C-fiber(GO:0044299) |
0.4 | 1.2 | GO:0030478 | actin cap(GO:0030478) |
0.4 | 2.0 | GO:0042382 | paraspeckles(GO:0042382) |
0.4 | 2.8 | GO:0048188 | Set1C/COMPASS complex(GO:0048188) |
0.4 | 4.7 | GO:0043240 | Fanconi anaemia nuclear complex(GO:0043240) |
0.4 | 2.0 | GO:0071439 | clathrin complex(GO:0071439) |
0.4 | 3.9 | GO:0030126 | COPI vesicle coat(GO:0030126) |
0.4 | 0.8 | GO:0060053 | neurofilament cytoskeleton(GO:0060053) |
0.4 | 0.4 | GO:0030880 | RNA polymerase complex(GO:0030880) |
0.4 | 3.1 | GO:0031932 | TORC2 complex(GO:0031932) |
0.4 | 23.0 | GO:0071013 | catalytic step 2 spliceosome(GO:0071013) |
0.4 | 0.4 | GO:0031933 | telomeric heterochromatin(GO:0031933) |
0.4 | 0.4 | GO:0032437 | cuticular plate(GO:0032437) |
0.4 | 1.1 | GO:0043220 | Schmidt-Lanterman incisure(GO:0043220) |
0.4 | 1.5 | GO:0098536 | deuterosome(GO:0098536) |
0.4 | 1.1 | GO:0031523 | Myb complex(GO:0031523) |
0.4 | 2.9 | GO:0030991 | intraciliary transport particle A(GO:0030991) |
0.4 | 2.2 | GO:0032797 | SMN complex(GO:0032797) |
0.4 | 1.4 | GO:0001739 | sex chromatin(GO:0001739) |
0.4 | 4.7 | GO:0035327 | transcriptionally active chromatin(GO:0035327) |
0.4 | 4.0 | GO:0032154 | cleavage furrow(GO:0032154) cell surface furrow(GO:0097610) |
0.4 | 3.6 | GO:0001527 | microfibril(GO:0001527) |
0.4 | 5.0 | GO:0005852 | eukaryotic translation initiation factor 3 complex(GO:0005852) |
0.4 | 8.5 | GO:0030864 | cortical actin cytoskeleton(GO:0030864) |
0.4 | 0.4 | GO:0000974 | Prp19 complex(GO:0000974) |
0.3 | 1.0 | GO:0005745 | m-AAA complex(GO:0005745) |
0.3 | 3.5 | GO:0005697 | telomerase holoenzyme complex(GO:0005697) |
0.3 | 11.8 | GO:0005834 | heterotrimeric G-protein complex(GO:0005834) |
0.3 | 0.3 | GO:0035867 | alphav-beta3 integrin-IGF-1-IGF1R complex(GO:0035867) |
0.3 | 1.4 | GO:0097422 | tubular endosome(GO:0097422) |
0.3 | 5.8 | GO:0097228 | sperm principal piece(GO:0097228) |
0.3 | 7.2 | GO:0044448 | cell cortex part(GO:0044448) |
0.3 | 0.7 | GO:0005945 | 6-phosphofructokinase complex(GO:0005945) |
0.3 | 20.4 | GO:0005681 | spliceosomal complex(GO:0005681) |
0.3 | 8.0 | GO:0016363 | nuclear matrix(GO:0016363) |
0.3 | 3.7 | GO:0098799 | outer mitochondrial membrane protein complex(GO:0098799) |
0.3 | 0.7 | GO:0031464 | Cul4A-RING E3 ubiquitin ligase complex(GO:0031464) |
0.3 | 0.3 | GO:0070820 | tertiary granule(GO:0070820) |
0.3 | 2.6 | GO:0098827 | endoplasmic reticulum subcompartment(GO:0098827) |
0.3 | 7.9 | GO:0032993 | protein-DNA complex(GO:0032993) |
0.3 | 2.9 | GO:0031371 | ubiquitin conjugating enzyme complex(GO:0031371) |
0.3 | 1.0 | GO:0000502 | proteasome complex(GO:0000502) |
0.3 | 0.3 | GO:0042599 | lamellar body(GO:0042599) |
0.3 | 2.2 | GO:0005916 | fascia adherens(GO:0005916) |
0.3 | 4.3 | GO:0005892 | acetylcholine-gated channel complex(GO:0005892) |
0.3 | 1.5 | GO:0000812 | Swr1 complex(GO:0000812) |
0.3 | 55.9 | GO:0030055 | cell-substrate junction(GO:0030055) |
0.3 | 3.6 | GO:0030123 | AP-3 adaptor complex(GO:0030123) |
0.3 | 4.8 | GO:0016327 | apicolateral plasma membrane(GO:0016327) |
0.3 | 3.3 | GO:0033391 | chromatoid body(GO:0033391) |
0.3 | 6.9 | GO:0035097 | histone methyltransferase complex(GO:0035097) |
0.3 | 1.2 | GO:0042613 | MHC class II protein complex(GO:0042613) |
0.3 | 1.8 | GO:0033061 | DNA recombinase mediator complex(GO:0033061) |
0.3 | 0.6 | GO:0061700 | GATOR2 complex(GO:0061700) |
0.3 | 2.4 | GO:0035631 | CD40 receptor complex(GO:0035631) |
0.3 | 1.2 | GO:1990246 | uniplex complex(GO:1990246) |
0.3 | 1.7 | GO:0000788 | nuclear nucleosome(GO:0000788) |
0.3 | 1.2 | GO:0005968 | Rab-protein geranylgeranyltransferase complex(GO:0005968) |
0.3 | 0.6 | GO:0031262 | Ndc80 complex(GO:0031262) |
0.3 | 0.9 | GO:0070545 | PeBoW complex(GO:0070545) |
0.3 | 4.9 | GO:0030686 | 90S preribosome(GO:0030686) |
0.3 | 1.7 | GO:0016272 | prefoldin complex(GO:0016272) |
0.3 | 0.3 | GO:0046540 | U4/U6 x U5 tri-snRNP complex(GO:0046540) |
0.3 | 6.5 | GO:0031519 | PcG protein complex(GO:0031519) |
0.3 | 1.1 | GO:0044613 | nuclear pore central transport channel(GO:0044613) |
0.3 | 2.5 | GO:0035145 | exon-exon junction complex(GO:0035145) |
0.3 | 0.3 | GO:0061574 | ASAP complex(GO:0061574) |
0.3 | 3.6 | GO:0030057 | desmosome(GO:0030057) |
0.3 | 3.0 | GO:0032039 | integrator complex(GO:0032039) |
0.3 | 0.8 | GO:0071564 | npBAF complex(GO:0071564) |
0.3 | 0.5 | GO:0045259 | proton-transporting ATP synthase complex(GO:0045259) |
0.3 | 2.4 | GO:0030061 | mitochondrial crista(GO:0030061) |
0.3 | 9.7 | GO:0016605 | PML body(GO:0016605) |
0.3 | 2.7 | GO:0001741 | XY body(GO:0001741) |
0.3 | 1.9 | GO:0031083 | BLOC-1 complex(GO:0031083) |
0.3 | 7.6 | GO:0000228 | nuclear chromosome(GO:0000228) |
0.3 | 2.9 | GO:0065010 | extracellular membrane-bounded organelle(GO:0065010) |
0.3 | 1.0 | GO:0072487 | MSL complex(GO:0072487) |
0.3 | 1.5 | GO:0097225 | sperm midpiece(GO:0097225) |
0.3 | 2.8 | GO:0000164 | protein phosphatase type 1 complex(GO:0000164) |
0.2 | 12.2 | GO:0001669 | acrosomal vesicle(GO:0001669) |
0.2 | 2.7 | GO:0016471 | vacuolar proton-transporting V-type ATPase complex(GO:0016471) |
0.2 | 5.2 | GO:0016459 | myosin complex(GO:0016459) |
0.2 | 0.7 | GO:0000835 | ER ubiquitin ligase complex(GO:0000835) Hrd1p ubiquitin ligase complex(GO:0000836) |
0.2 | 1.7 | GO:0031091 | platelet alpha granule(GO:0031091) |
0.2 | 2.7 | GO:0043196 | varicosity(GO:0043196) |
0.2 | 2.7 | GO:0005666 | DNA-directed RNA polymerase III complex(GO:0005666) |
0.2 | 0.7 | GO:0005721 | pericentric heterochromatin(GO:0005721) |
0.2 | 1.2 | GO:0019773 | proteasome core complex, alpha-subunit complex(GO:0019773) |
0.2 | 5.5 | GO:0005844 | polysome(GO:0005844) |
0.2 | 15.5 | GO:0005903 | brush border(GO:0005903) |
0.2 | 5.8 | GO:0045171 | intercellular bridge(GO:0045171) |
0.2 | 5.1 | GO:0016592 | mediator complex(GO:0016592) |
0.2 | 0.7 | GO:0030956 | glutamyl-tRNA(Gln) amidotransferase complex(GO:0030956) |
0.2 | 0.9 | GO:0097197 | tetraspanin-enriched microdomain(GO:0097197) |
0.2 | 2.9 | GO:0030687 | preribosome, large subunit precursor(GO:0030687) |
0.2 | 0.7 | GO:0044294 | dendritic growth cone(GO:0044294) |
0.2 | 1.1 | GO:0005942 | phosphatidylinositol 3-kinase complex(GO:0005942) |
0.2 | 0.7 | GO:1990716 | axonemal central apparatus(GO:1990716) |
0.2 | 5.5 | GO:0015935 | small ribosomal subunit(GO:0015935) |
0.2 | 11.5 | GO:0016607 | nuclear speck(GO:0016607) |
0.2 | 20.2 | GO:0000790 | nuclear chromatin(GO:0000790) |
0.2 | 0.6 | GO:0034673 | inhibin-betaglycan-ActRII complex(GO:0034673) |
0.2 | 0.9 | GO:0044214 | spanning component of plasma membrane(GO:0044214) spanning component of membrane(GO:0089717) |
0.2 | 0.6 | GO:0005944 | phosphatidylinositol 3-kinase complex, class IB(GO:0005944) |
0.2 | 2.3 | GO:0017119 | Golgi transport complex(GO:0017119) |
0.2 | 0.2 | GO:0097651 | phosphatidylinositol 3-kinase complex, class I(GO:0097651) |
0.2 | 17.6 | GO:0043296 | apical junction complex(GO:0043296) |
0.2 | 207.6 | GO:0005615 | extracellular space(GO:0005615) |
0.2 | 8.1 | GO:0001750 | photoreceptor outer segment(GO:0001750) |
0.2 | 0.8 | GO:0031080 | nuclear pore outer ring(GO:0031080) |
0.2 | 0.6 | GO:0002177 | manchette(GO:0002177) |
0.2 | 0.8 | GO:0005744 | mitochondrial inner membrane presequence translocase complex(GO:0005744) |
0.2 | 2.0 | GO:0002199 | zona pellucida receptor complex(GO:0002199) |
0.2 | 0.8 | GO:0070652 | HAUS complex(GO:0070652) |
0.2 | 0.4 | GO:0005879 | axonemal microtubule(GO:0005879) |
0.2 | 1.6 | GO:0008540 | proteasome regulatory particle, base subcomplex(GO:0008540) |
0.2 | 0.6 | GO:0031010 | ISWI-type complex(GO:0031010) |
0.2 | 3.7 | GO:0005922 | connexon complex(GO:0005922) |
0.2 | 1.5 | GO:0000124 | SAGA complex(GO:0000124) |
0.2 | 0.4 | GO:0070761 | pre-snoRNP complex(GO:0070761) |
0.2 | 0.9 | GO:0035686 | sperm fibrous sheath(GO:0035686) |
0.2 | 3.0 | GO:0005876 | spindle microtubule(GO:0005876) |
0.2 | 1.9 | GO:0008180 | COP9 signalosome(GO:0008180) |
0.2 | 14.5 | GO:0045111 | intermediate filament cytoskeleton(GO:0045111) |
0.2 | 6.1 | GO:0044391 | ribosomal subunit(GO:0044391) |
0.2 | 172.6 | GO:0005654 | nucleoplasm(GO:0005654) |
0.2 | 0.5 | GO:0042405 | nuclear inclusion body(GO:0042405) |
0.2 | 1.5 | GO:0008250 | oligosaccharyltransferase complex(GO:0008250) |
0.2 | 0.2 | GO:0008275 | gamma-tubulin small complex(GO:0008275) |
0.2 | 0.3 | GO:0072687 | meiotic spindle(GO:0072687) |
0.2 | 0.2 | GO:0070765 | gamma-secretase complex(GO:0070765) |
0.2 | 0.9 | GO:0016328 | lateral plasma membrane(GO:0016328) |
0.2 | 0.5 | GO:0032937 | SREBP-SCAP-Insig complex(GO:0032937) |
0.2 | 17.4 | GO:0000323 | lytic vacuole(GO:0000323) lysosome(GO:0005764) |
0.1 | 14.5 | GO:0035068 | micro-ribonucleoprotein complex(GO:0035068) |
0.1 | 0.4 | GO:0005784 | Sec61 translocon complex(GO:0005784) translocon complex(GO:0071256) |
0.1 | 2.8 | GO:0030667 | secretory granule membrane(GO:0030667) |
0.1 | 4.2 | GO:0030529 | intracellular ribonucleoprotein complex(GO:0030529) ribonucleoprotein complex(GO:1990904) |
0.1 | 5.7 | GO:0005811 | lipid particle(GO:0005811) |
0.1 | 0.5 | GO:0031462 | Cul2-RING ubiquitin ligase complex(GO:0031462) |
0.1 | 1.6 | GO:0097223 | sperm part(GO:0097223) |
0.1 | 2.6 | GO:0032587 | ruffle membrane(GO:0032587) |
0.1 | 1.3 | GO:0031229 | integral component of nuclear inner membrane(GO:0005639) intrinsic component of nuclear inner membrane(GO:0031229) nuclear membrane part(GO:0044453) |
0.1 | 1.5 | GO:0000421 | autophagosome membrane(GO:0000421) |
0.1 | 0.2 | GO:0030688 | preribosome, small subunit precursor(GO:0030688) |
0.1 | 3.1 | GO:0001726 | ruffle(GO:0001726) |
0.1 | 0.1 | GO:0030663 | COPI-coated vesicle membrane(GO:0030663) |
0.1 | 23.6 | GO:0005743 | mitochondrial inner membrane(GO:0005743) |
0.1 | 1.0 | GO:0005761 | organellar ribosome(GO:0000313) mitochondrial ribosome(GO:0005761) |
0.1 | 0.5 | GO:0060091 | kinocilium(GO:0060091) |
0.1 | 2.8 | GO:0031970 | organelle envelope lumen(GO:0031970) |
0.1 | 1.9 | GO:0009295 | nucleoid(GO:0009295) mitochondrial nucleoid(GO:0042645) |
0.1 | 1.3 | GO:0001772 | immunological synapse(GO:0001772) |
0.1 | 0.3 | GO:0097539 | ciliary transition fiber(GO:0097539) |
0.1 | 0.7 | GO:0000176 | nuclear exosome (RNase complex)(GO:0000176) |
0.1 | 0.1 | GO:0089701 | U2AF(GO:0089701) |
0.1 | 0.1 | GO:0032426 | stereocilium tip(GO:0032426) |
0.1 | 0.1 | GO:0005832 | chaperonin-containing T-complex(GO:0005832) |
0.1 | 0.3 | GO:0005851 | eukaryotic translation initiation factor 2B complex(GO:0005851) |
0.1 | 6.7 | GO:0030176 | integral component of endoplasmic reticulum membrane(GO:0030176) |
0.1 | 0.4 | GO:1902493 | protein acetyltransferase complex(GO:0031248) acetyltransferase complex(GO:1902493) |
0.1 | 0.3 | GO:0036056 | filtration diaphragm(GO:0036056) slit diaphragm(GO:0036057) |
0.1 | 0.3 | GO:0000275 | mitochondrial proton-transporting ATP synthase complex, catalytic core F(1)(GO:0000275) proton-transporting ATP synthase complex, catalytic core F(1)(GO:0045261) |
0.1 | 59.7 | GO:0070062 | extracellular exosome(GO:0070062) |
0.1 | 0.1 | GO:0030312 | external encapsulating structure(GO:0030312) |
0.1 | 1.0 | GO:0031514 | motile cilium(GO:0031514) |
0.1 | 1.2 | GO:0046658 | anchored component of plasma membrane(GO:0046658) |
0.1 | 165.9 | GO:0005634 | nucleus(GO:0005634) |
0.0 | 0.0 | GO:0002142 | stereocilia coupling link(GO:0002139) stereocilia ankle link(GO:0002141) stereocilia ankle link complex(GO:0002142) USH2 complex(GO:1990696) |
0.0 | 0.1 | GO:1990923 | PET complex(GO:1990923) |
0.0 | 0.1 | GO:0031084 | BLOC-2 complex(GO:0031084) |
0.0 | 0.1 | GO:0098636 | protein complex involved in cell adhesion(GO:0098636) |
0.0 | 0.1 | GO:0031501 | mannosyltransferase complex(GO:0031501) |
0.0 | 0.0 | GO:0036449 | microtubule minus-end(GO:0036449) |
0.0 | 1.2 | GO:0016324 | apical plasma membrane(GO:0016324) |
0.0 | 0.1 | GO:0070971 | endoplasmic reticulum exit site(GO:0070971) |
0.0 | 2.9 | GO:0009897 | external side of plasma membrane(GO:0009897) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
5.8 | 23.1 | GO:0031720 | haptoglobin binding(GO:0031720) |
4.9 | 14.6 | GO:1902282 | voltage-gated potassium channel activity involved in ventricular cardiac muscle cell action potential repolarization(GO:1902282) |
4.4 | 26.6 | GO:0005072 | transforming growth factor beta receptor, cytoplasmic mediator activity(GO:0005072) |
4.1 | 12.2 | GO:0070644 | vitamin D response element binding(GO:0070644) |
3.8 | 11.5 | GO:0003886 | DNA (cytosine-5-)-methyltransferase activity(GO:0003886) DNA (cytosine-5-)-methyltransferase activity, acting on CpG substrates(GO:0051718) |
3.7 | 11.2 | GO:0008401 | retinoic acid 4-hydroxylase activity(GO:0008401) |
3.5 | 21.2 | GO:0003708 | retinoic acid receptor activity(GO:0003708) |
3.1 | 9.4 | GO:0005128 | erythropoietin receptor binding(GO:0005128) |
3.1 | 3.1 | GO:0055056 | D-glucose transmembrane transporter activity(GO:0055056) |
3.1 | 12.3 | GO:0052851 | cupric reductase activity(GO:0008823) ferric-chelate reductase (NADPH) activity(GO:0052851) |
3.0 | 9.1 | GO:0004832 | valine-tRNA ligase activity(GO:0004832) |
3.0 | 35.7 | GO:0048407 | platelet-derived growth factor binding(GO:0048407) |
2.8 | 2.8 | GO:0008097 | 5S rRNA binding(GO:0008097) |
2.8 | 25.3 | GO:0008093 | cytoskeletal adaptor activity(GO:0008093) |
2.8 | 11.2 | GO:0009374 | biotin binding(GO:0009374) |
2.8 | 16.7 | GO:0016176 | superoxide-generating NADPH oxidase activator activity(GO:0016176) |
2.7 | 8.1 | GO:0003829 | beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,6-N-acetylglucosaminyltransferase activity(GO:0003829) |
2.7 | 10.7 | GO:0022833 | mechanically-gated ion channel activity(GO:0008381) mechanically gated channel activity(GO:0022833) |
2.7 | 10.7 | GO:1990715 | mRNA CDS binding(GO:1990715) |
2.6 | 7.7 | GO:0005146 | leukemia inhibitory factor receptor binding(GO:0005146) |
2.5 | 22.8 | GO:0001972 | retinoic acid binding(GO:0001972) |
2.5 | 7.4 | GO:0008449 | N-acetylglucosamine-6-sulfatase activity(GO:0008449) |
2.4 | 7.2 | GO:0004793 | threonine aldolase activity(GO:0004793) L-allo-threonine aldolase activity(GO:0008732) |
2.4 | 7.2 | GO:0004687 | myosin light chain kinase activity(GO:0004687) |
2.4 | 31.0 | GO:0070742 | C2H2 zinc finger domain binding(GO:0070742) |
2.3 | 6.8 | GO:0070915 | lysophosphatidic acid receptor activity(GO:0070915) |
2.1 | 2.1 | GO:0008142 | oxysterol binding(GO:0008142) |
2.1 | 10.5 | GO:0051525 | NFAT protein binding(GO:0051525) |
2.1 | 12.6 | GO:0001727 | lipid kinase activity(GO:0001727) |
2.0 | 28.6 | GO:0071837 | HMG box domain binding(GO:0071837) |
2.0 | 6.1 | GO:0031708 | endothelin B receptor binding(GO:0031708) |
2.0 | 18.1 | GO:0000983 | transcription factor activity, RNA polymerase II core promoter sequence-specific(GO:0000983) |
2.0 | 7.9 | GO:0034618 | arginine binding(GO:0034618) |
2.0 | 11.8 | GO:0005344 | oxygen transporter activity(GO:0005344) |
1.9 | 9.7 | GO:0005499 | vitamin D binding(GO:0005499) |
1.9 | 7.6 | GO:0097493 | structural molecule activity conferring elasticity(GO:0097493) |
1.8 | 5.5 | GO:0047276 | N-acetyllactosaminide 3-alpha-galactosyltransferase activity(GO:0047276) |
1.8 | 20.2 | GO:0008301 | DNA binding, bending(GO:0008301) |
1.8 | 5.5 | GO:0004514 | nicotinate-nucleotide diphosphorylase (carboxylating) activity(GO:0004514) |
1.8 | 5.5 | GO:0004505 | phenylalanine 4-monooxygenase activity(GO:0004505) |
1.8 | 5.4 | GO:0015141 | succinate transmembrane transporter activity(GO:0015141) |
1.8 | 7.2 | GO:0031014 | troponin T binding(GO:0031014) |
1.8 | 1.8 | GO:0030375 | thyroid hormone receptor coactivator activity(GO:0030375) |
1.8 | 7.1 | GO:0003680 | AT DNA binding(GO:0003680) |
1.8 | 21.3 | GO:0031994 | insulin-like growth factor I binding(GO:0031994) |
1.8 | 3.5 | GO:0031711 | bradykinin receptor binding(GO:0031711) |
1.7 | 8.7 | GO:0004668 | protein-arginine deiminase activity(GO:0004668) |
1.7 | 5.2 | GO:0004366 | glycerol-3-phosphate O-acyltransferase activity(GO:0004366) |
1.7 | 5.1 | GO:0008107 | galactoside 2-alpha-L-fucosyltransferase activity(GO:0008107) alpha-(1,2)-fucosyltransferase activity(GO:0031127) |
1.7 | 5.1 | GO:0035851 | Krueppel-associated box domain binding(GO:0035851) |
1.7 | 5.1 | GO:0102007 | lactonohydrolase activity(GO:0046573) acyl-L-homoserine-lactone lactonohydrolase activity(GO:0102007) |
1.7 | 20.2 | GO:0035198 | miRNA binding(GO:0035198) |
1.7 | 11.8 | GO:0016308 | 1-phosphatidylinositol-4-phosphate 5-kinase activity(GO:0016308) |
1.7 | 182.0 | GO:0001078 | transcriptional repressor activity, RNA polymerase II core promoter proximal region sequence-specific binding(GO:0001078) |
1.6 | 6.6 | GO:0031493 | nucleosomal histone binding(GO:0031493) |
1.6 | 6.6 | GO:1990932 | 5.8S rRNA binding(GO:1990932) |
1.6 | 9.7 | GO:0030274 | LIM domain binding(GO:0030274) |
1.6 | 6.4 | GO:0016361 | activin receptor activity, type I(GO:0016361) |
1.6 | 4.8 | GO:0017098 | sulfonylurea receptor binding(GO:0017098) |
1.6 | 11.2 | GO:0042910 | xenobiotic transporter activity(GO:0042910) |
1.6 | 3.2 | GO:0004704 | NF-kappaB-inducing kinase activity(GO:0004704) |
1.6 | 3.2 | GO:0030350 | iron-responsive element binding(GO:0030350) |
1.6 | 6.3 | GO:0008865 | fructokinase activity(GO:0008865) mannokinase activity(GO:0019158) |
1.6 | 15.7 | GO:0070700 | BMP receptor binding(GO:0070700) |
1.6 | 3.1 | GO:0030172 | troponin C binding(GO:0030172) |
1.6 | 4.7 | GO:0043120 | tumor necrosis factor binding(GO:0043120) |
1.6 | 4.7 | GO:0061676 | importin-alpha family protein binding(GO:0061676) |
1.6 | 127.5 | GO:0003705 | transcription factor activity, RNA polymerase II distal enhancer sequence-specific binding(GO:0003705) |
1.5 | 10.8 | GO:0003836 | beta-galactoside (CMP) alpha-2,3-sialyltransferase activity(GO:0003836) |
1.5 | 9.3 | GO:0030249 | guanylate cyclase regulator activity(GO:0030249) |
1.5 | 21.6 | GO:0001047 | core promoter binding(GO:0001047) |
1.5 | 3.1 | GO:0004897 | ciliary neurotrophic factor receptor activity(GO:0004897) |
1.5 | 4.6 | GO:0005219 | ryanodine-sensitive calcium-release channel activity(GO:0005219) |
1.5 | 7.5 | GO:0005007 | fibroblast growth factor-activated receptor activity(GO:0005007) |
1.5 | 3.0 | GO:0034739 | histone deacetylase activity (H4-K16 specific)(GO:0034739) |
1.5 | 7.5 | GO:0035662 | Toll-like receptor 4 binding(GO:0035662) |
1.5 | 10.5 | GO:0001162 | RNA polymerase II intronic transcription regulatory region sequence-specific DNA binding(GO:0001162) |
1.5 | 6.0 | GO:0003953 | NAD+ nucleosidase activity(GO:0003953) |
1.5 | 4.4 | GO:0097108 | hedgehog family protein binding(GO:0097108) |
1.5 | 5.9 | GO:0004060 | arylamine N-acetyltransferase activity(GO:0004060) |
1.5 | 5.8 | GO:0016899 | oxidoreductase activity, acting on the CH-OH group of donors, oxygen as acceptor(GO:0016899) |
1.5 | 4.4 | GO:0043546 | molybdopterin cofactor binding(GO:0043546) |
1.4 | 8.6 | GO:0008131 | primary amine oxidase activity(GO:0008131) |
1.4 | 2.9 | GO:0015111 | iodide transmembrane transporter activity(GO:0015111) |
1.4 | 5.8 | GO:0004127 | cytidylate kinase activity(GO:0004127) |
1.4 | 5.7 | GO:0034714 | type III transforming growth factor beta receptor binding(GO:0034714) |
1.4 | 11.4 | GO:0048027 | mRNA 5'-UTR binding(GO:0048027) |
1.4 | 5.7 | GO:0016936 | galactoside binding(GO:0016936) |
1.4 | 21.3 | GO:0015106 | bicarbonate transmembrane transporter activity(GO:0015106) |
1.4 | 4.2 | GO:0051430 | corticotropin-releasing hormone receptor 1 binding(GO:0051430) |
1.4 | 5.6 | GO:0015016 | [heparan sulfate]-glucosamine N-sulfotransferase activity(GO:0015016) |
1.4 | 2.8 | GO:0044213 | intronic transcription regulatory region sequence-specific DNA binding(GO:0001161) intronic transcription regulatory region DNA binding(GO:0044213) |
1.4 | 8.4 | GO:0070181 | small ribosomal subunit rRNA binding(GO:0070181) |
1.4 | 6.9 | GO:0035033 | histone deacetylase regulator activity(GO:0035033) |
1.4 | 11.0 | GO:0035497 | cAMP response element binding(GO:0035497) |
1.4 | 5.4 | GO:0004839 | ubiquitin activating enzyme activity(GO:0004839) |
1.4 | 4.1 | GO:0008321 | Ral guanyl-nucleotide exchange factor activity(GO:0008321) |
1.4 | 5.4 | GO:0002060 | purine nucleobase binding(GO:0002060) |
1.4 | 4.1 | GO:0003720 | telomerase activity(GO:0003720) RNA-directed DNA polymerase activity(GO:0003964) |
1.4 | 2.7 | GO:0004772 | sterol O-acyltransferase activity(GO:0004772) |
1.4 | 1.4 | GO:0031821 | G-protein coupled serotonin receptor binding(GO:0031821) |
1.3 | 4.0 | GO:0005345 | purine nucleobase transmembrane transporter activity(GO:0005345) pyrimidine nucleobase transmembrane transporter activity(GO:0005350) nucleobase transmembrane transporter activity(GO:0015205) |
1.3 | 10.8 | GO:0019869 | chloride channel inhibitor activity(GO:0019869) |
1.3 | 5.4 | GO:0005534 | galactose binding(GO:0005534) |
1.3 | 39.0 | GO:0000980 | RNA polymerase II distal enhancer sequence-specific DNA binding(GO:0000980) |
1.3 | 10.7 | GO:0003810 | protein-glutamine gamma-glutamyltransferase activity(GO:0003810) |
1.3 | 7.9 | GO:0001013 | RNA polymerase I regulatory region DNA binding(GO:0001013) RNA polymerase I regulatory region sequence-specific DNA binding(GO:0001163) RNA polymerase I CORE element sequence-specific DNA binding(GO:0001164) |
1.3 | 7.9 | GO:0070891 | lipoteichoic acid binding(GO:0070891) |
1.3 | 3.9 | GO:0046979 | TAP1 binding(GO:0046978) TAP2 binding(GO:0046979) |
1.3 | 3.9 | GO:0070573 | metallodipeptidase activity(GO:0070573) |
1.3 | 11.7 | GO:0097027 | ubiquitin-protein transferase activator activity(GO:0097027) |
1.3 | 3.9 | GO:0070653 | high-density lipoprotein particle receptor binding(GO:0070653) |
1.3 | 5.2 | GO:0004046 | aminoacylase activity(GO:0004046) |
1.3 | 2.6 | GO:0043559 | insulin binding(GO:0043559) |
1.3 | 3.8 | GO:0043024 | ribosomal small subunit binding(GO:0043024) |
1.3 | 8.9 | GO:0070888 | E-box binding(GO:0070888) |
1.3 | 3.8 | GO:0052723 | inositol hexakisphosphate kinase activity(GO:0000828) inositol hexakisphosphate 5-kinase activity(GO:0000832) inositol hexakisphosphate 1-kinase activity(GO:0052723) inositol hexakisphosphate 3-kinase activity(GO:0052724) |
1.3 | 5.0 | GO:0017176 | phosphatidylinositol N-acetylglucosaminyltransferase activity(GO:0017176) |
1.2 | 3.7 | GO:0061731 | ribonucleoside-diphosphate reductase activity, thioredoxin disulfide as acceptor(GO:0004748) oxidoreductase activity, acting on CH or CH2 groups, disulfide as acceptor(GO:0016728) ribonucleoside-diphosphate reductase activity(GO:0061731) |
1.2 | 2.5 | GO:0019959 | interleukin-8 binding(GO:0019959) |
1.2 | 2.5 | GO:0051434 | BH3 domain binding(GO:0051434) |
1.2 | 4.9 | GO:0004090 | carbonyl reductase (NADPH) activity(GO:0004090) |
1.2 | 3.7 | GO:0047756 | chondroitin 4-sulfotransferase activity(GO:0047756) |
1.2 | 3.7 | GO:0048408 | epidermal growth factor binding(GO:0048408) |
1.2 | 7.3 | GO:0039706 | co-receptor binding(GO:0039706) |
1.2 | 3.6 | GO:0034988 | Fc-gamma receptor I complex binding(GO:0034988) |
1.2 | 3.6 | GO:0008898 | S-adenosylmethionine-homocysteine S-methyltransferase activity(GO:0008898) |
1.2 | 3.6 | GO:0004365 | glyceraldehyde-3-phosphate dehydrogenase (NAD+) (phosphorylating) activity(GO:0004365) glyceraldehyde-3-phosphate dehydrogenase (NAD(P)+) (phosphorylating) activity(GO:0043891) |
1.2 | 3.6 | GO:0008515 | sucrose:proton symporter activity(GO:0008506) sucrose transmembrane transporter activity(GO:0008515) disaccharide transmembrane transporter activity(GO:0015154) oligosaccharide transmembrane transporter activity(GO:0015157) |
1.2 | 10.7 | GO:0070180 | large ribosomal subunit rRNA binding(GO:0070180) |
1.2 | 3.5 | GO:0060228 | phosphatidylcholine-sterol O-acyltransferase activator activity(GO:0060228) |
1.2 | 3.5 | GO:0015087 | cobalt ion transmembrane transporter activity(GO:0015087) |
1.2 | 4.7 | GO:0061665 | SUMO ligase activity(GO:0061665) |
1.2 | 5.8 | GO:0005127 | ciliary neurotrophic factor receptor binding(GO:0005127) |
1.2 | 2.3 | GO:0060230 | lipoprotein lipase activator activity(GO:0060230) |
1.2 | 9.3 | GO:0000982 | transcription factor activity, RNA polymerase II core promoter proximal region sequence-specific binding(GO:0000982) |
1.2 | 3.5 | GO:0016647 | oxidoreductase activity, acting on the CH-NH group of donors, oxygen as acceptor(GO:0016647) |
1.2 | 2.3 | GO:0000702 | oxidized base lesion DNA N-glycosylase activity(GO:0000702) |
1.2 | 3.5 | GO:1990050 | phosphatidic acid transporter activity(GO:1990050) |
1.1 | 2.3 | GO:0008525 | phosphatidylcholine transporter activity(GO:0008525) |
1.1 | 3.4 | GO:0015265 | urea channel activity(GO:0015265) |
1.1 | 2.3 | GO:0015252 | hydrogen ion channel activity(GO:0015252) |
1.1 | 2.3 | GO:0033677 | DNA/RNA helicase activity(GO:0033677) |
1.1 | 4.5 | GO:0005105 | type 1 fibroblast growth factor receptor binding(GO:0005105) |
1.1 | 2.2 | GO:0002094 | polyprenyltransferase activity(GO:0002094) |
1.1 | 6.7 | GO:0030368 | interleukin-17 receptor activity(GO:0030368) |
1.1 | 1.1 | GO:0004924 | oncostatin-M receptor activity(GO:0004924) |
1.1 | 5.5 | GO:0019784 | NEDD8-specific protease activity(GO:0019784) |
1.1 | 2.2 | GO:0005111 | type 2 fibroblast growth factor receptor binding(GO:0005111) |
1.1 | 4.3 | GO:0016401 | palmitoyl-CoA oxidase activity(GO:0016401) |
1.1 | 2.1 | GO:0070698 | type I activin receptor binding(GO:0070698) |
1.1 | 4.3 | GO:0005134 | interleukin-2 receptor binding(GO:0005134) |
1.1 | 3.2 | GO:0004967 | glucagon receptor activity(GO:0004967) |
1.0 | 2.1 | GO:0034481 | chondroitin sulfotransferase activity(GO:0034481) |
1.0 | 3.1 | GO:0035529 | NADH pyrophosphatase activity(GO:0035529) |
1.0 | 3.1 | GO:0050508 | glucuronosyl-N-acetylglucosaminyl-proteoglycan 4-alpha-N-acetylglucosaminyltransferase activity(GO:0050508) |
1.0 | 7.2 | GO:0048406 | nerve growth factor binding(GO:0048406) |
1.0 | 4.1 | GO:0004945 | angiotensin type II receptor activity(GO:0004945) |
1.0 | 5.1 | GO:0008429 | phosphatidylethanolamine binding(GO:0008429) |
1.0 | 5.1 | GO:0008140 | cAMP response element binding protein binding(GO:0008140) |
1.0 | 1.0 | GO:0000403 | Y-form DNA binding(GO:0000403) |
1.0 | 9.1 | GO:0045294 | alpha-catenin binding(GO:0045294) |
1.0 | 2.0 | GO:0003997 | acyl-CoA oxidase activity(GO:0003997) |
1.0 | 4.0 | GO:0008349 | MAP kinase kinase kinase kinase activity(GO:0008349) |
1.0 | 1.0 | GO:0030523 | dihydrolipoamide S-acyltransferase activity(GO:0030523) |
1.0 | 5.0 | GO:0000774 | adenyl-nucleotide exchange factor activity(GO:0000774) |
1.0 | 4.0 | GO:0004749 | ribose phosphate diphosphokinase activity(GO:0004749) |
1.0 | 13.0 | GO:0070567 | cytidylyltransferase activity(GO:0070567) |
1.0 | 3.0 | GO:0019862 | IgA binding(GO:0019862) |
1.0 | 3.0 | GO:0015222 | serotonin transmembrane transporter activity(GO:0015222) |
1.0 | 230.9 | GO:0001228 | transcriptional activator activity, RNA polymerase II transcription regulatory region sequence-specific binding(GO:0001228) |
1.0 | 4.9 | GO:0004791 | thioredoxin-disulfide reductase activity(GO:0004791) |
1.0 | 2.9 | GO:0034235 | GPI anchor binding(GO:0034235) |
1.0 | 6.8 | GO:0019957 | C-C chemokine binding(GO:0019957) |
1.0 | 1.0 | GO:0004416 | hydroxyacylglutathione hydrolase activity(GO:0004416) |
1.0 | 1.0 | GO:0030284 | estrogen receptor activity(GO:0030284) |
1.0 | 1.0 | GO:0070840 | dynein complex binding(GO:0070840) |
1.0 | 34.3 | GO:0005109 | frizzled binding(GO:0005109) |
0.9 | 3.8 | GO:0001222 | transcription corepressor binding(GO:0001222) |
0.9 | 4.7 | GO:0046624 | sphingolipid transporter activity(GO:0046624) |
0.9 | 9.4 | GO:0003993 | acid phosphatase activity(GO:0003993) |
0.9 | 9.4 | GO:0000701 | purine-specific mismatch base pair DNA N-glycosylase activity(GO:0000701) |
0.9 | 2.8 | GO:0015319 | sodium:inorganic phosphate symporter activity(GO:0015319) |
0.9 | 5.6 | GO:0048185 | activin binding(GO:0048185) |
0.9 | 12.1 | GO:0000400 | four-way junction DNA binding(GO:0000400) |
0.9 | 2.8 | GO:1990226 | histone methyltransferase binding(GO:1990226) |
0.9 | 4.6 | GO:0043522 | leucine zipper domain binding(GO:0043522) |
0.9 | 11.0 | GO:0016641 | oxidoreductase activity, acting on the CH-NH2 group of donors, oxygen as acceptor(GO:0016641) |
0.9 | 4.6 | GO:0005143 | interleukin-12 receptor binding(GO:0005143) |
0.9 | 2.7 | GO:0017151 | DEAD/H-box RNA helicase binding(GO:0017151) |
0.9 | 4.6 | GO:0005384 | manganese ion transmembrane transporter activity(GO:0005384) |
0.9 | 2.7 | GO:0050220 | prostaglandin-E synthase activity(GO:0050220) |
0.9 | 1.8 | GO:0038100 | nodal binding(GO:0038100) |
0.9 | 9.8 | GO:0051787 | misfolded protein binding(GO:0051787) |
0.9 | 1.8 | GO:0004104 | cholinesterase activity(GO:0004104) |
0.9 | 1.8 | GO:0031871 | proteinase activated receptor binding(GO:0031871) |
0.9 | 0.9 | GO:0031727 | CCR2 chemokine receptor binding(GO:0031727) |
0.9 | 2.7 | GO:0045134 | uridine-diphosphatase activity(GO:0045134) |
0.9 | 2.6 | GO:0015232 | heme transporter activity(GO:0015232) |
0.9 | 2.6 | GO:1901702 | urate transmembrane transporter activity(GO:0015143) salt transmembrane transporter activity(GO:1901702) |
0.9 | 6.1 | GO:0001758 | retinal dehydrogenase activity(GO:0001758) |
0.9 | 3.5 | GO:0004035 | alkaline phosphatase activity(GO:0004035) |
0.9 | 2.6 | GO:0019770 | IgG receptor activity(GO:0019770) |
0.9 | 9.6 | GO:0030898 | actin-dependent ATPase activity(GO:0030898) |
0.9 | 6.1 | GO:0046790 | virion binding(GO:0046790) |
0.9 | 4.3 | GO:0004311 | farnesyltranstransferase activity(GO:0004311) |
0.9 | 6.9 | GO:0015254 | glycerol transmembrane transporter activity(GO:0015168) glycerol channel activity(GO:0015254) |
0.9 | 14.6 | GO:0070008 | serine-type exopeptidase activity(GO:0070008) |
0.9 | 2.6 | GO:0004735 | pyrroline-5-carboxylate reductase activity(GO:0004735) |
0.9 | 12.8 | GO:0043539 | protein serine/threonine kinase activator activity(GO:0043539) |
0.9 | 5.1 | GO:0030983 | mismatched DNA binding(GO:0030983) |
0.9 | 5.1 | GO:0047498 | calcium-dependent phospholipase A2 activity(GO:0047498) |
0.8 | 5.9 | GO:0000014 | single-stranded DNA endodeoxyribonuclease activity(GO:0000014) |
0.8 | 3.4 | GO:0004095 | carnitine O-palmitoyltransferase activity(GO:0004095) |
0.8 | 3.4 | GO:0005173 | stem cell factor receptor binding(GO:0005173) |
0.8 | 2.5 | GO:0031433 | telethonin binding(GO:0031433) |
0.8 | 2.5 | GO:0008310 | single-stranded DNA 3'-5' exodeoxyribonuclease activity(GO:0008310) |
0.8 | 3.3 | GO:0016833 | oxo-acid-lyase activity(GO:0016833) |
0.8 | 6.6 | GO:0017070 | U6 snRNA binding(GO:0017070) |
0.8 | 3.3 | GO:0015057 | thrombin receptor activity(GO:0015057) |
0.8 | 0.8 | GO:0003905 | alkylbase DNA N-glycosylase activity(GO:0003905) DNA-3-methylbase glycosylase activity(GO:0043733) |
0.8 | 6.6 | GO:0070097 | delta-catenin binding(GO:0070097) |
0.8 | 9.0 | GO:0015129 | lactate transmembrane transporter activity(GO:0015129) |
0.8 | 1.6 | GO:0030619 | U1 snRNA binding(GO:0030619) |
0.8 | 4.1 | GO:0005412 | glucose:sodium symporter activity(GO:0005412) |
0.8 | 7.3 | GO:0022889 | L-serine transmembrane transporter activity(GO:0015194) serine transmembrane transporter activity(GO:0022889) |
0.8 | 1.6 | GO:0008143 | poly(A) binding(GO:0008143) |
0.8 | 3.2 | GO:0004052 | arachidonate 12-lipoxygenase activity(GO:0004052) |
0.8 | 4.8 | GO:0016175 | superoxide-generating NADPH oxidase activity(GO:0016175) |
0.8 | 2.4 | GO:0004611 | phosphoenolpyruvate carboxykinase activity(GO:0004611) |
0.8 | 2.4 | GO:0004103 | choline kinase activity(GO:0004103) |
0.8 | 15.9 | GO:0017069 | snRNA binding(GO:0017069) |
0.8 | 0.8 | GO:0046976 | histone methyltransferase activity (H3-K27 specific)(GO:0046976) |
0.8 | 3.2 | GO:0030229 | very-low-density lipoprotein particle receptor activity(GO:0030229) |
0.8 | 4.8 | GO:0038036 | sphingosine-1-phosphate receptor activity(GO:0038036) |
0.8 | 4.8 | GO:0046965 | retinoid X receptor binding(GO:0046965) |
0.8 | 2.4 | GO:0016634 | oxidoreductase activity, acting on the CH-CH group of donors, oxygen as acceptor(GO:0016634) |
0.8 | 11.9 | GO:0004089 | carbonate dehydratase activity(GO:0004089) |
0.8 | 4.0 | GO:0045182 | translation regulator activity(GO:0045182) |
0.8 | 0.8 | GO:0015562 | efflux transmembrane transporter activity(GO:0015562) |
0.8 | 1.6 | GO:0005114 | type II transforming growth factor beta receptor binding(GO:0005114) |
0.8 | 0.8 | GO:0017153 | sodium:dicarboxylate symporter activity(GO:0017153) |
0.8 | 4.7 | GO:0016889 | endodeoxyribonuclease activity, producing 3'-phosphomonoesters(GO:0016889) |
0.8 | 1.6 | GO:0051185 | coenzyme transporter activity(GO:0051185) |
0.8 | 3.1 | GO:0008486 | diphosphoinositol-polyphosphate diphosphatase activity(GO:0008486) |
0.8 | 3.1 | GO:0019834 | phospholipase A2 inhibitor activity(GO:0019834) |
0.8 | 9.2 | GO:0044466 | 2-oxoglutaryl-CoA thioesterase activity(GO:0034843) 2,4,4-trimethyl-3-oxopentanoyl-CoA thioesterase activity(GO:0034869) 3-isopropylbut-3-enoyl-CoA thioesterase activity(GO:0034946) glutaryl-CoA hydrolase activity(GO:0044466) |
0.8 | 334.3 | GO:0043565 | sequence-specific DNA binding(GO:0043565) |
0.8 | 2.3 | GO:0003987 | acetate-CoA ligase activity(GO:0003987) |
0.8 | 1.5 | GO:0043199 | sulfate binding(GO:0043199) |
0.8 | 3.0 | GO:0052650 | NADP-retinol dehydrogenase activity(GO:0052650) |
0.8 | 2.3 | GO:0004346 | glucose-6-phosphatase activity(GO:0004346) sugar-terminal-phosphatase activity(GO:0050309) |
0.8 | 3.0 | GO:0003956 | NAD(P)+-protein-arginine ADP-ribosyltransferase activity(GO:0003956) |
0.8 | 2.3 | GO:0071553 | uridine nucleotide receptor activity(GO:0015065) G-protein coupled pyrimidinergic nucleotide receptor activity(GO:0071553) |
0.8 | 6.8 | GO:0016857 | racemase and epimerase activity, acting on carbohydrates and derivatives(GO:0016857) |
0.8 | 3.8 | GO:0017169 | CDP-alcohol phosphatidyltransferase activity(GO:0017169) |
0.7 | 1.5 | GO:0047045 | testosterone 17-beta-dehydrogenase (NADP+) activity(GO:0047045) |
0.7 | 5.9 | GO:0071933 | Arp2/3 complex binding(GO:0071933) |
0.7 | 11.1 | GO:0017049 | GTP-Rho binding(GO:0017049) |
0.7 | 1.5 | GO:0031686 | A1 adenosine receptor binding(GO:0031686) |
0.7 | 1.5 | GO:0035613 | RNA stem-loop binding(GO:0035613) |
0.7 | 3.0 | GO:0004126 | cytidine deaminase activity(GO:0004126) |
0.7 | 25.0 | GO:0005044 | scavenger receptor activity(GO:0005044) |
0.7 | 2.9 | GO:0030275 | LRR domain binding(GO:0030275) |
0.7 | 8.0 | GO:0070577 | lysine-acetylated histone binding(GO:0070577) |
0.7 | 4.4 | GO:0016724 | ferroxidase activity(GO:0004322) oxidoreductase activity, oxidizing metal ions, oxygen as acceptor(GO:0016724) |
0.7 | 4.4 | GO:0015321 | sodium:phosphate symporter activity(GO:0005436) sodium-dependent phosphate transmembrane transporter activity(GO:0015321) |
0.7 | 8.0 | GO:0017166 | vinculin binding(GO:0017166) |
0.7 | 2.2 | GO:0072542 | protein phosphatase activator activity(GO:0072542) |
0.7 | 5.8 | GO:0046977 | TAP binding(GO:0046977) |
0.7 | 2.2 | GO:0042296 | ISG15 transferase activity(GO:0042296) |
0.7 | 1.4 | GO:0004814 | arginine-tRNA ligase activity(GO:0004814) |
0.7 | 4.3 | GO:0097371 | MDM2/MDM4 family protein binding(GO:0097371) |
0.7 | 1.4 | GO:0008517 | folic acid transporter activity(GO:0008517) |
0.7 | 4.3 | GO:0030228 | lipoprotein particle receptor activity(GO:0030228) |
0.7 | 6.4 | GO:0042500 | aspartic endopeptidase activity, intramembrane cleaving(GO:0042500) |
0.7 | 12.1 | GO:0004602 | glutathione peroxidase activity(GO:0004602) |
0.7 | 1.4 | GO:0019002 | GMP binding(GO:0019002) |
0.7 | 2.1 | GO:0008073 | ornithine decarboxylase inhibitor activity(GO:0008073) |
0.7 | 2.1 | GO:0036435 | K48-linked polyubiquitin binding(GO:0036435) |
0.7 | 2.8 | GO:0017150 | tRNA dihydrouridine synthase activity(GO:0017150) |
0.7 | 9.0 | GO:0005243 | gap junction channel activity(GO:0005243) |
0.7 | 0.7 | GO:0038132 | neuregulin binding(GO:0038132) |
0.7 | 2.1 | GO:0070324 | thyroid hormone binding(GO:0070324) |
0.7 | 2.7 | GO:0035256 | G-protein coupled glutamate receptor binding(GO:0035256) |
0.7 | 4.1 | GO:0050700 | CARD domain binding(GO:0050700) |
0.7 | 3.4 | GO:0031432 | titin binding(GO:0031432) |
0.7 | 5.4 | GO:0001055 | RNA polymerase II activity(GO:0001055) |
0.7 | 11.4 | GO:0005035 | tumor necrosis factor-activated receptor activity(GO:0005031) death receptor activity(GO:0005035) |
0.7 | 5.3 | GO:0004415 | hyalurononglucosaminidase activity(GO:0004415) |
0.7 | 3.3 | GO:0047035 | testosterone dehydrogenase (NAD+) activity(GO:0047035) |
0.7 | 8.0 | GO:0034185 | apolipoprotein binding(GO:0034185) |
0.7 | 2.0 | GO:0016262 | protein N-acetylglucosaminyltransferase activity(GO:0016262) |
0.7 | 2.0 | GO:0005001 | transmembrane receptor protein tyrosine phosphatase activity(GO:0005001) |
0.7 | 13.9 | GO:0015002 | cytochrome-c oxidase activity(GO:0004129) heme-copper terminal oxidase activity(GO:0015002) oxidoreductase activity, acting on a heme group of donors, oxygen as acceptor(GO:0016676) |
0.7 | 1.3 | GO:0003986 | acetyl-CoA hydrolase activity(GO:0003986) |
0.6 | 2.6 | GO:0035325 | Toll-like receptor binding(GO:0035325) |
0.6 | 2.6 | GO:0004000 | adenosine deaminase activity(GO:0004000) |
0.6 | 3.2 | GO:0009378 | four-way junction helicase activity(GO:0009378) |
0.6 | 4.4 | GO:0008046 | axon guidance receptor activity(GO:0008046) |
0.6 | 2.5 | GO:0004792 | thiosulfate sulfurtransferase activity(GO:0004792) |
0.6 | 24.7 | GO:0042826 | histone deacetylase binding(GO:0042826) |
0.6 | 2.5 | GO:0004656 | procollagen-proline 4-dioxygenase activity(GO:0004656) |
0.6 | 1.9 | GO:0005094 | Rho GDP-dissociation inhibitor activity(GO:0005094) |
0.6 | 1.3 | GO:1990829 | C-rich single-stranded DNA binding(GO:1990829) |
0.6 | 9.4 | GO:1990939 | ATP-dependent microtubule motor activity(GO:1990939) |
0.6 | 1.9 | GO:0016774 | phosphotransferase activity, carboxyl group as acceptor(GO:0016774) |
0.6 | 6.9 | GO:0051183 | vitamin transporter activity(GO:0051183) |
0.6 | 0.6 | GO:0001221 | transcription cofactor binding(GO:0001221) |
0.6 | 1.9 | GO:0004938 | alpha2-adrenergic receptor activity(GO:0004938) |
0.6 | 0.6 | GO:0000217 | DNA secondary structure binding(GO:0000217) |
0.6 | 4.4 | GO:0042975 | peroxisome proliferator activated receptor binding(GO:0042975) |
0.6 | 2.5 | GO:0033613 | activating transcription factor binding(GO:0033613) |
0.6 | 7.4 | GO:0008307 | structural constituent of muscle(GO:0008307) |
0.6 | 2.5 | GO:0004028 | 3-chloroallyl aldehyde dehydrogenase activity(GO:0004028) |
0.6 | 3.7 | GO:0035005 | 1-phosphatidylinositol-4-phosphate 3-kinase activity(GO:0035005) |
0.6 | 2.5 | GO:0032027 | myosin light chain binding(GO:0032027) |
0.6 | 2.4 | GO:1990254 | keratin filament binding(GO:1990254) |
0.6 | 1.8 | GO:0051425 | PTB domain binding(GO:0051425) |
0.6 | 2.4 | GO:0019145 | aminobutyraldehyde dehydrogenase activity(GO:0019145) 4-trimethylammoniobutyraldehyde dehydrogenase activity(GO:0047105) |
0.6 | 1.8 | GO:0016823 | hydrolase activity, acting on acid carbon-carbon bonds(GO:0016822) hydrolase activity, acting on acid carbon-carbon bonds, in ketonic substances(GO:0016823) |
0.6 | 3.6 | GO:0008641 | small protein activating enzyme activity(GO:0008641) |
0.6 | 3.6 | GO:0015174 | basic amino acid transmembrane transporter activity(GO:0015174) |
0.6 | 0.6 | GO:0004427 | inorganic diphosphatase activity(GO:0004427) |
0.6 | 1.2 | GO:0036033 | mediator complex binding(GO:0036033) |
0.6 | 4.1 | GO:0034918 | pinocarveol dehydrogenase activity(GO:0018446) chloral hydrate dehydrogenase activity(GO:0018447) hydroxymethylmethylsilanediol oxidase activity(GO:0018448) 1-phenylethanol dehydrogenase activity(GO:0018449) myrtenol dehydrogenase activity(GO:0018450) cis-1,2-dihydroxy-1,2-dihydro-8-carboxynaphthalene dehydrogenase activity(GO:0034522) 3-hydroxy-4-methyloctanoyl-CoA dehydrogenase activity(GO:0034582) 2-hydroxy-4-isopropenylcyclohexane-1-carboxyl-CoA dehydrogenase activity(GO:0034778) cis-9,10-dihydroanthracene-9,10-diol dehydrogenase activity(GO:0034817) citronellol dehydrogenase activity(GO:0034821) naphthyl-2-hydroxymethyl-succinyl-CoA dehydrogenase activity(GO:0034847) 2,4,4-trimethyl-1-pentanol dehydrogenase activity(GO:0034863) 2,4,4-trimethyl-3-hydroxypentanoyl-CoA dehydrogenase activity(GO:0034868) 1-hydroxy-4,4-dimethylpentan-3-one dehydrogenase activity(GO:0034871) endosulfan diol dehydrogenase activity(GO:0034891) endosulfan hydroxyether dehydrogenase activity(GO:0034901) 3-hydroxy-2-methylhexanoyl-CoA dehydrogenase activity(GO:0034918) 3-hydroxy-2,6-dimethyl-5-methylene-heptanoyl-CoA dehydrogenase activity(GO:0034944) versicolorin reductase activity(GO:0042469) ketoreductase activity(GO:0045703) |
0.6 | 2.3 | GO:0070815 | peptidyl-lysine 5-dioxygenase activity(GO:0070815) |
0.6 | 2.9 | GO:0032036 | myosin heavy chain binding(GO:0032036) |
0.6 | 2.9 | GO:0033691 | sialic acid binding(GO:0033691) |
0.6 | 7.5 | GO:0005542 | folic acid binding(GO:0005542) |
0.6 | 2.3 | GO:0031730 | CCR5 chemokine receptor binding(GO:0031730) |
0.6 | 2.8 | GO:0008467 | [heparan sulfate]-glucosamine 3-sulfotransferase 1 activity(GO:0008467) |
0.6 | 8.5 | GO:0042056 | chemoattractant activity(GO:0042056) |
0.6 | 1.7 | GO:0005220 | inositol 1,4,5-trisphosphate-sensitive calcium-release channel activity(GO:0005220) |
0.6 | 5.1 | GO:0016493 | C-C chemokine receptor activity(GO:0016493) |
0.6 | 1.7 | GO:0004829 | threonine-tRNA ligase activity(GO:0004829) |
0.6 | 2.3 | GO:0031781 | melanocortin receptor binding(GO:0031779) type 3 melanocortin receptor binding(GO:0031781) type 4 melanocortin receptor binding(GO:0031782) |
0.6 | 7.8 | GO:0001784 | phosphotyrosine binding(GO:0001784) |
0.6 | 0.6 | GO:0051373 | FATZ binding(GO:0051373) |
0.6 | 1.7 | GO:0070579 | methylcytosine dioxygenase activity(GO:0070579) |
0.5 | 1.1 | GO:0097506 | uracil DNA N-glycosylase activity(GO:0004844) deaminated base DNA N-glycosylase activity(GO:0097506) |
0.5 | 1.6 | GO:0097200 | cysteine-type endopeptidase activity involved in execution phase of apoptosis(GO:0097200) |
0.5 | 4.9 | GO:0008568 | microtubule-severing ATPase activity(GO:0008568) |
0.5 | 1.6 | GO:0004771 | sterol esterase activity(GO:0004771) |
0.5 | 14.0 | GO:0018024 | histone-lysine N-methyltransferase activity(GO:0018024) |
0.5 | 1.6 | GO:0016838 | carbon-oxygen lyase activity, acting on phosphates(GO:0016838) |
0.5 | 0.5 | GO:0001016 | RNA polymerase III regulatory region DNA binding(GO:0001016) |
0.5 | 1.6 | GO:0004345 | glucose-6-phosphate dehydrogenase activity(GO:0004345) |
0.5 | 9.0 | GO:0001968 | fibronectin binding(GO:0001968) |
0.5 | 0.5 | GO:0019912 | cyclin-dependent protein kinase activating kinase activity(GO:0019912) |
0.5 | 2.7 | GO:0003910 | DNA ligase activity(GO:0003909) DNA ligase (ATP) activity(GO:0003910) |
0.5 | 3.2 | GO:0004630 | phospholipase D activity(GO:0004630) |
0.5 | 2.1 | GO:0034889 | alkyl sulfatase activity(GO:0018741) endosulfan hemisulfate sulfatase activity(GO:0034889) endosulfan sulfate hydrolase activity(GO:0034902) |
0.5 | 1.6 | GO:0016638 | oxidoreductase activity, acting on the CH-NH2 group of donors(GO:0016638) |
0.5 | 1.6 | GO:0070491 | repressing transcription factor binding(GO:0070491) |
0.5 | 1.6 | GO:0032052 | bile acid binding(GO:0032052) |
0.5 | 0.5 | GO:0098748 | clathrin adaptor activity(GO:0035615) endocytic adaptor activity(GO:0098748) |
0.5 | 2.1 | GO:0015173 | aromatic amino acid transmembrane transporter activity(GO:0015173) |
0.5 | 1.6 | GO:0008503 | benzodiazepine receptor activity(GO:0008503) |
0.5 | 1.6 | GO:0017108 | 5'-flap endonuclease activity(GO:0017108) |
0.5 | 1.0 | GO:0005346 | adenine nucleotide transmembrane transporter activity(GO:0000295) purine ribonucleotide transmembrane transporter activity(GO:0005346) purine nucleotide transmembrane transporter activity(GO:0015216) |
0.5 | 1.5 | GO:0004013 | adenosylhomocysteinase activity(GO:0004013) trialkylsulfonium hydrolase activity(GO:0016802) |
0.5 | 7.7 | GO:0042813 | Wnt-activated receptor activity(GO:0042813) |
0.5 | 2.6 | GO:0097153 | cysteine-type endopeptidase activity involved in apoptotic process(GO:0097153) |
0.5 | 1.5 | GO:0001595 | angiotensin receptor activity(GO:0001595) |
0.5 | 4.6 | GO:0005520 | insulin-like growth factor binding(GO:0005520) |
0.5 | 4.0 | GO:0005523 | tropomyosin binding(GO:0005523) |
0.5 | 1.0 | GO:0034452 | dynactin binding(GO:0034452) |
0.5 | 2.5 | GO:0003916 | DNA topoisomerase activity(GO:0003916) |
0.5 | 0.5 | GO:0031705 | bombesin receptor binding(GO:0031705) |
0.5 | 6.5 | GO:0016780 | phosphotransferase activity, for other substituted phosphate groups(GO:0016780) |
0.5 | 1.0 | GO:0047623 | AMP deaminase activity(GO:0003876) adenosine-phosphate deaminase activity(GO:0047623) |
0.5 | 4.5 | GO:0031490 | chromatin DNA binding(GO:0031490) |
0.5 | 3.0 | GO:0047184 | 1-acylglycerophosphocholine O-acyltransferase activity(GO:0047184) |
0.5 | 2.0 | GO:0070051 | fibrinogen binding(GO:0070051) |
0.5 | 6.4 | GO:0050998 | nitric-oxide synthase binding(GO:0050998) |
0.5 | 4.0 | GO:0016861 | intramolecular oxidoreductase activity, interconverting aldoses and ketoses(GO:0016861) |
0.5 | 0.5 | GO:0038181 | bile acid receptor activity(GO:0038181) |
0.5 | 2.0 | GO:0042731 | PH domain binding(GO:0042731) |
0.5 | 8.3 | GO:0004181 | metallocarboxypeptidase activity(GO:0004181) |
0.5 | 2.4 | GO:0070061 | fructose binding(GO:0070061) |
0.5 | 2.4 | GO:0001665 | alpha-N-acetylgalactosaminide alpha-2,6-sialyltransferase activity(GO:0001665) |
0.5 | 1.5 | GO:0033592 | RNA strand annealing activity(GO:0033592) |
0.5 | 13.6 | GO:0005160 | transforming growth factor beta receptor binding(GO:0005160) |
0.5 | 4.8 | GO:0015238 | drug transmembrane transporter activity(GO:0015238) |
0.5 | 1.9 | GO:0008494 | translation activator activity(GO:0008494) |
0.5 | 1.4 | GO:0070883 | pre-miRNA binding(GO:0070883) |
0.5 | 0.9 | GO:0004069 | L-aspartate:2-oxoglutarate aminotransferase activity(GO:0004069) |
0.5 | 1.4 | GO:0051022 | Rho GDP-dissociation inhibitor binding(GO:0051022) |
0.5 | 0.5 | GO:0016309 | 1-phosphatidylinositol-5-phosphate 4-kinase activity(GO:0016309) |
0.5 | 5.2 | GO:0005521 | lamin binding(GO:0005521) |
0.5 | 4.2 | GO:0019789 | SUMO transferase activity(GO:0019789) |
0.5 | 1.4 | GO:0019808 | polyamine binding(GO:0019808) |
0.5 | 2.3 | GO:0019911 | structural constituent of myelin sheath(GO:0019911) |
0.5 | 2.3 | GO:0004634 | phosphopyruvate hydratase activity(GO:0004634) |
0.5 | 2.3 | GO:0004652 | polynucleotide adenylyltransferase activity(GO:0004652) |
0.5 | 1.4 | GO:0004477 | methenyltetrahydrofolate cyclohydrolase activity(GO:0004477) methylenetetrahydrofolate dehydrogenase (NAD+) activity(GO:0004487) |
0.5 | 0.9 | GO:0030546 | receptor activator activity(GO:0030546) |
0.5 | 3.6 | GO:0038191 | neuropilin binding(GO:0038191) |
0.5 | 0.5 | GO:0015166 | polyol transmembrane transporter activity(GO:0015166) |
0.4 | 3.6 | GO:0001106 | RNA polymerase II transcription corepressor activity(GO:0001106) |
0.4 | 0.9 | GO:0016886 | ligase activity, forming phosphoric ester bonds(GO:0016886) |
0.4 | 2.7 | GO:0004128 | cytochrome-b5 reductase activity, acting on NAD(P)H(GO:0004128) |
0.4 | 1.8 | GO:0015226 | amino-acid betaine transmembrane transporter activity(GO:0015199) carnitine transmembrane transporter activity(GO:0015226) |
0.4 | 0.4 | GO:0016743 | carboxyl- or carbamoyltransferase activity(GO:0016743) |
0.4 | 0.9 | GO:0035673 | oligopeptide transmembrane transporter activity(GO:0035673) |
0.4 | 0.4 | GO:0070878 | primary miRNA binding(GO:0070878) |
0.4 | 0.9 | GO:0047023 | androsterone dehydrogenase activity(GO:0047023) |
0.4 | 81.5 | GO:0003735 | structural constituent of ribosome(GO:0003735) |
0.4 | 2.2 | GO:0015288 | porin activity(GO:0015288) |
0.4 | 4.3 | GO:0010314 | phosphatidylinositol-5-phosphate binding(GO:0010314) |
0.4 | 2.1 | GO:0042015 | interleukin-20 binding(GO:0042015) |
0.4 | 1.7 | GO:0070411 | I-SMAD binding(GO:0070411) |
0.4 | 6.4 | GO:0004012 | phospholipid-translocating ATPase activity(GO:0004012) |
0.4 | 2.5 | GO:0016646 | oxidoreductase activity, acting on the CH-NH group of donors, NAD or NADP as acceptor(GO:0016646) |
0.4 | 1.7 | GO:0008526 | phosphatidylinositol transporter activity(GO:0008526) |
0.4 | 0.8 | GO:1990825 | sequence-specific mRNA binding(GO:1990825) |
0.4 | 2.1 | GO:0016803 | ether hydrolase activity(GO:0016803) |
0.4 | 2.5 | GO:0005113 | patched binding(GO:0005113) |
0.4 | 1.2 | GO:0042392 | sphingosine-1-phosphate phosphatase activity(GO:0042392) |
0.4 | 4.9 | GO:0003950 | NAD+ ADP-ribosyltransferase activity(GO:0003950) |
0.4 | 45.2 | GO:0004867 | serine-type endopeptidase inhibitor activity(GO:0004867) |
0.4 | 0.4 | GO:0035515 | oxidative RNA demethylase activity(GO:0035515) |
0.4 | 6.5 | GO:0017025 | TBP-class protein binding(GO:0017025) |
0.4 | 0.4 | GO:0032558 | adenyl deoxyribonucleotide binding(GO:0032558) dATP binding(GO:0032564) |
0.4 | 1.2 | GO:0034511 | U3 snoRNA binding(GO:0034511) |
0.4 | 34.4 | GO:0051015 | actin filament binding(GO:0051015) |
0.4 | 63.1 | GO:0004252 | serine-type endopeptidase activity(GO:0004252) |
0.4 | 1.2 | GO:0046848 | hydroxyapatite binding(GO:0046848) |
0.4 | 0.8 | GO:0051429 | corticotropin-releasing hormone receptor binding(GO:0051429) |
0.4 | 1.6 | GO:0042974 | retinoic acid receptor binding(GO:0042974) |
0.4 | 1.5 | GO:0016714 | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced pteridine as one donor, and incorporation of one atom of oxygen(GO:0016714) |
0.4 | 1.2 | GO:0008745 | N-acetylmuramoyl-L-alanine amidase activity(GO:0008745) peptidoglycan receptor activity(GO:0016019) |
0.4 | 2.7 | GO:0015215 | nucleotide transmembrane transporter activity(GO:0015215) |
0.4 | 0.8 | GO:0043842 | Kdo transferase activity(GO:0043842) |
0.4 | 1.1 | GO:0045504 | dynein heavy chain binding(GO:0045504) |
0.4 | 12.2 | GO:0003697 | single-stranded DNA binding(GO:0003697) |
0.4 | 2.3 | GO:0008190 | eukaryotic initiation factor 4E binding(GO:0008190) |
0.4 | 2.3 | GO:0005049 | nuclear export signal receptor activity(GO:0005049) |
0.4 | 2.2 | GO:0008420 | CTD phosphatase activity(GO:0008420) |
0.4 | 1.9 | GO:0001849 | complement component C1q binding(GO:0001849) |
0.4 | 1.1 | GO:0004711 | ribosomal protein S6 kinase activity(GO:0004711) |
0.4 | 1.1 | GO:0016941 | natriuretic peptide receptor activity(GO:0016941) |
0.4 | 1.5 | GO:0005047 | signal recognition particle binding(GO:0005047) |
0.4 | 16.1 | GO:0016765 | transferase activity, transferring alkyl or aryl (other than methyl) groups(GO:0016765) |
0.4 | 7.0 | GO:0016504 | peptidase activator activity(GO:0016504) |
0.4 | 0.7 | GO:0050321 | tau-protein kinase activity(GO:0050321) |
0.4 | 0.7 | GO:0050145 | nucleoside phosphate kinase activity(GO:0050145) |
0.4 | 1.5 | GO:0031419 | cobalamin binding(GO:0031419) |
0.4 | 0.7 | GO:0022829 | wide pore channel activity(GO:0022829) |
0.4 | 1.1 | GO:0055100 | adiponectin binding(GO:0055100) |
0.4 | 1.1 | GO:0015605 | organophosphate ester transmembrane transporter activity(GO:0015605) |
0.4 | 1.1 | GO:0050072 | m7G(5')pppN diphosphatase activity(GO:0050072) |
0.3 | 2.4 | GO:0036312 | phosphatidylinositol 3-kinase regulatory subunit binding(GO:0036312) |
0.3 | 2.1 | GO:0050431 | transforming growth factor beta binding(GO:0050431) |
0.3 | 1.7 | GO:0016721 | superoxide dismutase activity(GO:0004784) oxidoreductase activity, acting on superoxide radicals as acceptor(GO:0016721) |
0.3 | 3.8 | GO:0043236 | laminin binding(GO:0043236) |
0.3 | 4.5 | GO:0036002 | pre-mRNA binding(GO:0036002) |
0.3 | 2.4 | GO:0035174 | histone serine kinase activity(GO:0035174) |
0.3 | 0.3 | GO:0032190 | acrosin binding(GO:0032190) |
0.3 | 1.3 | GO:0004523 | RNA-DNA hybrid ribonuclease activity(GO:0004523) |
0.3 | 7.3 | GO:0005385 | zinc ion transmembrane transporter activity(GO:0005385) |
0.3 | 1.7 | GO:0030544 | Hsp70 protein binding(GO:0030544) |
0.3 | 5.0 | GO:0043027 | cysteine-type endopeptidase inhibitor activity involved in apoptotic process(GO:0043027) |
0.3 | 2.0 | GO:0043138 | 3'-5' DNA helicase activity(GO:0043138) |
0.3 | 0.7 | GO:0035326 | enhancer binding(GO:0035326) |
0.3 | 1.3 | GO:0045505 | dynein intermediate chain binding(GO:0045505) |
0.3 | 2.6 | GO:0034987 | immunoglobulin receptor binding(GO:0034987) |
0.3 | 1.3 | GO:0052717 | N-cyclopropylmelamine deaminase activity(GO:0034547) N-cyclopropylammeline deaminase activity(GO:0034548) N-cyclopropylammelide alkylamino hydrolase activity(GO:0034549) 2,5-diamino-6-ribitylamino-4(3H)-pyrimidinone 5'-phosphate deaminase activity(GO:0043723) tRNA-specific adenosine-37 deaminase activity(GO:0043829) archaeal-specific GTP cyclohydrolase activity(GO:0044682) tRNA-specific adenosine-34 deaminase activity(GO:0052717) |
0.3 | 6.6 | GO:0004693 | cyclin-dependent protein serine/threonine kinase activity(GO:0004693) cyclin-dependent protein kinase activity(GO:0097472) |
0.3 | 1.6 | GO:0043566 | structure-specific DNA binding(GO:0043566) |
0.3 | 1.3 | GO:0004694 | eukaryotic translation initiation factor 2alpha kinase activity(GO:0004694) |
0.3 | 4.1 | GO:0008353 | RNA polymerase II carboxy-terminal domain kinase activity(GO:0008353) |
0.3 | 1.2 | GO:0005161 | platelet-derived growth factor receptor binding(GO:0005161) |
0.3 | 1.6 | GO:0038024 | cargo receptor activity(GO:0038024) |
0.3 | 1.6 | GO:0004622 | lysophospholipase activity(GO:0004622) |
0.3 | 4.6 | GO:0016684 | oxidoreductase activity, acting on peroxide as acceptor(GO:0016684) |
0.3 | 5.2 | GO:0016701 | oxidoreductase activity, acting on single donors with incorporation of molecular oxygen(GO:0016701) |
0.3 | 0.9 | GO:0031826 | type 2A serotonin receptor binding(GO:0031826) |
0.3 | 0.9 | GO:0004942 | anaphylatoxin receptor activity(GO:0004942) |
0.3 | 1.8 | GO:1904264 | ubiquitin protein ligase activity involved in ERAD pathway(GO:1904264) |
0.3 | 0.6 | GO:0000340 | RNA 7-methylguanosine cap binding(GO:0000340) |
0.3 | 8.7 | GO:0018733 | 3,4-dihydrocoumarin hydrolase activity(GO:0018733) |
0.3 | 1.1 | GO:0016018 | cyclosporin A binding(GO:0016018) |
0.3 | 1.1 | GO:0004974 | leukotriene receptor activity(GO:0004974) |
0.3 | 0.6 | GO:0034513 | box H/ACA snoRNA binding(GO:0034513) |
0.3 | 0.6 | GO:0019961 | interferon binding(GO:0019961) |
0.3 | 1.1 | GO:0005167 | neurotrophin TRK receptor binding(GO:0005167) |
0.3 | 0.8 | GO:0070034 | telomerase RNA binding(GO:0070034) |
0.3 | 1.6 | GO:0004180 | carboxypeptidase activity(GO:0004180) |
0.3 | 1.4 | GO:0050733 | RS domain binding(GO:0050733) |
0.3 | 11.1 | GO:0003714 | transcription corepressor activity(GO:0003714) |
0.3 | 0.8 | GO:0046404 | ATP-dependent polydeoxyribonucleotide 5'-hydroxyl-kinase activity(GO:0046404) polydeoxyribonucleotide kinase activity(GO:0051733) |
0.3 | 0.3 | GO:0008193 | tRNA guanylyltransferase activity(GO:0008193) |
0.3 | 1.3 | GO:0005337 | nucleoside transmembrane transporter activity(GO:0005337) |
0.3 | 0.5 | GO:0045236 | CXCR chemokine receptor binding(GO:0045236) |
0.3 | 1.9 | GO:0001618 | virus receptor activity(GO:0001618) |
0.3 | 0.3 | GO:0000339 | RNA cap binding(GO:0000339) |
0.3 | 0.3 | GO:0001025 | RNA polymerase III transcription factor binding(GO:0001025) |
0.3 | 0.5 | GO:0097603 | temperature-gated ion channel activity(GO:0097603) |
0.3 | 6.5 | GO:0004683 | calmodulin-dependent protein kinase activity(GO:0004683) |
0.3 | 0.8 | GO:0032041 | histone deacetylase activity (H3-K14 specific)(GO:0031078) NAD-dependent histone deacetylase activity (H3-K14 specific)(GO:0032041) |
0.3 | 0.8 | GO:0004024 | alcohol dehydrogenase activity, zinc-dependent(GO:0004024) |
0.3 | 1.3 | GO:0034236 | protein kinase A catalytic subunit binding(GO:0034236) |
0.3 | 2.3 | GO:0019206 | nucleoside kinase activity(GO:0019206) |
0.2 | 0.7 | GO:0004813 | alanine-tRNA ligase activity(GO:0004813) |
0.2 | 1.2 | GO:0051371 | muscle alpha-actinin binding(GO:0051371) |
0.2 | 0.7 | GO:0035651 | AP-3 adaptor complex binding(GO:0035651) |
0.2 | 2.0 | GO:0034450 | ubiquitin-ubiquitin ligase activity(GO:0034450) |
0.2 | 2.9 | GO:0003727 | single-stranded RNA binding(GO:0003727) |
0.2 | 0.7 | GO:0042809 | vitamin D receptor binding(GO:0042809) |
0.2 | 0.2 | GO:0050693 | LBD domain binding(GO:0050693) |
0.2 | 1.4 | GO:0016681 | ubiquinol-cytochrome-c reductase activity(GO:0008121) oxidoreductase activity, acting on diphenols and related substances as donors, cytochrome as acceptor(GO:0016681) |
0.2 | 0.7 | GO:0000171 | ribonuclease MRP activity(GO:0000171) |
0.2 | 1.1 | GO:0070990 | snRNP binding(GO:0070990) |
0.2 | 0.7 | GO:0004699 | calcium-independent protein kinase C activity(GO:0004699) |
0.2 | 0.7 | GO:0050567 | glutaminyl-tRNA synthase (glutamine-hydrolyzing) activity(GO:0050567) |
0.2 | 1.4 | GO:0016812 | hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in cyclic amides(GO:0016812) |
0.2 | 2.5 | GO:0004312 | fatty acid synthase activity(GO:0004312) |
0.2 | 2.5 | GO:0008198 | ferrous iron binding(GO:0008198) |
0.2 | 0.9 | GO:0004566 | beta-glucuronidase activity(GO:0004566) |
0.2 | 1.6 | GO:0044548 | S100 protein binding(GO:0044548) |
0.2 | 0.4 | GO:0017116 | single-stranded DNA-dependent ATP-dependent DNA helicase activity(GO:0017116) |
0.2 | 0.9 | GO:1990247 | N6-methyladenosine-containing RNA binding(GO:1990247) |
0.2 | 2.4 | GO:0008061 | chitin binding(GO:0008061) |
0.2 | 3.3 | GO:0051879 | Hsp90 protein binding(GO:0051879) |
0.2 | 0.4 | GO:0008384 | IkappaB kinase activity(GO:0008384) |
0.2 | 0.2 | GO:0080130 | L-phenylalanine:2-oxoglutarate aminotransferase activity(GO:0080130) |
0.2 | 0.6 | GO:0070087 | chromo shadow domain binding(GO:0070087) |
0.2 | 3.9 | GO:0019843 | rRNA binding(GO:0019843) |
0.2 | 6.0 | GO:0001076 | transcription factor activity, RNA polymerase II transcription factor binding(GO:0001076) |
0.2 | 2.1 | GO:0004745 | retinol dehydrogenase activity(GO:0004745) |
0.2 | 1.9 | GO:0003796 | lysozyme activity(GO:0003796) |
0.2 | 2.3 | GO:0016929 | SUMO-specific protease activity(GO:0016929) |
0.2 | 0.8 | GO:0098634 | protein binding involved in cell-matrix adhesion(GO:0098634) |
0.2 | 0.4 | GO:0071987 | WD40-repeat domain binding(GO:0071987) |
0.2 | 0.2 | GO:0051575 | 5'-deoxyribose-5-phosphate lyase activity(GO:0051575) |
0.2 | 0.4 | GO:0016778 | diphosphotransferase activity(GO:0016778) |
0.2 | 3.3 | GO:0005527 | macrolide binding(GO:0005527) FK506 binding(GO:0005528) |
0.2 | 0.4 | GO:0042030 | ATPase inhibitor activity(GO:0042030) |
0.2 | 2.7 | GO:0004679 | AMP-activated protein kinase activity(GO:0004679) |
0.2 | 2.3 | GO:0001530 | lipopolysaccharide binding(GO:0001530) |
0.2 | 0.2 | GO:0002054 | nucleobase binding(GO:0002054) |
0.2 | 4.6 | GO:0034062 | RNA polymerase activity(GO:0034062) |
0.2 | 0.6 | GO:0019767 | IgE receptor activity(GO:0019767) |
0.2 | 0.8 | GO:0003945 | N-acetyllactosamine synthase activity(GO:0003945) |
0.2 | 0.6 | GO:0043023 | ribosomal large subunit binding(GO:0043023) |
0.2 | 1.8 | GO:0042288 | MHC class I protein binding(GO:0042288) |
0.2 | 0.6 | GO:0030280 | structural constituent of epidermis(GO:0030280) |
0.2 | 3.7 | GO:0004198 | calcium-dependent cysteine-type endopeptidase activity(GO:0004198) |
0.2 | 7.7 | GO:0004197 | cysteine-type endopeptidase activity(GO:0004197) |
0.2 | 14.8 | GO:0046906 | tetrapyrrole binding(GO:0046906) |
0.2 | 29.0 | GO:0005125 | cytokine activity(GO:0005125) |
0.2 | 0.7 | GO:0043996 | histone acetyltransferase activity (H4-K5 specific)(GO:0043995) histone acetyltransferase activity (H4-K8 specific)(GO:0043996) histone acetyltransferase activity (H4-K16 specific)(GO:0046972) |
0.2 | 1.3 | GO:0004579 | dolichyl-diphosphooligosaccharide-protein glycotransferase activity(GO:0004579) |
0.2 | 4.6 | GO:0019706 | protein-cysteine S-palmitoyltransferase activity(GO:0019706) |
0.2 | 0.7 | GO:0016841 | ammonia-lyase activity(GO:0016841) |
0.2 | 0.7 | GO:0004045 | aminoacyl-tRNA hydrolase activity(GO:0004045) |
0.2 | 0.4 | GO:0002161 | aminoacyl-tRNA editing activity(GO:0002161) |
0.2 | 2.7 | GO:0043548 | phosphatidylinositol 3-kinase binding(GO:0043548) |
0.2 | 10.9 | GO:0005178 | integrin binding(GO:0005178) |
0.2 | 0.4 | GO:0000146 | microfilament motor activity(GO:0000146) |
0.2 | 1.6 | GO:0030291 | protein serine/threonine kinase inhibitor activity(GO:0030291) |
0.2 | 4.9 | GO:0017112 | Rab guanyl-nucleotide exchange factor activity(GO:0017112) |
0.2 | 3.7 | GO:0005212 | structural constituent of eye lens(GO:0005212) |
0.2 | 0.3 | GO:0050816 | phosphothreonine binding(GO:0050816) |
0.2 | 8.8 | GO:0003724 | RNA helicase activity(GO:0003724) ATP-dependent RNA helicase activity(GO:0004004) RNA-dependent ATPase activity(GO:0008186) |
0.2 | 0.2 | GO:0019960 | C-X3-C chemokine binding(GO:0019960) |
0.2 | 3.8 | GO:0016538 | cyclin-dependent protein serine/threonine kinase regulator activity(GO:0016538) |
0.2 | 4.7 | GO:0001085 | RNA polymerase II transcription factor binding(GO:0001085) |
0.2 | 8.5 | GO:0004536 | deoxyribonuclease activity(GO:0004536) |
0.2 | 0.3 | GO:0010997 | anaphase-promoting complex binding(GO:0010997) |
0.2 | 0.3 | GO:0042289 | MHC class II protein binding(GO:0042289) |
0.2 | 1.1 | GO:0001848 | complement binding(GO:0001848) |
0.2 | 0.6 | GO:0030346 | protein phosphatase 2B binding(GO:0030346) |
0.2 | 1.3 | GO:0004697 | protein kinase C activity(GO:0004697) |
0.2 | 0.6 | GO:0004594 | pantothenate kinase activity(GO:0004594) |
0.2 | 0.2 | GO:0016716 | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, another compound as one donor, and incorporation of one atom of oxygen(GO:0016716) |
0.2 | 4.4 | GO:0016749 | N-succinyltransferase activity(GO:0016749) |
0.2 | 0.2 | GO:0070546 | L-phenylalanine aminotransferase activity(GO:0070546) |
0.1 | 95.0 | GO:0044822 | poly(A) RNA binding(GO:0044822) |
0.1 | 1.9 | GO:0003755 | peptidyl-prolyl cis-trans isomerase activity(GO:0003755) |
0.1 | 0.3 | GO:0004779 | sulfate adenylyltransferase activity(GO:0004779) |
0.1 | 0.6 | GO:0052833 | inositol monophosphate 1-phosphatase activity(GO:0008934) inositol monophosphate 3-phosphatase activity(GO:0052832) inositol monophosphate 4-phosphatase activity(GO:0052833) inositol monophosphate phosphatase activity(GO:0052834) |
0.1 | 1.2 | GO:0070412 | R-SMAD binding(GO:0070412) |
0.1 | 0.6 | GO:0016799 | hydrolase activity, hydrolyzing N-glycosyl compounds(GO:0016799) |
0.1 | 1.5 | GO:0031404 | chloride ion binding(GO:0031404) |
0.1 | 0.5 | GO:0004165 | dodecenoyl-CoA delta-isomerase activity(GO:0004165) |
0.1 | 0.5 | GO:0097642 | calcitonin family receptor activity(GO:0097642) |
0.1 | 0.1 | GO:0015180 | L-alanine transmembrane transporter activity(GO:0015180) alanine transmembrane transporter activity(GO:0022858) |
0.1 | 1.1 | GO:0071949 | FAD binding(GO:0071949) |
0.1 | 0.6 | GO:0016813 | hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in linear amidines(GO:0016813) |
0.1 | 0.1 | GO:0004731 | purine-nucleoside phosphorylase activity(GO:0004731) |
0.1 | 0.6 | GO:0005123 | death receptor binding(GO:0005123) |
0.1 | 0.1 | GO:0019956 | chemokine binding(GO:0019956) |
0.1 | 0.2 | GO:1990841 | promoter-specific chromatin binding(GO:1990841) |
0.1 | 0.1 | GO:0034711 | inhibin binding(GO:0034711) |
0.1 | 0.3 | GO:0016901 | oxidoreductase activity, acting on the CH-OH group of donors, quinone or similar compound as acceptor(GO:0016901) |
0.1 | 0.8 | GO:0008252 | nucleotidase activity(GO:0008252) |
0.1 | 1.3 | GO:0003690 | double-stranded DNA binding(GO:0003690) |
0.1 | 0.3 | GO:0032453 | histone demethylase activity (H3-K4 specific)(GO:0032453) |
0.1 | 2.0 | GO:0005070 | SH3/SH2 adaptor activity(GO:0005070) |
0.1 | 9.0 | GO:0004222 | metalloendopeptidase activity(GO:0004222) |
0.1 | 0.2 | GO:0034805 | enoyl-[acyl-carrier-protein] reductase activity(GO:0016631) 2,3-dihydroxy-2,3-dihydro-phenylpropionate dehydrogenase activity(GO:0018498) cis-2,3-dihydrodiol DDT dehydrogenase activity(GO:0018499) trans-9R,10R-dihydrodiolphenanthrene dehydrogenase activity(GO:0018500) cis-chlorobenzene dihydrodiol dehydrogenase activity(GO:0018501) 2,5-dichloro-2,5-cyclohexadiene-1,4-diol dehydrogenase activity(GO:0018502) trans-1,2-dihydrodiolphenanthrene dehydrogenase activity(GO:0018503) 3,4-dihydroxy-3,4-dihydrofluorene dehydrogenase activity(GO:0034790) benzo(a)pyrene-trans-11,12-dihydrodiol dehydrogenase activity(GO:0034805) benzo(a)pyrene-cis-4,5-dihydrodiol dehydrogenase activity(GO:0034809) citronellyl-CoA dehydrogenase activity(GO:0034824) menthone dehydrogenase activity(GO:0034838) phthalate 3,4-cis-dihydrodiol dehydrogenase activity(GO:0034912) cinnamate reductase activity(GO:0043786) NADPH-dependent curcumin reductase activity(GO:0052849) NADPH-dependent dihydrocurcumin reductase activity(GO:0052850) |
0.1 | 1.8 | GO:0004298 | threonine-type endopeptidase activity(GO:0004298) threonine-type peptidase activity(GO:0070003) |
0.1 | 0.5 | GO:0004769 | steroid delta-isomerase activity(GO:0004769) |
0.1 | 0.1 | GO:0016532 | superoxide dismutase copper chaperone activity(GO:0016532) |
0.1 | 1.7 | GO:0031683 | G-protein beta/gamma-subunit complex binding(GO:0031683) |
0.1 | 0.3 | GO:0102345 | 3-hydroxy-behenoyl-CoA dehydratase activity(GO:0102344) 3-hydroxy-lignoceroyl-CoA dehydratase activity(GO:0102345) |
0.1 | 0.1 | GO:0019863 | IgE binding(GO:0019863) |
0.1 | 1.6 | GO:0051059 | NF-kappaB binding(GO:0051059) |
0.1 | 0.1 | GO:0018479 | benzaldehyde dehydrogenase (NAD+) activity(GO:0018479) |
0.1 | 0.2 | GO:0005005 | transmembrane-ephrin receptor activity(GO:0005005) |
0.1 | 0.9 | GO:0032794 | GTPase activating protein binding(GO:0032794) |
0.1 | 4.7 | GO:0004843 | thiol-dependent ubiquitin-specific protease activity(GO:0004843) |
0.1 | 0.5 | GO:0005536 | glucose binding(GO:0005536) |
0.1 | 0.4 | GO:0004582 | dolichyl-phosphate beta-D-mannosyltransferase activity(GO:0004582) |
0.1 | 4.6 | GO:0008134 | transcription factor binding(GO:0008134) |
0.1 | 0.1 | GO:0005166 | neurotrophin p75 receptor binding(GO:0005166) |
0.1 | 48.1 | GO:0003677 | DNA binding(GO:0003677) |
0.1 | 0.3 | GO:0030151 | molybdenum ion binding(GO:0030151) |
0.1 | 0.5 | GO:0070300 | phosphatidic acid binding(GO:0070300) |
0.1 | 0.2 | GO:0019103 | pyrimidine nucleotide binding(GO:0019103) |
0.1 | 0.1 | GO:0000386 | second spliceosomal transesterification activity(GO:0000386) |
0.1 | 0.3 | GO:0005329 | dopamine transmembrane transporter activity(GO:0005329) |
0.1 | 0.3 | GO:0005159 | insulin-like growth factor receptor binding(GO:0005159) |
0.1 | 0.2 | GO:0018685 | alkane 1-monooxygenase activity(GO:0018685) |
0.1 | 0.1 | GO:1904288 | BAT3 complex binding(GO:1904288) |
0.1 | 0.1 | GO:0019763 | immunoglobulin receptor activity(GO:0019763) |
0.1 | 1.9 | GO:0052771 | coenzyme F390-A hydrolase activity(GO:0052770) coenzyme F390-G hydrolase activity(GO:0052771) |
0.1 | 0.3 | GO:0036374 | gamma-glutamyltransferase activity(GO:0003840) glutathione hydrolase activity(GO:0036374) |
0.1 | 0.5 | GO:0004931 | extracellular ATP-gated cation channel activity(GO:0004931) ATP-gated ion channel activity(GO:0035381) |
0.1 | 1.2 | GO:0004709 | MAP kinase kinase kinase activity(GO:0004709) |
0.1 | 0.1 | GO:0031893 | vasopressin receptor binding(GO:0031893) |
0.1 | 0.3 | GO:0004614 | phosphoglucomutase activity(GO:0004614) |
0.1 | 0.4 | GO:0017040 | ceramidase activity(GO:0017040) |
0.1 | 0.5 | GO:0008020 | G-protein coupled photoreceptor activity(GO:0008020) |
0.1 | 0.4 | GO:0016454 | C-palmitoyltransferase activity(GO:0016454) |
0.1 | 0.3 | GO:0004690 | cyclic nucleotide-dependent protein kinase activity(GO:0004690) |
0.1 | 0.4 | GO:0004029 | aldehyde dehydrogenase (NAD) activity(GO:0004029) |
0.1 | 0.3 | GO:0001609 | G-protein coupled adenosine receptor activity(GO:0001609) |
0.1 | 2.6 | GO:0008527 | taste receptor activity(GO:0008527) |
0.1 | 0.4 | GO:0047760 | butyrate-CoA ligase activity(GO:0047760) |
0.1 | 1.3 | GO:0042605 | peptide antigen binding(GO:0042605) |
0.1 | 0.7 | GO:0016500 | protein-hormone receptor activity(GO:0016500) |
0.1 | 0.4 | GO:0032452 | histone demethylase activity(GO:0032452) |
0.1 | 0.1 | GO:0015038 | glutathione disulfide oxidoreductase activity(GO:0015038) |
0.1 | 0.1 | GO:0071253 | connexin binding(GO:0071253) |
0.1 | 1.0 | GO:0008536 | Ran GTPase binding(GO:0008536) |
0.1 | 0.8 | GO:0004623 | phospholipase A2 activity(GO:0004623) |
0.1 | 0.1 | GO:0015116 | sulfate transmembrane transporter activity(GO:0015116) |
0.1 | 0.1 | GO:0045125 | bioactive lipid receptor activity(GO:0045125) |
0.1 | 0.1 | GO:0001227 | transcriptional repressor activity, RNA polymerase II transcription regulatory region sequence-specific binding(GO:0001227) |
0.1 | 4.6 | GO:0000287 | magnesium ion binding(GO:0000287) |
0.1 | 0.1 | GO:0008147 | structural constituent of bone(GO:0008147) |
0.1 | 0.2 | GO:0030515 | snoRNA binding(GO:0030515) |
0.1 | 0.4 | GO:0043274 | phospholipase binding(GO:0043274) |
0.0 | 0.1 | GO:0070095 | fructose-6-phosphate binding(GO:0070095) |
0.0 | 0.1 | GO:1990190 | peptide-serine-N-acetyltransferase activity(GO:1990189) peptide-glutamate-N-acetyltransferase activity(GO:1990190) |
0.0 | 1.2 | GO:0061631 | ubiquitin conjugating enzyme activity(GO:0061631) |
0.0 | 0.0 | GO:0004980 | melanocyte-stimulating hormone receptor activity(GO:0004980) |
0.0 | 1.1 | GO:0005507 | copper ion binding(GO:0005507) |
0.0 | 1.2 | GO:0043021 | ribonucleoprotein complex binding(GO:0043021) |
0.0 | 0.1 | GO:0004703 | G-protein coupled receptor kinase activity(GO:0004703) |
0.0 | 0.9 | GO:0005547 | phosphatidylinositol-3,4,5-trisphosphate binding(GO:0005547) |
0.0 | 0.2 | GO:0045028 | G-protein coupled nucleotide receptor activity(GO:0001608) G-protein coupled purinergic nucleotide receptor activity(GO:0045028) |
0.0 | 3.4 | GO:0005550 | pheromone binding(GO:0005550) |
0.0 | 0.7 | GO:0004812 | aminoacyl-tRNA ligase activity(GO:0004812) |
0.0 | 0.1 | GO:0046935 | 1-phosphatidylinositol-3-kinase regulator activity(GO:0046935) |
0.0 | 1.1 | GO:0061134 | peptidase regulator activity(GO:0061134) |
0.0 | 2.8 | GO:0044389 | ubiquitin-like protein ligase binding(GO:0044389) |
0.0 | 0.1 | GO:0004800 | thyroxine 5'-deiodinase activity(GO:0004800) |
0.0 | 0.3 | GO:0030374 | ligand-dependent nuclear receptor transcription coactivator activity(GO:0030374) |
0.0 | 0.2 | GO:0015266 | protein channel activity(GO:0015266) |
0.0 | 0.1 | GO:0002046 | opsin binding(GO:0002046) |
0.0 | 0.0 | GO:0008905 | mannose-phosphate guanylyltransferase activity(GO:0008905) |
0.0 | 0.0 | GO:0004950 | G-protein coupled chemoattractant receptor activity(GO:0001637) chemokine receptor activity(GO:0004950) |
0.0 | 0.1 | GO:0019865 | immunoglobulin binding(GO:0019865) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
6.2 | 6.2 | NABA BASEMENT MEMBRANES | Genes encoding structural components of basement membranes |
2.1 | 22.7 | PID ALK2 PATHWAY | ALK2 signaling events |
1.8 | 1.8 | ST DIFFERENTIATION PATHWAY IN PC12 CELLS | Differentiation Pathway in PC12 Cells; this is a specific case of PAC1 Receptor Pathway. |
1.5 | 42.7 | PID WNT SIGNALING PATHWAY | Wnt signaling network |
1.4 | 9.9 | SA REG CASCADE OF CYCLIN EXPR | Expression of cyclins regulates progression through the cell cycle by activating cyclin-dependent kinases. |
1.4 | 60.9 | NABA COLLAGENS | Genes encoding collagen proteins |
1.4 | 1.4 | PID LPA4 PATHWAY | LPA4-mediated signaling events |
1.4 | 2.7 | PID WNT NONCANONICAL PATHWAY | Noncanonical Wnt signaling pathway |
1.3 | 58.4 | PID HNF3B PATHWAY | FOXA2 and FOXA3 transcription factor networks |
1.3 | 12.7 | PID P38 GAMMA DELTA PATHWAY | Signaling mediated by p38-gamma and p38-delta |
1.3 | 47.0 | PID HES HEY PATHWAY | Notch-mediated HES/HEY network |
1.2 | 7.3 | PID AR NONGENOMIC PATHWAY | Nongenotropic Androgen signaling |
1.2 | 31.3 | PID RXR VDR PATHWAY | RXR and RAR heterodimerization with other nuclear receptor |
1.2 | 84.0 | PID SMAD2 3NUCLEAR PATHWAY | Regulation of nuclear SMAD2/3 signaling |
1.2 | 13.0 | PID INTEGRIN4 PATHWAY | Alpha6 beta4 integrin-ligand interactions |
1.2 | 1.2 | PID TCR RAS PATHWAY | Ras signaling in the CD4+ TCR pathway |
1.1 | 6.9 | ST STAT3 PATHWAY | STAT3 Pathway |
1.1 | 50.5 | PID HIF1 TFPATHWAY | HIF-1-alpha transcription factor network |
1.1 | 28.3 | PID FOXM1 PATHWAY | FOXM1 transcription factor network |
1.1 | 44.0 | PID ILK PATHWAY | Integrin-linked kinase signaling |
1.1 | 58.6 | PID CMYB PATHWAY | C-MYB transcription factor network |
1.1 | 10.0 | SA TRKA RECEPTOR | The TrkA receptor binds nerve growth factor to activate MAP kinase pathways and promote cell growth. |
1.0 | 30.0 | PID RB 1PATHWAY | Regulation of retinoblastoma protein |
1.0 | 14.4 | PID P38 MK2 PATHWAY | p38 signaling mediated by MAPKAP kinases |
0.9 | 3.8 | PID ERBB1 RECEPTOR PROXIMAL PATHWAY | EGF receptor (ErbB1) signaling pathway |
0.9 | 32.3 | PID ECADHERIN STABILIZATION PATHWAY | Stabilization and expansion of the E-cadherin adherens junction |
0.9 | 7.1 | PID IGF1 PATHWAY | IGF1 pathway |
0.9 | 28.0 | SIG PIP3 SIGNALING IN B LYMPHOCYTES | Genes related to PIP3 signaling in B lymphocytes |
0.9 | 4.4 | PID IL5 PATHWAY | IL5-mediated signaling events |
0.9 | 1.7 | PID THROMBIN PAR4 PATHWAY | PAR4-mediated thrombin signaling events |
0.8 | 17.5 | PID FRA PATHWAY | Validated transcriptional targets of AP1 family members Fra1 and Fra2 |
0.8 | 9.0 | PID IL27 PATHWAY | IL27-mediated signaling events |
0.8 | 4.1 | PID EPHA2 FWD PATHWAY | EPHA2 forward signaling |
0.8 | 8.1 | PID A6B1 A6B4 INTEGRIN PATHWAY | a6b1 and a6b4 Integrin signaling |
0.8 | 16.6 | PID S1P META PATHWAY | Sphingosine 1-phosphate (S1P) pathway |
0.8 | 9.5 | PID PDGFRA PATHWAY | PDGFR-alpha signaling pathway |
0.8 | 0.8 | PID IL8 CXCR1 PATHWAY | IL8- and CXCR1-mediated signaling events |
0.8 | 2.3 | ST TYPE I INTERFERON PATHWAY | Type I Interferon (alpha/beta IFN) Pathway |
0.8 | 1.5 | SA CASPASE CASCADE | Apoptosis is mediated by caspases, cysteine proteases arranged in a proteolytic cascade. |
0.7 | 26.0 | PID PLK1 PATHWAY | PLK1 signaling events |
0.7 | 16.2 | PID FAK PATHWAY | Signaling events mediated by focal adhesion kinase |
0.7 | 24.0 | PID TELOMERASE PATHWAY | Regulation of Telomerase |
0.7 | 5.8 | PID AMB2 NEUTROPHILS PATHWAY | amb2 Integrin signaling |
0.7 | 15.2 | PID EPHRINB REV PATHWAY | Ephrin B reverse signaling |
0.7 | 7.2 | SA MMP CYTOKINE CONNECTION | Cytokines can induce activation of matrix metalloproteinases, which degrade extracellular matrix. |
0.7 | 15.7 | PID SYNDECAN 4 PATHWAY | Syndecan-4-mediated signaling events |
0.7 | 19.6 | PID BMP PATHWAY | BMP receptor signaling |
0.7 | 19.6 | PID MYC REPRESS PATHWAY | Validated targets of C-MYC transcriptional repression |
0.7 | 5.6 | PID NFKAPPAB ATYPICAL PATHWAY | Atypical NF-kappaB pathway |
0.7 | 8.3 | PID AURORA A PATHWAY | Aurora A signaling |
0.7 | 6.9 | PID SYNDECAN 2 PATHWAY | Syndecan-2-mediated signaling events |
0.7 | 17.1 | PID HEDGEHOG GLI PATHWAY | Hedgehog signaling events mediated by Gli proteins |
0.7 | 1.4 | SA B CELL RECEPTOR COMPLEXES | Antigen binding to B cell receptors activates protein tyrosine kinases, such as the Src family, which ultimate activate MAP kinases. |
0.7 | 28.8 | WNT SIGNALING | Genes related to Wnt-mediated signal transduction |
0.6 | 8.9 | PID IL6 7 PATHWAY | IL6-mediated signaling events |
0.6 | 8.2 | ST B CELL ANTIGEN RECEPTOR | B Cell Antigen Receptor |
0.6 | 11.3 | PID AP1 PATHWAY | AP-1 transcription factor network |
0.6 | 13.6 | PID VEGFR1 2 PATHWAY | Signaling events mediated by VEGFR1 and VEGFR2 |
0.6 | 11.2 | PID INTEGRIN2 PATHWAY | Beta2 integrin cell surface interactions |
0.6 | 5.3 | ST WNT CA2 CYCLIC GMP PATHWAY | Wnt/Ca2+/cyclic GMP signaling. |
0.6 | 11.0 | PID P38 ALPHA BETA DOWNSTREAM PATHWAY | Signaling mediated by p38-alpha and p38-beta |
0.6 | 1.2 | PID INTEGRIN5 PATHWAY | Beta5 beta6 beta7 and beta8 integrin cell surface interactions |
0.6 | 12.1 | PID AR TF PATHWAY | Regulation of Androgen receptor activity |
0.6 | 2.8 | SA FAS SIGNALING | The TNF-type receptor Fas induces apoptosis on ligand binding. |
0.5 | 1.6 | SIG IL4RECEPTOR IN B LYPHOCYTES | Genes related to IL4 rceptor signaling in B lymphocytes |
0.5 | 10.3 | PID FGF PATHWAY | FGF signaling pathway |
0.5 | 2.5 | PID HDAC CLASSIII PATHWAY | Signaling events mediated by HDAC Class III |
0.5 | 2.5 | PID TCR JNK PATHWAY | JNK signaling in the CD4+ TCR pathway |
0.5 | 21.5 | PID MYC ACTIV PATHWAY | Validated targets of C-MYC transcriptional activation |
0.5 | 3.0 | PID PI3KCI AKT PATHWAY | Class I PI3K signaling events mediated by Akt |
0.5 | 4.9 | ST P38 MAPK PATHWAY | p38 MAPK Pathway |
0.5 | 16.1 | PID CASPASE PATHWAY | Caspase cascade in apoptosis |
0.5 | 3.9 | PID PRL SIGNALING EVENTS PATHWAY | Signaling events mediated by PRL |
0.5 | 13.3 | PID RAC1 PATHWAY | RAC1 signaling pathway |
0.5 | 0.5 | PID P38 ALPHA BETA PATHWAY | Regulation of p38-alpha and p38-beta |
0.5 | 10.9 | PID E2F PATHWAY | E2F transcription factor network |
0.5 | 30.2 | PID P53 DOWNSTREAM PATHWAY | Direct p53 effectors |
0.5 | 7.8 | PID FCER1 PATHWAY | Fc-epsilon receptor I signaling in mast cells |
0.5 | 3.6 | PID ALK1 PATHWAY | ALK1 signaling events |
0.4 | 6.7 | PID DELTA NP63 PATHWAY | Validated transcriptional targets of deltaNp63 isoforms |
0.4 | 4.9 | PID RAS PATHWAY | Regulation of Ras family activation |
0.4 | 8.7 | PID ERBB1 DOWNSTREAM PATHWAY | ErbB1 downstream signaling |
0.4 | 5.1 | PID INTEGRIN CS PATHWAY | Integrin family cell surface interactions |
0.4 | 5.5 | PID BARD1 PATHWAY | BARD1 signaling events |
0.4 | 6.3 | PID AJDISS 2PATHWAY | Posttranslational regulation of adherens junction stability and dissassembly |
0.4 | 2.5 | PID RHODOPSIN PATHWAY | Visual signal transduction: Rods |
0.4 | 1.6 | PID CD40 PATHWAY | CD40/CD40L signaling |
0.4 | 2.4 | PID ERB GENOMIC PATHWAY | Validated nuclear estrogen receptor beta network |
0.4 | 3.9 | PID HIF2PATHWAY | HIF-2-alpha transcription factor network |
0.4 | 7.3 | PID P53 REGULATION PATHWAY | p53 pathway |
0.4 | 7.0 | PID CONE PATHWAY | Visual signal transduction: Cones |
0.4 | 69.8 | NABA ECM REGULATORS | Genes encoding enzymes and their regulators involved in the remodeling of the extracellular matrix |
0.4 | 2.5 | PID WNT CANONICAL PATHWAY | Canonical Wnt signaling pathway |
0.4 | 1.4 | PID NEPHRIN NEPH1 PATHWAY | Nephrin/Neph1 signaling in the kidney podocyte |
0.3 | 6.2 | PID TOLL ENDOGENOUS PATHWAY | Endogenous TLR signaling |
0.3 | 49.7 | NABA ECM GLYCOPROTEINS | Genes encoding structural ECM glycoproteins |
0.3 | 4.0 | PID IL1 PATHWAY | IL1-mediated signaling events |
0.3 | 1.5 | PID HDAC CLASSII PATHWAY | Signaling events mediated by HDAC Class II |
0.3 | 3.3 | PID BCR 5PATHWAY | BCR signaling pathway |
0.3 | 1.5 | PID NFKAPPAB CANONICAL PATHWAY | Canonical NF-kappaB pathway |
0.3 | 5.7 | PID TAP63 PATHWAY | Validated transcriptional targets of TAp63 isoforms |
0.3 | 3.2 | PID HEDGEHOG 2PATHWAY | Signaling events mediated by the Hedgehog family |
0.3 | 6.2 | PID IL12 2PATHWAY | IL12-mediated signaling events |
0.3 | 2.7 | PID ALPHA SYNUCLEIN PATHWAY | Alpha-synuclein signaling |
0.3 | 1.1 | PID SMAD2 3PATHWAY | Regulation of cytoplasmic and nuclear SMAD2/3 signaling |
0.3 | 2.3 | PID ATM PATHWAY | ATM pathway |
0.3 | 5.1 | PID AR PATHWAY | Coregulation of Androgen receptor activity |
0.3 | 0.3 | ST TUMOR NECROSIS FACTOR PATHWAY | Tumor Necrosis Factor Pathway. |
0.2 | 0.5 | PID BETA CATENIN DEG PATHWAY | Degradation of beta catenin |
0.2 | 4.0 | PID AURORA B PATHWAY | Aurora B signaling |
0.2 | 1.6 | PID IL23 PATHWAY | IL23-mediated signaling events |
0.2 | 2.3 | PID CD8 TCR DOWNSTREAM PATHWAY | Downstream signaling in naïve CD8+ T cells |
0.2 | 5.3 | PID ERA GENOMIC PATHWAY | Validated nuclear estrogen receptor alpha network |
0.2 | 3.8 | PID MTOR 4PATHWAY | mTOR signaling pathway |
0.2 | 5.8 | PID RHOA REG PATHWAY | Regulation of RhoA activity |
0.2 | 3.2 | PID TCR PATHWAY | TCR signaling in naïve CD4+ T cells |
0.2 | 0.3 | PID LYMPH ANGIOGENESIS PATHWAY | VEGFR3 signaling in lymphatic endothelium |
0.2 | 4.4 | PID HDAC CLASSI PATHWAY | Signaling events mediated by HDAC Class I |
0.2 | 0.2 | ST JAK STAT PATHWAY | Jak-STAT Pathway |
0.2 | 0.2 | SA PTEN PATHWAY | PTEN is a tumor suppressor that dephosphorylates the lipid messenger phosphatidylinositol triphosphate. |
0.1 | 0.3 | PID IL2 STAT5 PATHWAY | IL2 signaling events mediated by STAT5 |
0.1 | 22.9 | NABA SECRETED FACTORS | Genes encoding secreted soluble factors |
0.1 | 0.2 | PID THROMBIN PAR1 PATHWAY | PAR1-mediated thrombin signaling events |
0.1 | 0.4 | PID IL2 PI3K PATHWAY | IL2 signaling events mediated by PI3K |
0.1 | 0.2 | ST PAC1 RECEPTOR PATHWAY | PAC1 Receptor Pathway |
0.1 | 0.4 | PID ATR PATHWAY | ATR signaling pathway |
0.1 | 1.0 | PID ARF6 TRAFFICKING PATHWAY | Arf6 trafficking events |
0.1 | 0.6 | PID NFAT TFPATHWAY | Calcineurin-regulated NFAT-dependent transcription in lymphocytes |
0.1 | 0.3 | PID INSULIN GLUCOSE PATHWAY | Insulin-mediated glucose transport |
0.0 | 0.2 | PID ECADHERIN NASCENT AJ PATHWAY | E-cadherin signaling in the nascent adherens junction |
0.0 | 0.1 | PID FOXO PATHWAY | FoxO family signaling |
0.0 | 0.1 | PID DNA PK PATHWAY | DNA-PK pathway in nonhomologous end joining |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
5.4 | 5.4 | REACTOME SIGNALING BY FGFR IN DISEASE | Genes involved in Signaling by FGFR in disease |
2.6 | 37.0 | REACTOME REGULATION OF INSULIN LIKE GROWTH FACTOR IGF ACTIVITY BY INSULIN LIKE GROWTH FACTOR BINDING PROTEINS IGFBPS | Genes involved in Regulation of Insulin-like Growth Factor (IGF) Activity by Insulin-like Growth Factor Binding Proteins (IGFBPs) |
2.6 | 2.6 | REACTOME DESTABILIZATION OF MRNA BY BRF1 | Genes involved in Destabilization of mRNA by Butyrate Response Factor 1 (BRF1) |
2.0 | 28.6 | REACTOME METABOLISM OF PORPHYRINS | Genes involved in Metabolism of porphyrins |
2.0 | 58.3 | REACTOME REGULATION OF BETA CELL DEVELOPMENT | Genes involved in Regulation of beta-cell development |
1.7 | 28.0 | REACTOME CHYLOMICRON MEDIATED LIPID TRANSPORT | Genes involved in Chylomicron-mediated lipid transport |
1.7 | 30.9 | REACTOME ACTIVATED AMPK STIMULATES FATTY ACID OXIDATION IN MUSCLE | Genes involved in Activated AMPK stimulates fatty-acid oxidation in muscle |
1.7 | 5.0 | REACTOME CROSS PRESENTATION OF SOLUBLE EXOGENOUS ANTIGENS ENDOSOMES | Genes involved in Cross-presentation of soluble exogenous antigens (endosomes) |
1.6 | 21.2 | REACTOME ASSOCIATION OF LICENSING FACTORS WITH THE PRE REPLICATIVE COMPLEX | Genes involved in Association of licensing factors with the pre-replicative complex |
1.6 | 6.5 | REACTOME PLATELET AGGREGATION PLUG FORMATION | Genes involved in Platelet Aggregation (Plug Formation) |
1.6 | 4.8 | REACTOME REGULATION OF RHEB GTPASE ACTIVITY BY AMPK | Genes involved in Regulation of Rheb GTPase activity by AMPK |
1.6 | 4.7 | REACTOME NEGATIVE REGULATION OF FGFR SIGNALING | Genes involved in Negative regulation of FGFR signaling |
1.5 | 3.0 | REACTOME RIG I MDA5 MEDIATED INDUCTION OF IFN ALPHA BETA PATHWAYS | Genes involved in RIG-I/MDA5 mediated induction of IFN-alpha/beta pathways |
1.5 | 1.5 | REACTOME ELEVATION OF CYTOSOLIC CA2 LEVELS | Genes involved in Elevation of cytosolic Ca2+ levels |
1.5 | 17.5 | REACTOME SYNTHESIS SECRETION AND INACTIVATION OF GIP | Genes involved in Synthesis, Secretion, and Inactivation of Glucose-dependent Insulinotropic Polypeptide (GIP) |
1.5 | 33.4 | REACTOME SMAD2 SMAD3 SMAD4 HETEROTRIMER REGULATES TRANSCRIPTION | Genes involved in SMAD2/SMAD3:SMAD4 heterotrimer regulates transcription |
1.3 | 14.4 | REACTOME BILE SALT AND ORGANIC ANION SLC TRANSPORTERS | Genes involved in Bile salt and organic anion SLC transporters |
1.3 | 27.0 | REACTOME YAP1 AND WWTR1 TAZ STIMULATED GENE EXPRESSION | Genes involved in YAP1- and WWTR1 (TAZ)-stimulated gene expression |
1.3 | 66.0 | REACTOME COLLAGEN FORMATION | Genes involved in Collagen formation |
1.2 | 1.2 | REACTOME TRAF6 MEDIATED NFKB ACTIVATION | Genes involved in TRAF6 mediated NF-kB activation |
1.2 | 6.1 | REACTOME ERKS ARE INACTIVATED | Genes involved in ERKs are inactivated |
1.2 | 4.8 | REACTOME APOBEC3G MEDIATED RESISTANCE TO HIV1 INFECTION | Genes involved in APOBEC3G mediated resistance to HIV-1 infection |
1.2 | 8.3 | REACTOME ABACAVIR TRANSPORT AND METABOLISM | Genes involved in Abacavir transport and metabolism |
1.2 | 10.5 | REACTOME ACTIVATION OF CHAPERONE GENES BY ATF6 ALPHA | Genes involved in Activation of Chaperone Genes by ATF6-alpha |
1.1 | 17.2 | REACTOME PLATELET SENSITIZATION BY LDL | Genes involved in Platelet sensitization by LDL |
1.1 | 30.6 | REACTOME STRIATED MUSCLE CONTRACTION | Genes involved in Striated Muscle Contraction |
1.1 | 13.1 | REACTOME PURINE SALVAGE | Genes involved in Purine salvage |
1.1 | 29.3 | REACTOME SPHINGOLIPID DE NOVO BIOSYNTHESIS | Genes involved in Sphingolipid de novo biosynthesis |
1.1 | 10.7 | REACTOME PASSIVE TRANSPORT BY AQUAPORINS | Genes involved in Passive Transport by Aquaporins |
1.1 | 8.5 | REACTOME CYCLIN A B1 ASSOCIATED EVENTS DURING G2 M TRANSITION | Genes involved in Cyclin A/B1 associated events during G2/M transition |
1.1 | 15.9 | REACTOME GRB2 SOS PROVIDES LINKAGE TO MAPK SIGNALING FOR INTERGRINS | Genes involved in GRB2:SOS provides linkage to MAPK signaling for Intergrins |
1.0 | 19.8 | REACTOME E2F MEDIATED REGULATION OF DNA REPLICATION | Genes involved in E2F mediated regulation of DNA replication |
1.0 | 4.0 | REACTOME ACYL CHAIN REMODELLING OF PG | Genes involved in Acyl chain remodelling of PG |
1.0 | 6.9 | REACTOME SYNTHESIS SECRETION AND INACTIVATION OF GLP1 | Genes involved in Synthesis, Secretion, and Inactivation of Glucagon-like Peptide-1 (GLP-1) |
1.0 | 8.8 | REACTOME APOPTOTIC CLEAVAGE OF CELL ADHESION PROTEINS | Genes involved in Apoptotic cleavage of cell adhesion proteins |
1.0 | 7.7 | REACTOME PLATELET ADHESION TO EXPOSED COLLAGEN | Genes involved in Platelet Adhesion to exposed collagen |
0.9 | 12.2 | REACTOME ACYL CHAIN REMODELLING OF PI | Genes involved in Acyl chain remodelling of PI |
0.9 | 73.4 | REACTOME PEPTIDE CHAIN ELONGATION | Genes involved in Peptide chain elongation |
0.9 | 15.6 | REACTOME TERMINATION OF O GLYCAN BIOSYNTHESIS | Genes involved in Termination of O-glycan biosynthesis |
0.9 | 25.7 | REACTOME CYTOCHROME P450 ARRANGED BY SUBSTRATE TYPE | Genes involved in Cytochrome P450 - arranged by substrate type |
0.9 | 11.8 | REACTOME CELL EXTRACELLULAR MATRIX INTERACTIONS | Genes involved in Cell-extracellular matrix interactions |
0.9 | 7.2 | REACTOME RECYCLING OF BILE ACIDS AND SALTS | Genes involved in Recycling of bile acids and salts |
0.9 | 0.9 | REACTOME FORMATION OF THE HIV1 EARLY ELONGATION COMPLEX | Genes involved in Formation of the HIV-1 Early Elongation Complex |
0.9 | 10.4 | REACTOME INITIAL TRIGGERING OF COMPLEMENT | Genes involved in Initial triggering of complement |
0.9 | 12.9 | REACTOME SIGNALING BY NODAL | Genes involved in Signaling by NODAL |
0.9 | 25.6 | REACTOME AMINO ACID TRANSPORT ACROSS THE PLASMA MEMBRANE | Genes involved in Amino acid transport across the plasma membrane |
0.8 | 15.2 | REACTOME G1 PHASE | Genes involved in G1 Phase |
0.8 | 3.4 | REACTOME DCC MEDIATED ATTRACTIVE SIGNALING | Genes involved in DCC mediated attractive signaling |
0.8 | 12.5 | REACTOME NEGATIVE REGULATORS OF RIG I MDA5 SIGNALING | Genes involved in Negative regulators of RIG-I/MDA5 signaling |
0.8 | 10.8 | REACTOME ACTIVATED TAK1 MEDIATES P38 MAPK ACTIVATION | Genes involved in activated TAK1 mediates p38 MAPK activation |
0.8 | 8.1 | REACTOME HYALURONAN UPTAKE AND DEGRADATION | Genes involved in Hyaluronan uptake and degradation |
0.8 | 8.1 | REACTOME SYNTHESIS OF PE | Genes involved in Synthesis of PE |
0.8 | 0.8 | REACTOME FRS2 MEDIATED CASCADE | Genes involved in FRS2-mediated cascade |
0.8 | 7.8 | REACTOME LATENT INFECTION OF HOMO SAPIENS WITH MYCOBACTERIUM TUBERCULOSIS | Genes involved in Latent infection of Homo sapiens with Mycobacterium tuberculosis |
0.8 | 10.0 | REACTOME TRAF3 DEPENDENT IRF ACTIVATION PATHWAY | Genes involved in TRAF3-dependent IRF activation pathway |
0.8 | 12.1 | REACTOME RIP MEDIATED NFKB ACTIVATION VIA DAI | Genes involved in RIP-mediated NFkB activation via DAI |
0.7 | 6.7 | REACTOME UNWINDING OF DNA | Genes involved in Unwinding of DNA |
0.7 | 1.5 | REACTOME ADVANCED GLYCOSYLATION ENDPRODUCT RECEPTOR SIGNALING | Genes involved in Advanced glycosylation endproduct receptor signaling |
0.7 | 20.9 | REACTOME TIGHT JUNCTION INTERACTIONS | Genes involved in Tight junction interactions |
0.7 | 12.3 | REACTOME SIGNALING BY BMP | Genes involved in Signaling by BMP |
0.7 | 6.3 | REACTOME ORGANIC CATION ANION ZWITTERION TRANSPORT | Genes involved in Organic cation/anion/zwitterion transport |
0.7 | 11.8 | REACTOME RNA POL I TRANSCRIPTION INITIATION | Genes involved in RNA Polymerase I Transcription Initiation |
0.7 | 2.8 | REACTOME AKT PHOSPHORYLATES TARGETS IN THE CYTOSOL | Genes involved in AKT phosphorylates targets in the cytosol |
0.7 | 7.5 | REACTOME EXTRINSIC PATHWAY FOR APOPTOSIS | Genes involved in Extrinsic Pathway for Apoptosis |
0.7 | 10.1 | REACTOME AMINE DERIVED HORMONES | Genes involved in Amine-derived hormones |
0.7 | 6.1 | REACTOME MTORC1 MEDIATED SIGNALLING | Genes involved in mTORC1-mediated signalling |
0.7 | 0.7 | REACTOME TRANSLOCATION OF ZAP 70 TO IMMUNOLOGICAL SYNAPSE | Genes involved in Translocation of ZAP-70 to Immunological synapse |
0.7 | 0.7 | REACTOME MRNA DECAY BY 3 TO 5 EXORIBONUCLEASE | Genes involved in mRNA Decay by 3' to 5' Exoribonuclease |
0.7 | 3.3 | REACTOME NFKB IS ACTIVATED AND SIGNALS SURVIVAL | Genes involved in NF-kB is activated and signals survival |
0.7 | 15.7 | REACTOME SHC MEDIATED CASCADE | Genes involved in SHC-mediated cascade |
0.7 | 17.0 | REACTOME MEIOTIC RECOMBINATION | Genes involved in Meiotic Recombination |
0.7 | 2.0 | REACTOME PROCESSING OF CAPPED INTRONLESS PRE MRNA | Genes involved in Processing of Capped Intronless Pre-mRNA |
0.7 | 5.9 | REACTOME ROLE OF DCC IN REGULATING APOPTOSIS | Genes involved in Role of DCC in regulating apoptosis |
0.6 | 57.7 | REACTOME FACTORS INVOLVED IN MEGAKARYOCYTE DEVELOPMENT AND PLATELET PRODUCTION | Genes involved in Factors involved in megakaryocyte development and platelet production |
0.6 | 58.8 | REACTOME MRNA SPLICING | Genes involved in mRNA Splicing |
0.6 | 6.4 | REACTOME REGULATION OF INSULIN SECRETION BY ACETYLCHOLINE | Genes involved in Regulation of Insulin Secretion by Acetylcholine |
0.6 | 11.3 | REACTOME SMOOTH MUSCLE CONTRACTION | Genes involved in Smooth Muscle Contraction |
0.6 | 13.2 | REACTOME REGULATORY RNA PATHWAYS | Genes involved in Regulatory RNA pathways |
0.6 | 5.0 | REACTOME GAMMA CARBOXYLATION TRANSPORT AND AMINO TERMINAL CLEAVAGE OF PROTEINS | Genes involved in Gamma-carboxylation, transport, and amino-terminal cleavage of proteins |
0.6 | 5.6 | REACTOME DOWNSTREAM SIGNALING EVENTS OF B CELL RECEPTOR BCR | Genes involved in Downstream Signaling Events Of B Cell Receptor (BCR) |
0.6 | 5.6 | REACTOME NOD1 2 SIGNALING PATHWAY | Genes involved in NOD1/2 Signaling Pathway |
0.6 | 9.2 | REACTOME ZINC TRANSPORTERS | Genes involved in Zinc transporters |
0.6 | 10.3 | REACTOME PROSTACYCLIN SIGNALLING THROUGH PROSTACYCLIN RECEPTOR | Genes involved in Prostacyclin signalling through prostacyclin receptor |
0.6 | 7.7 | REACTOME ENOS ACTIVATION AND REGULATION | Genes involved in eNOS activation and regulation |
0.6 | 0.6 | REACTOME P75NTR SIGNALS VIA NFKB | Genes involved in p75NTR signals via NF-kB |
0.6 | 7.9 | REACTOME SIGNALING BY FGFR MUTANTS | Genes involved in Signaling by FGFR mutants |
0.6 | 13.0 | REACTOME TRANSFERRIN ENDOCYTOSIS AND RECYCLING | Genes involved in Transferrin endocytosis and recycling |
0.6 | 1.7 | REACTOME ACYL CHAIN REMODELLING OF PS | Genes involved in Acyl chain remodelling of PS |
0.6 | 6.1 | REACTOME REGULATION OF IFNG SIGNALING | Genes involved in Regulation of IFNG signaling |
0.6 | 7.2 | REACTOME REGULATION OF HYPOXIA INDUCIBLE FACTOR HIF BY OXYGEN | Genes involved in Regulation of Hypoxia-inducible Factor (HIF) by Oxygen |
0.5 | 4.8 | REACTOME CASPASE MEDIATED CLEAVAGE OF CYTOSKELETAL PROTEINS | Genes involved in Caspase-mediated cleavage of cytoskeletal proteins |
0.5 | 1.1 | REACTOME REGULATION OF APOPTOSIS | Genes involved in Regulation of Apoptosis |
0.5 | 5.3 | REACTOME IL 7 SIGNALING | Genes involved in Interleukin-7 signaling |
0.5 | 10.6 | REACTOME INTERACTION BETWEEN L1 AND ANKYRINS | Genes involved in Interaction between L1 and Ankyrins |
0.5 | 2.6 | REACTOME REGULATION OF COMPLEMENT CASCADE | Genes involved in Regulation of Complement cascade |
0.5 | 10.2 | REACTOME ANTIGEN ACTIVATES B CELL RECEPTOR LEADING TO GENERATION OF SECOND MESSENGERS | Genes involved in Antigen Activates B Cell Receptor Leading to Generation of Second Messengers |
0.5 | 2.0 | REACTOME PLC BETA MEDIATED EVENTS | Genes involved in PLC beta mediated events |
0.5 | 4.0 | REACTOME THE NLRP3 INFLAMMASOME | Genes involved in The NLRP3 inflammasome |
0.5 | 4.5 | REACTOME RORA ACTIVATES CIRCADIAN EXPRESSION | Genes involved in RORA Activates Circadian Expression |
0.5 | 6.4 | REACTOME FANCONI ANEMIA PATHWAY | Genes involved in Fanconi Anemia pathway |
0.5 | 2.9 | REACTOME IRON UPTAKE AND TRANSPORT | Genes involved in Iron uptake and transport |
0.5 | 2.4 | REACTOME SIGNAL REGULATORY PROTEIN SIRP FAMILY INTERACTIONS | Genes involved in Signal regulatory protein (SIRP) family interactions |
0.5 | 12.6 | REACTOME MEIOTIC SYNAPSIS | Genes involved in Meiotic Synapsis |
0.5 | 11.6 | REACTOME INTERFERON GAMMA SIGNALING | Genes involved in Interferon gamma signaling |
0.5 | 2.9 | REACTOME THROMBIN SIGNALLING THROUGH PROTEINASE ACTIVATED RECEPTORS PARS | Genes involved in Thrombin signalling through proteinase activated receptors (PARs) |
0.5 | 5.3 | REACTOME P2Y RECEPTORS | Genes involved in P2Y receptors |
0.5 | 6.5 | REACTOME APC C CDC20 MEDIATED DEGRADATION OF CYCLIN B | Genes involved in APC/C:Cdc20 mediated degradation of Cyclin B |
0.5 | 3.7 | REACTOME G0 AND EARLY G1 | Genes involved in G0 and Early G1 |
0.5 | 2.3 | REACTOME SYNTHESIS SECRETION AND DEACYLATION OF GHRELIN | Genes involved in Synthesis, Secretion, and Deacylation of Ghrelin |
0.5 | 2.7 | REACTOME COMMON PATHWAY | Genes involved in Common Pathway |
0.5 | 2.7 | REACTOME APOPTOSIS INDUCED DNA FRAGMENTATION | Genes involved in Apoptosis induced DNA fragmentation |
0.5 | 20.8 | REACTOME METABOLISM OF VITAMINS AND COFACTORS | Genes involved in Metabolism of vitamins and cofactors |
0.4 | 2.2 | REACTOME ACTIVATION OF THE PRE REPLICATIVE COMPLEX | Genes involved in Activation of the pre-replicative complex |
0.4 | 22.7 | REACTOME MITOTIC PROMETAPHASE | Genes involved in Mitotic Prometaphase |
0.4 | 3.1 | REACTOME HORMONE LIGAND BINDING RECEPTORS | Genes involved in Hormone ligand-binding receptors |
0.4 | 9.3 | REACTOME RECYCLING PATHWAY OF L1 | Genes involved in Recycling pathway of L1 |
0.4 | 21.0 | REACTOME TRANSLATION | Genes involved in Translation |
0.4 | 14.5 | REACTOME GLUCOSE TRANSPORT | Genes involved in Glucose transport |
0.4 | 0.4 | REACTOME APC C CDC20 MEDIATED DEGRADATION OF MITOTIC PROTEINS | Genes involved in APC/C:Cdc20 mediated degradation of mitotic proteins |
0.4 | 4.6 | REACTOME SYNTHESIS OF PC | Genes involved in Synthesis of PC |
0.4 | 3.7 | REACTOME PYRIMIDINE CATABOLISM | Genes involved in Pyrimidine catabolism |
0.4 | 13.4 | REACTOME IMMUNOREGULATORY INTERACTIONS BETWEEN A LYMPHOID AND A NON LYMPHOID CELL | Genes involved in Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell |
0.4 | 3.2 | REACTOME PURINE CATABOLISM | Genes involved in Purine catabolism |
0.4 | 5.1 | REACTOME SYNTHESIS OF PA | Genes involved in Synthesis of PA |
0.4 | 3.1 | REACTOME TGF BETA RECEPTOR SIGNALING IN EMT EPITHELIAL TO MESENCHYMAL TRANSITION | Genes involved in TGF-beta receptor signaling in EMT (epithelial to mesenchymal transition) |
0.4 | 4.9 | REACTOME MRNA DECAY BY 5 TO 3 EXORIBONUCLEASE | Genes involved in mRNA Decay by 5' to 3' Exoribonuclease |
0.4 | 9.1 | REACTOME SYNTHESIS OF PIPS AT THE PLASMA MEMBRANE | Genes involved in Synthesis of PIPs at the plasma membrane |
0.4 | 6.4 | REACTOME SULFUR AMINO ACID METABOLISM | Genes involved in Sulfur amino acid metabolism |
0.4 | 11.2 | REACTOME SIGNALING BY SCF KIT | Genes involved in Signaling by SCF-KIT |
0.4 | 4.3 | REACTOME PTM GAMMA CARBOXYLATION HYPUSINE FORMATION AND ARYLSULFATASE ACTIVATION | Genes involved in PTM: gamma carboxylation, hypusine formation and arylsulfatase activation |
0.4 | 1.4 | REACTOME DIGESTION OF DIETARY CARBOHYDRATE | Genes involved in Digestion of dietary carbohydrate |
0.4 | 3.9 | REACTOME FORMATION OF FIBRIN CLOT CLOTTING CASCADE | Genes involved in Formation of Fibrin Clot (Clotting Cascade) |
0.4 | 1.1 | REACTOME DESTABILIZATION OF MRNA BY KSRP | Genes involved in Destabilization of mRNA by KSRP |
0.3 | 3.3 | REACTOME BASE FREE SUGAR PHOSPHATE REMOVAL VIA THE SINGLE NUCLEOTIDE REPLACEMENT PATHWAY | Genes involved in Base-free sugar-phosphate removal via the single-nucleotide replacement pathway |
0.3 | 5.3 | REACTOME RNA POL II TRANSCRIPTION PRE INITIATION AND PROMOTER OPENING | Genes involved in RNA Polymerase II Transcription Pre-Initiation And Promoter Opening |
0.3 | 1.6 | REACTOME BETA DEFENSINS | Genes involved in Beta defensins |
0.3 | 0.3 | REACTOME APC C CDH1 MEDIATED DEGRADATION OF CDC20 AND OTHER APC C CDH1 TARGETED PROTEINS IN LATE MITOSIS EARLY G1 | Genes involved in APC/C:Cdh1 mediated degradation of Cdc20 and other APC/C:Cdh1 targeted proteins in late mitosis/early G1 |
0.3 | 1.6 | REACTOME REGULATION OF ORNITHINE DECARBOXYLASE ODC | Genes involved in Regulation of ornithine decarboxylase (ODC) |
0.3 | 2.5 | REACTOME FORMATION OF INCISION COMPLEX IN GG NER | Genes involved in Formation of incision complex in GG-NER |
0.3 | 4.3 | REACTOME AMINO ACID SYNTHESIS AND INTERCONVERSION TRANSAMINATION | Genes involved in Amino acid synthesis and interconversion (transamination) |
0.3 | 2.1 | REACTOME RNA POL III TRANSCRIPTION INITIATION FROM TYPE 3 PROMOTER | Genes involved in RNA Polymerase III Transcription Initiation From Type 3 Promoter |
0.3 | 11.3 | REACTOME NUCLEAR RECEPTOR TRANSCRIPTION PATHWAY | Genes involved in Nuclear Receptor transcription pathway |
0.3 | 4.1 | REACTOME METABOLISM OF POLYAMINES | Genes involved in Metabolism of polyamines |
0.3 | 11.3 | REACTOME TRANSCRIPTIONAL REGULATION OF WHITE ADIPOCYTE DIFFERENTIATION | Genes involved in Transcriptional Regulation of White Adipocyte Differentiation |
0.3 | 2.6 | REACTOME TRAFFICKING AND PROCESSING OF ENDOSOMAL TLR | Genes involved in Trafficking and processing of endosomal TLR |
0.3 | 2.5 | REACTOME COPI MEDIATED TRANSPORT | Genes involved in COPI Mediated Transport |
0.3 | 4.5 | REACTOME GAP JUNCTION ASSEMBLY | Genes involved in Gap junction assembly |
0.3 | 0.8 | REACTOME BINDING AND ENTRY OF HIV VIRION | Genes involved in Binding and entry of HIV virion |
0.3 | 1.1 | REACTOME REGULATION OF WATER BALANCE BY RENAL AQUAPORINS | Genes involved in Regulation of Water Balance by Renal Aquaporins |
0.3 | 5.1 | REACTOME EXTRACELLULAR MATRIX ORGANIZATION | Genes involved in Extracellular matrix organization |
0.3 | 2.6 | REACTOME N GLYCAN TRIMMING IN THE ER AND CALNEXIN CALRETICULIN CYCLE | Genes involved in N-glycan trimming in the ER and Calnexin/Calreticulin cycle |
0.3 | 3.1 | REACTOME DESTABILIZATION OF MRNA BY TRISTETRAPROLIN TTP | Genes involved in Destabilization of mRNA by Tristetraprolin (TTP) |
0.2 | 1.2 | REACTOME INFLUENZA LIFE CYCLE | Genes involved in Influenza Life Cycle |
0.2 | 8.8 | REACTOME CHEMOKINE RECEPTORS BIND CHEMOKINES | Genes involved in Chemokine receptors bind chemokines |
0.2 | 5.1 | REACTOME CYTOSOLIC TRNA AMINOACYLATION | Genes involved in Cytosolic tRNA aminoacylation |
0.2 | 5.7 | REACTOME ASSOCIATION OF TRIC CCT WITH TARGET PROTEINS DURING BIOSYNTHESIS | Genes involved in Association of TriC/CCT with target proteins during biosynthesis |
0.2 | 3.6 | REACTOME ANTIVIRAL MECHANISM BY IFN STIMULATED GENES | Genes involved in Antiviral mechanism by IFN-stimulated genes |
0.2 | 0.7 | REACTOME ACTIVATION OF GENES BY ATF4 | Genes involved in Activation of Genes by ATF4 |
0.2 | 5.1 | REACTOME GLYCEROPHOSPHOLIPID BIOSYNTHESIS | Genes involved in Glycerophospholipid biosynthesis |
0.2 | 0.7 | REACTOME DEFENSINS | Genes involved in Defensins |
0.2 | 0.2 | REACTOME TRANSPORT OF MATURE MRNA DERIVED FROM AN INTRONLESS TRANSCRIPT | Genes involved in Transport of Mature mRNA Derived from an Intronless Transcript |
0.2 | 1.8 | REACTOME PYRIMIDINE METABOLISM | Genes involved in Pyrimidine metabolism |
0.2 | 3.2 | REACTOME NOTCH1 INTRACELLULAR DOMAIN REGULATES TRANSCRIPTION | Genes involved in NOTCH1 Intracellular Domain Regulates Transcription |
0.2 | 2.9 | REACTOME RNA POL III TRANSCRIPTION INITIATION FROM TYPE 2 PROMOTER | Genes involved in RNA Polymerase III Transcription Initiation From Type 2 Promoter |
0.2 | 1.9 | REACTOME NONSENSE MEDIATED DECAY ENHANCED BY THE EXON JUNCTION COMPLEX | Genes involved in Nonsense Mediated Decay Enhanced by the Exon Junction Complex |
0.2 | 11.3 | REACTOME CLASS B 2 SECRETIN FAMILY RECEPTORS | Genes involved in Class B/2 (Secretin family receptors) |
0.2 | 3.1 | REACTOME EXTENSION OF TELOMERES | Genes involved in Extension of Telomeres |
0.2 | 0.5 | REACTOME SIGNAL TRANSDUCTION BY L1 | Genes involved in Signal transduction by L1 |
0.2 | 3.0 | REACTOME SYNTHESIS OF GLYCOSYLPHOSPHATIDYLINOSITOL GPI | Genes involved in Synthesis of glycosylphosphatidylinositol (GPI) |
0.2 | 0.2 | REACTOME CIRCADIAN REPRESSION OF EXPRESSION BY REV ERBA | Genes involved in Circadian Repression of Expression by REV-ERBA |
0.2 | 3.9 | REACTOME ENDOSOMAL SORTING COMPLEX REQUIRED FOR TRANSPORT ESCRT | Genes involved in Endosomal Sorting Complex Required For Transport (ESCRT) |
0.2 | 18.3 | REACTOME ANTIGEN PROCESSING UBIQUITINATION PROTEASOME DEGRADATION | Genes involved in Antigen processing: Ubiquitination & Proteasome degradation |
0.2 | 0.5 | REACTOME FORMATION OF RNA POL II ELONGATION COMPLEX | Genes involved in Formation of RNA Pol II elongation complex |
0.2 | 3.6 | REACTOME GLUCONEOGENESIS | Genes involved in Gluconeogenesis |
0.2 | 6.9 | REACTOME MITOCHONDRIAL PROTEIN IMPORT | Genes involved in Mitochondrial Protein Import |
0.2 | 1.7 | REACTOME PRE NOTCH TRANSCRIPTION AND TRANSLATION | Genes involved in Pre-NOTCH Transcription and Translation |
0.1 | 0.1 | REACTOME P53 INDEPENDENT G1 S DNA DAMAGE CHECKPOINT | Genes involved in p53-Independent G1/S DNA damage checkpoint |
0.1 | 0.3 | REACTOME ER PHAGOSOME PATHWAY | Genes involved in ER-Phagosome pathway |
0.1 | 2.3 | REACTOME GLUTATHIONE CONJUGATION | Genes involved in Glutathione conjugation |
0.1 | 0.1 | REACTOME PROCESSING OF CAPPED INTRON CONTAINING PRE MRNA | Genes involved in Processing of Capped Intron-Containing Pre-mRNA |
0.1 | 6.7 | REACTOME DIABETES PATHWAYS | Genes involved in Diabetes pathways |
0.1 | 0.8 | REACTOME LATE PHASE OF HIV LIFE CYCLE | Genes involved in Late Phase of HIV Life Cycle |
0.1 | 4.5 | REACTOME RESPONSE TO ELEVATED PLATELET CYTOSOLIC CA2 | Genes involved in Response to elevated platelet cytosolic Ca2+ |
0.1 | 1.1 | REACTOME TRYPTOPHAN CATABOLISM | Genes involved in Tryptophan catabolism |
0.1 | 1.9 | REACTOME INTERFERON SIGNALING | Genes involved in Interferon Signaling |
0.1 | 5.3 | REACTOME REGULATION OF MRNA STABILITY BY PROTEINS THAT BIND AU RICH ELEMENTS | Genes involved in Regulation of mRNA Stability by Proteins that Bind AU-rich Elements |
0.1 | 0.7 | REACTOME LIPOPROTEIN METABOLISM | Genes involved in Lipoprotein metabolism |
0.1 | 0.4 | REACTOME REGULATION OF SIGNALING BY CBL | Genes involved in Regulation of signaling by CBL |
0.1 | 1.2 | REACTOME METABOLISM OF NON CODING RNA | Genes involved in Metabolism of non-coding RNA |
0.1 | 0.4 | REACTOME HS GAG DEGRADATION | Genes involved in HS-GAG degradation |
0.1 | 1.7 | REACTOME KERATAN SULFATE KERATIN METABOLISM | Genes involved in Keratan sulfate/keratin metabolism |
0.1 | 4.4 | REACTOME METABOLISM OF AMINO ACIDS AND DERIVATIVES | Genes involved in Metabolism of amino acids and derivatives |
0.1 | 0.6 | REACTOME LIPID DIGESTION MOBILIZATION AND TRANSPORT | Genes involved in Lipid digestion, mobilization, and transport |
0.1 | 1.6 | REACTOME CELL SURFACE INTERACTIONS AT THE VASCULAR WALL | Genes involved in Cell surface interactions at the vascular wall |
0.1 | 0.2 | REACTOME HOMOLOGOUS RECOMBINATION REPAIR OF REPLICATION INDEPENDENT DOUBLE STRAND BREAKS | Genes involved in Homologous recombination repair of replication-independent double-strand breaks |
0.1 | 0.5 | REACTOME OPSINS | Genes involved in Opsins |
0.1 | 0.3 | REACTOME ETHANOL OXIDATION | Genes involved in Ethanol oxidation |
0.1 | 0.1 | REACTOME S PHASE | Genes involved in S Phase |
0.1 | 0.2 | REACTOME IRAK1 RECRUITS IKK COMPLEX | Genes involved in IRAK1 recruits IKK complex |
0.0 | 0.1 | REACTOME FORMATION OF TRANSCRIPTION COUPLED NER TC NER REPAIR COMPLEX | Genes involved in Formation of transcription-coupled NER (TC-NER) repair complex |
0.0 | 0.5 | REACTOME COSTIMULATION BY THE CD28 FAMILY | Genes involved in Costimulation by the CD28 family |
0.0 | 0.2 | REACTOME ACTIVATION OF BH3 ONLY PROTEINS | Genes involved in Activation of BH3-only proteins |
0.0 | 0.1 | REACTOME ANDROGEN BIOSYNTHESIS | Genes involved in Androgen biosynthesis |